ROW_ID,ROW_VERSION,CSBC PSON Center,Consortium,PubMed,Journal,Publication Year,Title,Authors,Grant,Tool link,Other Data Location,SRA URLs,dbGaP URLs,GEO URLs,Synapse Location,Keywords,Abstract,grantType,datasets,studies,tissue_or_organ,diseaseType,experimentalStrategy,featured,dataset name,study name,doi,site,institution,Theme,modifiedOn,tissue_or_organ.sv,diseaseType.sv,experimentalStrategy.sv,Theme.sv,annotated.by,study.number,grantNumber,centerName
5214,196,syn17084095,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30279173,Cancer Discov,2018,Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility,"Kaur A, Ecker BL, Douglass SM, Kugel CH, Webster MR, Almeida FV, Somasundaram R, Hayden J, Ban E, Ahmadzadeh H, Franco-Barraza J, Shah N, Mellis IA, Keeney F, Kossenkov A, Tang HY, Yin X, Liu Q, Xu X, Fane M, Brafford P, Herlyn M, Speicher DW, Wargo JA, Tetzlaff MT, Haydu LE, Raj A, Shenoy V, Cukierman E, Weeraratna AT",U01 CA227550,,,,,,,,,U01,,,Skin,Melanoma,"Liquid Chromatography/Tandem Mass Spectrometry, 3D Cell Culture, Multiphoton Microscopy",,,,,,,"tumor-immune, microenvironment, metastasis",,Skin,,,,Sage,Not Applicable,CA227550,A plasticity and reprogramming paradigm for therapy resistance at the single cell level
5046,196,syn17084062,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29161592,Dev Cell,2017,Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer,"Bajikar SS, Wang CC, Borten MA, Pereira EJ, Atkins KA, Janes KA",U01 CA215794,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85224,,,,U01,,,Breast,Carcinoma in situ of Breast,"3D Cell Culture, Murine Model, Brightfield Microscopy, Fluorescence Microscopy, Expression Array",,,,,,,metastasis,,Breast,,,,Center,Not Applicable,CA215794,An Integrated Systems Approach for Incompletely Penetrant Onco-phenotypes
5184,196,syn17084062,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29593296,Sci Rep,2018,Automated brightfield morphometry of 3D organoid populations by OrganoSeg,"Borten MA, Bajikar SS, Sasaki N, Clevers H, Janes KA",U01 CA215794,Code available in Supplemental File S1: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871765/bin/41598_2017_18815_MOESM2_ESM.doc,,,,,,,,U01,,,"Breast, Colon","Carcinoma in situ of Breast, Carcinoma in situ of Colon","Computational Tool, 3D Cell Culture",,,,,,,,,"Breast, Colon",,,,Center,Not Applicable,CA215794,An Integrated Systems Approach for Incompletely Penetrant Onco-phenotypes
4647,196,syn9771796,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29093439,Nat Commun,2018,Combating subclonal evolution of resistant cancer phenotypes,"Brady SW, McQuerry JA, Qiao Y, Piccolo SR, Shrestha G, Jenkins DF, Layer RM, Pedersen BS, Miller RH, Esch A, Selitsky SR, Parker JS, Anderson LA, Dalley BK, Factor RE, Reddy CB, Boltax JP, Li DY, Moos PJ, Gray JW, Heiser LM, Buys SS, Cohen AL, Johnson WE, Quinlan AR, Marth G, Werner TL, Bild AH",U54 CA209978,,EGAS00001002436,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP064353,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73628,,"tumor heterogeneity, clonal evolution, scRNA-Seq",,U54,,,Breast,Carcinoma in situ of Breast,"Whole Genome Sequencing, Whole Transcriptome Sequencing, Whole Exome Sequencing, Single Cell DNA-Sequencing, Single Cell RNA-Sequencing, Single Nucleotide Polymorphism Array",,,,,,,"metastasis, heterogeneity/evolution",,Breast,,,,Center,1,CA209978,Cancer Systems Biology Center of HoPE (Heterogeneity of Phenotypic Evolution)
4935,196,syn9771796,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28871446,J Mol Med (Berl),2018,Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes,"McQuerry JA, Chang JT, Bowtell DDL, Cohen A, Bild AH",U54 CA209978,,,,,,,,,U54,,,Not Applicable,Carcinoma in situ of Breast,,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,1,CA209978,Cancer Systems Biology Center of HoPE (Heterogeneity of Phenotypic Evolution)
4949,196,syn9771796,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28446242,Genome Med,2017,Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes,"Rahman M, MacNeil SM, Jenkins DF, Shrestha G, Wyatt SR, McQuerry JA, Piccolo SR, Heiser LM, Gray JW, Johnson WE, Bild AH",U54 CA209978,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP076235,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83083,,,,U54,,,Breast,Carcinoma in situ of Breast,Whole Transcriptome Sequencing,,,,,,,heterogeneity/evolution,,Breast,,,,Sage,1,CA209978,Cancer Systems Biology Center of HoPE (Heterogeneity of Phenotypic Evolution)
5022,196,syn9771796,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29769279,J Clin Microbiol,2018,Microbial Interactions in the Cystic Fibrosis Airway,"Granchelli AM, Adler FR, Keogh RH, Kartsonaki C, Cox DR, Liou TG",U54 CA209978,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,Not Applicable,CA209978,Cancer Systems Biology Center of HoPE (Heterogeneity of Phenotypic Evolution)
5040,196,syn9771796,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29894664,J Oncol Pract,2018,Managing Patients With Relapsed Small-Cell Lung Cancer,"Gong J, Salgia R",U54 CA209978,,,,,,,,,U54,,,Lung,"Lung Carcinoma, Lung Small Cell Carcinoma",Not Applicable,,,,,,,drug resistance/sensitivity,,Lung,,,,Sage,Not Applicable,CA209978,Cancer Systems Biology Center of HoPE (Heterogeneity of Phenotypic Evolution)
5047,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30232459,Nat Commun,2018,Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer,"Risom T, Langer EM, Chapman MP, Rantala J, Fields AJ, Boniface C, Alvarez MJ, Kendsersky ND, Pelz CR, Johnson-Camacho K, Dobrolecki LE, Chin K, Aswani AJ, Wang NJ, Califano A, Lewis MT, Tomlin CJ, Spellman PT, Adey A, Gray JW, Sears RC","U54 CA209997, U54 CA209988",,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,,,,,,,,heterogeneity/evolution,,Breast,,,,Center,,"CA209997, CA209988",Center for Cancer Systems Therapeutics (CaST)
4628,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28331001,Mol Cell Proteomics,2017,Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response,"Zhang X, Maity T, Kashyap MK, Bansal M, Venugopalan A, Singh S, Awasthi S, Marimuthu A, Charles Jacob HK, Belkina N, Pitts S, Cultraro CM, Gao S, Kirkali G, Biswas R, Chaerkady R, Califano A, Pandey A, Guha U",U54 CA209997,,,,,,,"lung cancer, phosphoproteomics, tyrosine kinases",,U54,,,Lung,Carcinoma in situ of Bronchus and Lung,Mass Spectrometry,,,,,,,drug resistance/sensitivity,,Lung,,,"lung cancer, phosphoproteomics, tyrosine kinases",Sage,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4637,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27932399,Cancer Res,2017,Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity,"Udyavar AR, Wooten DJ, Hoeksema M, Bansal M, Califano A, Estrada L, Schnell S, Irish JM, Massion PP, Quaranta V",U54 CA209997,,,,,,,"lung cancer, flow cytometry, computational models, networks,",,U54,,,"Lung, NOS",Carcinoma in situ of Bronchus and Lung,Mathematical Modeling,,,,,,,,,"Lung, NOS",,,"lung cancer, flow cytometry, computational models, networks,",Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4629,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28411207,Cancer Discov,2018,Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer,"Zou M, Toivanen R, Mitrofanova A, Floch N, Hayati S, Sun Y, Le Magnen C, Chester D, Mostaghel EA, Califano A, Rubin MA, Shen MM, Abate-Shen C",U54 CA209997,,,,,,,"mouse model, prostate cancer",,U54,,,Prostate Gland,Carcinoma in situ of Prostate,Not Applicable,,,,,,,,,Prostate Gland,,,"mouse model, prostate cancer",Center,3,CA209997,Center for Cancer Systems Therapeutics (CaST)
4635,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28429718,Nat Commun,2018,A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue,"Talos F, Mitrofanova A, Bergren SK, Califano A, Shen MM",U54 CA209997,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83298,syn11712131,"prostate cancer, computational modeling",,U54,,,Prostate Gland,Carcinoma in situ of Prostate,,,,,,,,,,Prostate Gland,,,"prostate cancer, computational modeling",Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
5001,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29662057,Nat Commun,2018,Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm,"Ding H, Douglass EF Jr, Sonabend AM, Mela A, Bose S, Gonzalez C, Canoll PD, Sims PA, Alvarez MJ, Califano A",U54 CA209997,,,,,,,,,U54,"syn11958459,syn11678365",syn11678364,,Glioblastoma,Mathematical Modeling,,"GSE95157,Glioblastoma Data",scRNA-seq,,,,heterogeneity/evolution,,,,,,Center,2,CA209997,Center for Cancer Systems Therapeutics (CaST)
5023,196,syn7315802,"PS-ON, CSBC",https://www.ncbi.nlm.nih.gov/pubmed/?term=30041684,Genome Med,2018,Single-cell transcriptome analysis of lineage diversity in high-grade glioma,"Yuan J, Levitin HM, Frattini V, Bush EC, Boyett DM, Samanamud J, Ceccarelli M, Dovas A, Zanazzi G, Canoll P, Bruce JN, Lasorella A, Iavarone A, Sims PA","U54 CA209997, U54 CA193313",,,,,,,,,U54,,,Brain,Glioma,Single Cell Sequencing,,,,,,,heterogeneity/evolution,,Brain,,,,Sage,2,"CA209997, CA193313",Center for Cancer Systems Therapeutics (CaST)
4633,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28174276,Proc Natl Acad Sci U S A,2018,Synergistic antileukemic therapies in NOTCH1-induced T-ALL,"Sanchez-Martin M, Ambesi-Impiombato A, Qin Y, Herranz D, Bansal M, Girardi T, Paietta E, Tallman MS, Rowe JM, De Keersmaecker K, Califano A, Ferrando AA",U54 CA209997,,,,,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78189 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78188 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78187 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71089 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71087 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5827",syn11958286,"ALL, networks, drug sensitivity",,U54,,,Blood,"Leukemia, Unspecified",Mathematical Modeling,,,,,,,,,Blood,,,"ALL, networks, drug sensitivity",Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4914,196,syn7315802,"PS-ON, CSBC",https://www.ncbi.nlm.nih.gov/pubmed/?term=29342136,Nature,2018,Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia,"Tzoneva G, Dieck CL, Oshima K, Ambesi-Impiombato A, Snchez-Martn M, Madubata CJ, Khiabanian H, Yu J, Waanders E, Iacobucci I, Sulis ML, Kato M, Koh K, Paganin M, Basso G, Gastier-Foster JM, Loh ML, Kirschner-Schwabe R, Mullighan CG, Rabadan R, Ferrando AA","U54 CA209997, U54 CA193313",,,,,,,,,U54,,,Blood,"Leukemia, Unspecified",Not Applicable,,,,,,,,,Blood,,,,Center,2,"CA209997, CA193313",Center for Cancer Systems Therapeutics (CaST)
4922,196,syn7315802,"PS-ON, CSBC",https://www.ncbi.nlm.nih.gov/pubmed/?term=28924243,Leukemia,2019,Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile,"Giudice ID, Rigolin GM, Raponi S, Cafforio L, Ilari C, Wang J, Bordyuh M, Piciocchi A, Marinelli M, Nanni M, Tavolaro S, Filetti M, Bardi A, Tammiso E, Volta E, Negrini M, Saccenti E, Mauro FR, Rossi D, Gaidano G, Guarini A, Rabadan R, Cuneo A, Fo R","U54 CA209997, U54 CA193313",,,,,,,,,U54,,,Blood,"Leukemia, Unspecified",Not Applicable,,,,,,,,,Blood,,,,Center,2,"CA209997, CA193313",Center for Cancer Systems Therapeutics (CaST)
4977,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29684207,Nucleic Acids Res,2019,The number of titrated microRNA species dictates ceRNA regulation,"Chiu HS, Martnez MR, Komissarova EV, Llobet-Navas D, Bansal M, Paull EO, Silva J, Yang X, Sumazin P, Califano A",U54 CA209997,,,,,,,,,U54,,,Pancreas,Malignant Neoplasm of Pancreas,Mathematical Modeling,,,,,,,,,Pancreas,,,,Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4630,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28282273,J Oncol Pract,2018,Fanning the Flames of Cancer Chemoresistance: Inflammation and Anticancer Therapy,Olive KP,U54 CA209997,,,,,,,inflammation,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,inflammation,Center,1,CA209997,Center for Cancer Systems Therapeutics (CaST)
4632,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28740083,Nat Commun,2017,PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens,"Bush EC, Ray F, Alvarez MJ, Realubit R, Li H, Karan C, Califano A, Sims PA",U54 CA209997,,,,,,,"RNA-Seq, technology development",,U54,,,Not Applicable,Not Applicable,PlateSeq,,,,,,,,,Not Applicable,,,,Center,2,CA209997,Center for Cancer Systems Therapeutics (CaST)
4636,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27977008,Nat Rev Cancer,2017,"The recurrent architecture of tumour initiation, progression and drug sensitivity","Califano A, Alvarez MJ",U54 CA209997,,,,,,,regulatory network,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,regulatory network,Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4964,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29579153,Bioinformatics,2018,iterClust: a statistical framework for iterative clustering analysis,"Ding H, Wang W, Califano A",U54 CA209997,,,,,,,,,U54,,,Not Applicable,Not Applicable,,,,,,,,,,Not Applicable,,,,Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4972,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29510988,Cancer Discov,2018,Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma,"Rajbhandari P, Lopez G, Capdevila C, Salvatori B, Yu J, Rodriguez-Barrueco R, Martinez D, Yarmarkovich M, Weichert-Leahey N, Abraham BJ, Alvarez MJ, Iyer A, Harenza JL, Oldridge D, De Preter K, Koster J, Asgharzadeh S, Seeger RC, Wei JS, Khan J, Vandesompele J, Mestdagh P, Versteeg R, Look AT, Young RA, Iavarone A, Lasorella A, Silva JM, Maris JM, Califano A",U54 CA209997,,,,,,,,,U54,,,Nervous system,Not Applicable,Mathematical Modeling; Unspecified,,,,,,,,,Nervous system,,,,Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4987,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28950860,BMC Syst Biol,2018,Accelerated parallel algorithm for gene network reverse engineering,"He J, Zhou Z, Reed M, Califano A",U54 CA209997,,,,,,,,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4634,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27999735,Oncoimmunology,2018,Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases,"Koalolu Z, Zrnig I, Halama N, Kaiser I, Buchhalter I, Grabe N, Eils R, Schlesner M, Califano A, Jger D",U54 CA209997,,,,,,,"immunology, neuroendocrine tumors, microenvironment, neo-epitopes, neoantigens",,U54,,,Colon,Rectal Adenocarcinoma,,,,,,,,microenvironment,,Colon,,,,Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4626,196,syn7315802,"PS-ON, CSBC",https://www.ncbi.nlm.nih.gov/pubmed/?term=27670648,Sci Rep,2016,An Automated Microwell Platform for Large-Scale Single Cell RNA-Seq,"Yuan J, Sims PA","U54 CA209997, U54 CA193313",,"https://www.ncbi.nlm.nih.gov/sra/SRX2019091[accn], https://www.ncbi.nlm.nih.gov/sra/SRX2019092[accn]",,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85575,,,,U54,,,Brain,Glioma,Single Cell Sequencing,,,,,,,Not Applicable,,Brain,,,,Sage,2,"CA209997, CA193313",Center for Cancer Systems Therapeutics (CaST)
4627,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26178156,Protein Sci,2016,A hybrid method for protein-protein interface prediction,"Hwang H, Petrey D, Honig B",U54 CA209997,,,,,,,protein-protein interaction,,U54,,,Not Applicable,Not Applicable,Computational Tool,,,,,,,Not Applicable,,Not Applicable,,,protein-protein interaction,Sage,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4631,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27936040,PLoS One,2016,A High-Throughput Strategy for Dissecting Mammalian Genetic Interactions,"Stockman VB, Ghamsari L, Lasso G, Honig B, Shapira SD, Wang HH",U54 CA209997,,,,,,,genetic interactions,,U54,,,Kidney,Not Applicable,CRISPR,,,,,,,drug resistance/sensitivity,,Kidney,,,genetic interactions,Sage,1,CA209997,Center for Cancer Systems Therapeutics (CaST)
4638,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29040720,Nucleic Acids Res,2017,Genome-wide prediction of minor-groove electrostatic potential enables biophysical modeling of protein-DNA binding,"Chiu TP, Rao S, Mann RS, Honig B, Rohs R",U54 CA209997,,,,,,,"protein-DNA interactions, computational biology",,U54,,,Not Applicable,Not Applicable,"Mathematical Modeling, Computational Tool",,,,,,,Not Applicable,,Not Applicable,,,"protein-DNA interactions, computational biology",Sage,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4639,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28558729,BMC Genomics,2018,High-throughput validation of ceRNA regulatory networks,"Chiu HS, Martnez MR, Bansal M, Subramanian A, Golub TR, Yang X, Sumazin P, Califano A",U54 CA209997,,,,,,,,,U54,,,"Breast, Prostate","Carcinoma in situ of Breast, Carcinoma in situ of Prostate","High Throughput Screening, Computational Tool",,,,,,,Not Applicable,,"Breast, Prostate",,,,Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4951,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29628290,Immunity,2019,The Immune Landscape of Cancer,"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CE, Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich L",U54 CA209997,,,,,,,,,U54,,,,,,,,,,,,tumor-immune,,,,,,Center,1,CA209997,Center for Cancer Systems Therapeutics (CaST)
4975,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29023443,PLoS Comput Biol,2017,"Systematic, network-based characterization of therapeutic target inhibitors","Shen Y, Alvarez MJ, Bisikirska B, Lachmann A, Realubit R, Pampou S, Coku J, Karan C, Califano A",U54 CA209997,,,,,,,,,U54,,,,,Unspecified,,,,,,,,,,,,,Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
5006,196,syn7315802,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29625070,Cell Stem Cell,2019,A CLK3-HMGA2 Alternative Splicing Axis Impacts Human Hematopoietic Stem Cell Molecular Identity throughout Development,"Cesana M, Guo MH, Cacchiarelli D, Wahlster L, Barragan J, Doulatov S, Vo LT, Salvatori B, Trapnell C, Clement K, Cahan P, Tsanov KM, Sousa PM, Tazon-Vega B, Bolondi A, Giorgi FM, Califano A, Rinn JL, Meissner A, Hirschhorn JN, Daley GQ",U54 CA209997,,,,,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112486 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109093 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109092 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109091 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109090 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109089",,,,U54,,,Blood,,,,,,,,,,,Blood,,,,Center,,CA209997,Center for Cancer Systems Therapeutics (CaST)
4572,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28297639,Biophys J,2017,Enhanced Directional Migration of Cancer Stem Cells in 3D Aligned Collagen Matrices,"Ray A, Slama ZM, Morford RK, Madden SA, Provenzano PP",U54 CA210190,,,,,,,"breast carcinoma, migration, cell morphology, imaging",,U54,,,Breast,Carcinoma in situ of Breast,Imaging,,,,,,,"metastasis, microenvironment",,Breast,,,"breast carcinoma, migration, cell morphology, imaging",Center,2,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4578,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28381423,Mol Biol Cell,2017,Integrin-mediated traction force enhances paxillin molecular associations and adhesion dynamics that increase the invasiveness of tumor cells into a three-dimensional extracellular matrix,"Mekhdjian AH, Kai F, Rubashkin MG, Prahl LS, Przybyla LM, McGregor AL, Bell ES, Barnes JM, DuFort CC, Ou G, Chang AC, Cassereau L, Tan SJ, Pickup MW, Lakins JN, Ye X, Davidson MW, Lammerding J, Odde DJ, Dunn AR, Weaver VM","U54 CA210184, U54 CA210190",,,,,,,"imaging, microscopy, traction force microscopy, atomic force microscopy, migration, metastasis, breast cancer, proteomics, immunofluourescence, mathematical modeling",,U54,,,Breast,Carcinoma in situ of Breast,Atomic Force Microscopy; Fluorescent Antibody Procedure; Microfluidics; Cell Migration Assay; Traction Force Microscopy; Mathematical Modeling; Microscopy,,,,,,,"metastasis, microenvironment",,Breast,,,"imaging, microscopy, traction force microscopy, atomic force microscopy, migration, metastasis, breast cancer, proteomics, immunofluourescence, mathematical modeling",Center,1,"CA210184, CA210190",Center for Modeling Tumor Cell Migration Mechanics
4925,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29340409,Integr Biol (Camb),2018,Dynamics of 3D carcinoma cell invasion into aligned collagen,"Ray A , Morford RK , Ghaderi N , Odde DJ , Provenzano PP ",U54 CA210190,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Cell Migration Assay; Mathematical Modeling; Tissue Engineering; Multiphoton Microscopy,,,,,,,metastasis,,Breast,,,,Center,2,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4947,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29623978,Integr Biol (Camb),2019,In vitro elucidation of the role of pericellular matrix in metastatic extravasation and invasion of breast carcinoma cells,"Brett ME , Bomberger HE , Doak GR , Price MA , McCarthy JB , Wood DK ",U54 CA210190,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Fluorescent Antibody Procedure; Microfluidics; Flow Cytometry,,,,,,,metastasis,,Breast,,,,Center,2,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4573,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28052252,Cell Rep,2017,Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level,"Klank RL, Decker Grunke SA, Bangasser BL, Forster CL, Price MA, Odde TJ, SantaCruz KS, Rosenfeld SS, Canoll P, Turley EA, McCarthy JB, Ohlfest JR, Odde DJ",U54 CA210190,,,,,,,"glioma, migration, mathematical modeling, biophysical simulation",,U54,,,Brain,Glioblastoma,Immunohistochemistry Staining Method; Western Blotting; Bioluminescence Imaging; Mathematical Modeling; Murine Model,,,,,,,metastasis,,Brain,,,"glioma, migration, mathematical modeling, biophysical simulation",Center,1,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4575,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29150767,Ann Biomed Eng,2019,Cell Migration in 1D and 2D Nanofiber Microenvironments,"Estabridis HM, Jana A, Nain A, Odde DJ",U54 CA210190,,,,,,,"imaging, migration, glioblastoma, mathematical modeling, biophysical simulation",,U54,,,Brain,Glioblastoma,Mathematical Modeling,,,,,,,Not Applicable,,Brain,,,,Center,1,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4576,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28530245,Nat Commun,2018,Shifting the optimal stiffness for cell migration,"Bangasser BL, Shamsan GA, Chan CE, Opoku KN, Tzel E, Schlichtmann BW, Kasim JA, Fuller BJ, McCullough BR, Rosenfeld SS, Odde DJ",U54 CA210190,http://oddelab.umn.edu/code/cms%20v1.0.zip,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE95680,,"migration, mathematical modeling, biophysical simulation, glioma, imaging",,U54,,,Brain,Glioblastoma,Cell Migration Assay; Imaging; Traction Force Microscopy; Fluorescent Antibody Procedure; Mathematical Modeling,,,,,,,Not Applicable,,Brain,,,"migration, mathematical modeling, biophysical simulation, glioma, imaging",Center,1,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4574,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28401884,Nat Commun,2017,Anisotropic forces from spatially constrained focal adhesions mediate contact guidance directed cell migration,"Ray A, Lee O, Win Z, Edwards RM, Alford PW, Kim DH, Provenzano PP",U54 CA210190,,,,,,,"carcinoma, imaging, cell morphology, migration",,U54,,,Pancreas; Breast,"Malignant Neoplasm of Pancreas, Carcinoma in situ of Breast",Western Blotting; Cell Migration Assay; Imaging; Fluorescent Antibody Procedure; Multiphoton Microscopy; Nanopatterning,,,,,,,metastasis,,Pancreas; Breast,,,"carcinoma, imaging, cell morphology, migration",Center,2,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4577,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29188660,J Biomed Opt,2018,Multiphoton fluorescence lifetime imaging of chemotherapy distribution in solid tumors,"Carlson M, Watson AL, Anderson L, Largaespada DA, Provenzano PP",U54 CA210190,,,,,,,"cancer, fluorescence lifetime imaging microscopy, multiphoton microscopy, doxorubicin",,U54,,,Pancreas,Malignant Neoplasm of Pancreas,Multiphoton Microscopy; FLIM; Murine Model,,,,,,,drug resistance/sensitivity,,Pancreas,,,"cancer, fluorescence lifetime imaging microscopy, multiphoton microscopy, doxorubicin",Center,2,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4904,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28983745,Ann Biomed Eng,2019,Physical and Chemical Enhancement of and Adaptive Resistance to Irreversible Electroporation of Pancreatic Cancer,"Shao Q, Liu F, Chung C, Elahi-Gedwillo K, Provenzano PP, Forsyth B, Bischof JC",U54 CA210190,,,,,,,"adaptation, cancer treatment, enhancement, glucose, in vitro, in vivo, irreversible electroporation, pancreatic cancer, resistance",,U54,,,Pancreas,Malignant Neoplasm of Pancreas,Unspecified,,,,,,,drug resistance/sensitivity,,Pancreas,,,"adaptation, cancer treatment, enhancement, glucose, in vitro, in vivo, irreversible electroporation, pancreatic cancer, resistance",Center,2,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4570,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27966608,Sci Rep,2018,Slit-Robo GTPase-Activating Protein 2 as a metastasis suppressor in osteosarcoma,"Marko TA, Shamsan GA, Edwards EN, Hazelton PE, Rathe SK, Cornax I, Overn PR, Varshney J, Diessner BJ, Moriarity BS, O'Sullivan MG, Odde DJ, Largaespada DA",U54 CA210190,,,,,,,"osteosarcoma, Srgap2, Sleeping Beauty, CRISPR/Cas9, RNA-seq, IHC",,U54,,,"Bone, NOS",Osteosarcoma,Immunohistochemistry Staining Method; Polymerase Chain Reaction; Real Time PCR; Western Blotting; Cell Migration Assay,,,,,,,metastasis,,"Bone, NOS",,,,Center,1,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4571,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28494945,Biophys J,2018,Tug of War at the Cell-Matrix Interface,Provenzano PP,U54 CA210190,,,,,,,comment,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,microenvironment,,Not Applicable,,,comment,Center,2,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4906,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29480329,J Math Biol,2018,Getting in shape and swimming: the role of cortical forces and membrane heterogeneity in eukaryotic cells,"Wu H, de Len MAP, Othmer HG",U54 CA210190,,,,,,,,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,microenvironment,,Not Applicable,,,,Center,1,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4998,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29528224,Biochemistry,2018,In Silico Design and in Vitro Characterization of Universal Tyrosine Kinase Peptide Substrates,"Marholz LJ, Zeringo NA, Lou HJ, Turk BE, Parker LL",U54 CA210190,,,,,,,,,U54,,,Not Applicable,Not Applicable,Proteomics Assay,,,,,,,Not Applicable,,Not Applicable,,,,Center,Not Applicable,CA210190,Center for Modeling Tumor Cell Migration Mechanics
5003,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29860988,Trends Cancer,2019,Distant Relations: Macrophage Functions in the Metastatic Niche,"Doak GR, Schwertfeger KL, Wood DK",U54 CA210190,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,metastasis,,Not Applicable,,,,Center,Not Applicable,CA210190,Center for Modeling Tumor Cell Migration Mechanics
5045,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29927064,Curr Protoc Stem Cell Biol,2018,Cancer Stem Cell Migration in Three-Dimensional Aligned Collagen Matrices,"Ray A, Morford RK, Provenzano PP",U54 CA210190,,,,,,,,,U54,,,Not Applicable,Not Applicable,Cell Migration Assay; Tissue Engineering; Multiphoton Microscopy,,,,,,,metastasis,,Not Applicable,,,,Center,2,CA210190,Center for Modeling Tumor Cell Migration Mechanics
5107,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30459308,Nat Commun,2018,Bimodal sensing of guidance cues in mechanically distinct microenvironments,"Tabdanov ED, Puram VV, Win Z, Alamgir A, Alford PW, Provenzano PP",U54 CA210190,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Imaging; Traction Force Microscopy; Nanopatterning; Microscopy,,,,,,,microenvironment,,Breast,,,,Center,2,CA210190,Center for Modeling Tumor Cell Migration Mechanics
5179,196,syn7349745,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30304674,Cell Rep,2018,Microtubule-Actomyosin Mechanical Cooperation during Contact Guidance Sensing,"Tabdanov ED, Puram V, Zhovmer A, Provenzano PP",U54 CA210190,,,,,,,,,U54,,,Pancreas; Breast,"Malignant Neoplasm of Pancreas, Carcinoma in situ of Breast",Imaging; Traction Force Microscopy; Nanopatterning; Microscopy,,,,,,,metastasis,,Pancreas; Breast,,,,Center,2,CA210190,Center for Modeling Tumor Cell Migration Mechanics
4988,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29569971,Leuk Lymphoma,2018,Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells,"MacDonald RJ, Bunaciu RP, Ip V, Dai D, Tran D, Varner JD, Yen A",U54 CA210184,,,,,,,,,U54,,,Blood,Acute Promyelolitic Leukemia,Expression Array,,,,,,,drug resistance/sensitivity,,Blood,,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
4579,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29342134,Nature,2018,Chromosomal instability drives metastasis through a cytosolic DNA response,"Bakhoum SF, Ngo B, Laughney AM, Cavallo JA, Murphy CJ, Ly P, Shah P, Sriram RK, Watkins TBK, Taunk NK, Duran M, Pauli C, Shaw C, Chadalavada K, Rajasekhar VK, Genovese G, Venkatesan S, Birkbak NJ, McGranahan N, Lundquist M, LaPlant Q, Healey JH, Elemento O, Chung CH, Lee NY, Imielenski M, Nanjangud G, Pe'er D, Cleveland DW, Powell SN, Lammerding J, Swanton C, Cantley LC",U54 CA210184,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP105199,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE98183,,"chromosomal instability, micronuclei, metastasis, FISH, immunofluorescence microscopy, imaging, migration, xenograft, RNA-seq, scRNA-seq",,U54,,,Breast,Carcinoma in situ of Breast,Fluorescent Antibody Procedure; Immunohistochemistry Staining Method; Real Time PCR; Western Blotting; Whole Transcriptome Sequencing; Single Cell RNA-Sequencing,,,,,,,metastasis,,Breast,,,"chromosomal instability, micronuclei, metastasis, FISH, immunofluorescence microscopy, imaging, migration, xenograft, RNA-seq, scRNA-seq",Center,3,CA210184,Center on the Physics of Cancer Metabolism
4580,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27913195,Matrix Biol,2017,Breast cancer-derived extracellular vesicles stimulate myofibroblast differentiation and pro-angiogenic behavior of adipose stem cells,"Song YH, Warncke C, Choi SJ, Choi S, Chiou AE, Ling L, Liu HY, Daniel S, Antonyak MA, Cerione RA, Fischbach C",U54 CA210184,,,,,,,"breast cancer, differentiation, angiogenesis, scanning electron microscopy",,U54,,,Breast,Carcinoma in situ of Breast,Fluorescent Antibody Procedure; Electron Microscopy,,,,,,,microenvironment,,Breast,,,"breast cancer, differentiation, angiogenesis, scanning electron microscopy",Sage,2,CA210184,Center on the Physics of Cancer Metabolism
4584,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28270386,Cancer Prev Res (Phila),2017,"Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index","Iyengar NM, Brown KA, Zhou XK, Gucalp A, Subbaramaiah K, Giri DD, Zahid H, Bhardwaj P, Wendel NK, Falcone DJ, Wang H, Williams S, Pollak M, Morrow M, Hudis CA, Dannenberg AJ",U54 CA210184,,,,,,,"breast cancer, correlative study",,U54,,,Breast,Carcinoma in situ of Breast,Fluorescent Antibody Procedure; Immunohistochemistry Staining Method; Real Time PCR; Western Blotting,,,,,,,Not Applicable,,Breast,,,"breast cancer, correlative study",Center,1,CA210184,Center on the Physics of Cancer Metabolism
4585,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29222346,Cancer Prev Res (Phila),2019,"Adiposity, Inflammation and Breast Cancer Pathogenesis in Asian Women","Iyengar NM, Chen IC, Zhou XK, Giri DD, Falcone DJ, Winston LA, Wang H, Williams S, Lu YS, Hsueh TH, Cheng AL, Hudis CA, Lin CH, Dannenberg AJ",U54 CA210184,,,,,,,"obesity, white adipose tissue, breast cancer, clinical study",,U54,,,Breast,Carcinoma in situ of Breast,Immunohistochemistry Staining Method,,,,,,,Not Applicable,,Breast,,,,Center,1,CA210184,Center on the Physics of Cancer Metabolism
4588,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29203461,Cancer Discov,2019,Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple Negative Breast Cancer,"Liu H, Murphy CJ, Karreth FA, Emdal KB, White FM, Elemento O, Toker A, Wulf GM, Cantley LC",U54 CA210184,,,,,,,breast cancer,,U54,,,Breast,Carcinoma in situ of Breast,Murine Model; Whole Transcriptome Sequencing; Whole Exome Sequencing,,,,,,,drug resistance/sensitivity,,Breast,,,breast cancer,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4590,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28323914,J Clin Endocrinol Metab,2017,"Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers","Brown KA, Iyengar NM, Zhou XK, Gucalp A, Subbaramaiah K, Wang H, Giri DD, Morrow M, Falcone DJ, Wendel NK, Winston LA, Pollak M, Dierickx A, Hudis CA, Dannenberg AJ",U54 CA210184,,,,,,,"clinical study, metabolism",,U54,,,Breast,Carcinoma in situ of Breast,Immunohistochemistry Staining Method; Real Time PCR,,,,,,,Not Applicable,,Breast,,,"clinical study, metabolism",Center,1,CA210184,Center on the Physics of Cancer Metabolism
4594,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29104286,Int J Obes (Lond),2019,Leptin regulation of the p53-HIF1/PKM2-aromatase axis in breast adipose stromal cells-a novel mechanism for the obesity-breast cancer link,"Zahid H, Subbaramaiah K, Iyengar NM, Zhou XK, Chen IC, Bhardwaj P, Gucalp A, Morrow M, Hudis CA, Dannenberg AJ, Brown KA",U54 CA210184,,,,,,,breast cancer,,U54,,,Breast,Carcinoma in situ of Breast,Fluorescent Antibody Procedure; Real Time PCR; Western Blotting,,,,,,,Not Applicable,,Breast,,,breast cancer,Center,1,CA210184,Center on the Physics of Cancer Metabolism
4596,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28285738,Trends Cell Biol,2018,Bursting the Bubble - Nuclear Envelope Rupture as a Path to Genomic Instability?,"Shah P, Wolf K, Lammerding J",U54 CA210184,,,,,,,review,,U54,,,Not Applicable,Carcinoma in situ of Breast,,,,,,,,Not Applicable,,Not Applicable,,,review,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4942,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29221896,J Struct Biol,2018,Correlative imaging reveals physiochemical heterogeneity of microcalcifications in human breast carcinomas,"Kunitake JAMR, Choi S, Nguyen KX, Lee MM, He F, Sudilovsky D, Morris PG, Jochelson MS, Hudis CA, Muller DA, Fratzl P, Fischbach C, Masic A, Estroff LA",U54 CA210184,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Imaging,,,,,,,Not Applicable,,Breast,,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
4983,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27503584,Matrix Biol,2017,Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions,"Wang K, Wu F, Seo BR, Fischbach C, Chen W, Hsu L, Gourdon D",U54 CA210184,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Time Lapse Microscopy,,,,,,,microenvironment,,Breast,,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
4992,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29759731,Biomaterials,2018,"Intrafibrillar, bone-mimetic collagen mineralization regulates breast cancer cell adhesion and migration","Choi S, Friedrichs J, Song YH, Werner C, Estroff LA, Fischbach C",U54 CA210184,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,3D Cell Culture,,,,,,,microenvironment,,Breast,,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
5015,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30051890,Nature,2019,Suppression of insulin feedback enhances the efficacy of PI3K inhibitors,"Hopkins BD, Pauli C, Xing D, Wang DG, Li X, Wu D, Amadiume SC, Goncalves MD, Hodakoski C, Lundquist MR, Bareja R, Ma Y, Harris EM, Sboner A, Beltran H, Rubin MA, Mukherjee S, Cantley LC",U54 CA210184,,,,,,,,,U54,,,Pancreas,Carcinoma in situ of Breast,Murine Model,,,,,,,drug resistance/sensitivity,,Pancreas,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
5108,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29997220,Dis Model Mech,2018,Intravital microscopy of collective invasion plasticity in breast cancer,"Ilina O, Campanello L, Gritsenko PG, Vullings M, Wang C, Bult P, Losert W, Friedl P",U54 CA210184,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Intravital Microscopy,,,,,,,metastasis,,Breast,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
5130,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30193109,Cell,2018,The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment,"Bakhoum SF, Cantley LC",U54 CA210184,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Fluorescent Antibody Procedure; Immunohistochemistry Staining Method; Real Time PCR; Western Blotting,,,,,,,Not Applicable,,Breast,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
5010,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29921838,Nat Commun,2018,Patient derived organoids to model rare prostate cancer phenotypes,"Puca L, Bareja R, Prandi D, Shaw R, Benelli M, Karthaus WR, Hess J, Sigouros M, Donoghue A, Kossai M, Gao D, Cyrta J, Sailer V, Vosoughi A, Pauli C, Churakova Y, Cheung C, Deonarine LD, McNary TJ, Rosati R, Tagawa ST, Nanus DM, Mosquera JM, Sawyers CL, Chen Y, Inghirami G, Rao RA, Grandori C, Elemento O, Sboner A, Demichelis F, Rubin MA, Beltran H",U54 CA210184,,,"https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP137894, https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP137893, https://www.ncbi.nlm.nih.gov/sra/SRP138000",,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112830 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112829 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112786",,,,U54,,,Prostate Gland,Carcinoma in situ of Prostate,"3D Cell Culture, PDX, Whole Exome Sequencing, Whole Transcriptome Sequencing, Bisulfite Sequencing, High-throughput Drug Screen",,,,,,,drug resistance/sensitivity,,Prostate Gland,,,,Center,Not Applicable,CA210184,Center on the Physics of Cancer Metabolism
4981,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29450424,Integr Biol (Camb),2018,CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling,"Loureno BN, Springer NL, Ferreira D, Oliveira C, Granja PL, Fischbach C",U54 CA210184,,,,,,,,,U54,,,Stomach,Gastric Adenocarcinoma,Murine Model,,,,,,,Not Applicable,,Stomach,,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
4595,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27820599,Nat Cell Biol,2016,Tissue mechanics promote IDH1-dependent HIF1-tenascin C feedback to regulate glioblastomaaggression,"Miroshnikova YA, Mouw JK, Barnes JM, Pickup MW, Lakins JN, Kim Y, Lobo K, Persson AI, Reis GF, McKnight TR, Holland EC, Phillips JJ, Weaver VM",U54 CA210184,,,,,,,"glioblastoma, IDH1, HIF1alpha, extracellular matrix (ECM), stiffness, mechanosignalling, atomic force microscopy, nanostring, ChIP, imaging",,U54,,,Brain,Glioma,"Murine Model, Atomic Force Microscopy",,,,,,,microenvironment,,Brain,,,"glioblastoma, IDH1, HIF1alpha, extracellular matrix (ECM), stiffness, mechanosignalling, atomic force microscopy, nanostring, ChIP, imaging",Sage,1,CA210184,Center on the Physics of Cancer Metabolism
4592,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27914000,Cancer Metastasis Rev,2016,From transformation to metastasis: deconstructing the extracellular matrix in breast cancer,"Kaushik S, Pickup MW, Weaver VM",U54 CA210184,,,,,,,"breast cancer, desmoplasia, extracellular matrix (ECM), mechanosignaling, metastasis, treatment resistance, review",,U54,,,Breast,Intraductal carcinoma in situ of Breast,Not Applicable,,,,,,,metastasis,,Breast,,,"breast cancer, desmoplasia, extracellular matrix (ECM), mechanosignaling, metastasis, treatment resistance, review",Sage,1,CA210184,Center on the Physics of Cancer Metabolism
4583,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28923958,Proc Natl Acad Sci U S A,2017,Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis,"He F, Chiou AE, Loh HC, Lynch M, Seo BR, Song YH, Lee MJ, Hoerth R, Bortel EL, Willie BM, Duda GN, Estroff LA, Masic A, Wagermaier W, Fratzl P, Fischbach C",U54 CA210184,,,,,,,"breast cancer, metastasis, X-ray scattering, Raman imaging, backscattered electron microscopy, tomography, bone metastasis, bone mineral nanostructure",,U54,,,"Breast, Bone","Intraductal carcinoma in situ of Breast, Bone Tumor","Small-Angle X-ray Scattering, Murine Model",,,,,,,metastasis,,"Breast, Bone",,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
4973,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29483153,Genes Dev,2018,Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers,"Takai K, Drain AP, Lawson DA, Littlepage LE, Karpuj M, Kessenbrock K, Le A, Inoue K, Weaver VM, Werb Z",U54 CA210184,,,,,,,,,U54,,,"Breast, Lung","Intraductal carcinoma in situ of Breast, Lung Carcinoma","Atomic Force Microscopy, Traction Force Microscopy, 3D Cell Culture, Murine Model",,,,,,,metastasis,,"Breast, Lung",,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
5103,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29991514,J Cell Sci,2018,Adaptive adhesion systems mediate glioma cell invasion in complex environments,"Gritsenko PG, Friedl P",U54 CA210184,,,,,,,,,U54,,,Brain,Malignant Neoplasm of Brain,3D Cell Culture; Microscopy; Mass Spectrometry,,,,,,,Not Applicable,,Brain,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4586,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29467443,Nat Cell Biol,2019,Emerging views of the nucleus as a cellular mechanosensor,"Kirby TJ, Lammerding J",U54 CA210184,,,,,,,review,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,microenvironment,,Not Applicable,,,review,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4587,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28287898,Nucleus,2018,Consequences of a tight squeeze: Nuclear envelope rupture and repair,"Isermann P, Lammerding J",U54 CA210184,,,,,,,DNA damage,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4589,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27697927,J Cell Biol,2017,Nuclear envelope rupture: Actin fibers are putting the squeeze on the nucleus,"Lammerding J, Wolf K",U54 CA210184,,,,,,,"spotlight, nuclear envelope, rupture",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4591,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27876751,Nat Mater,2018,Cell mechanotransduction: Stretch to express,"Kirby TJ, Lammerding J",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4929,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29269951,Nat Cell Biol,2018,Mechanoreciprocity in cell migration,"van Helvert S, Storm C, Friedl P",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Microscopy,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4930,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29311302,Proc Natl Acad Sci U S A,2018,Fenofibrate prevents skeletal muscle loss in mice with lung cancer,"Goncalves MD, Hwang SK, Pauli C, Murphy CJ, Cheng Z, Hopkins BD, Wu D, Loughran RM, Emerling BM, Zhang G, Fearon DT, Cantley LC",U54 CA210184,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP125804,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE107470,,,,U54,,,"Lung, NOS",Lung Non-Small Cell Carcinoma,"Liquid Chromatography Mass Spectrometry, Whole Transcriptome Sequencing",,,,,,,Not Applicable,,"Lung, NOS",,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4944,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28802037,Cell,2017,The PI3K Pathway in Human Disease,"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4946,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29606313,Trends Cancer,2019,Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance,"Singh A, Brito I, Lammerding J",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,"drug resistance/sensitivity, microenvironment",,Not Applicable,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4954,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29541636,Front Cell Dev Biol,2018,Feeling Stress: The Mechanics of Cancer Progression and Aggression,"Northcott JM, Dean IS, Mouw JK, Weaver VM",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,microenvironment,,Not Applicable,,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
4958,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29601096,J Leukoc Biol,2019,Elevated nuclear lamin A is permissive for granulocyte transendothelial migration but not for motility through collagen I barriers,"Yadav SK, Feigelson SW, Roncato F, Antman-Passig M, Shefi O, Lammerding J, Alon R",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4978,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29794058,Sci Transl Med,2018,Cancer metabolism gets physical,"DelNero P, Hopkins BD, Cantley LC, Fischbach C",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,"microenvironment, drug resistance/sensitivity",,Not Applicable,,,,Center,1,CA210184,Center on the Physics of Cancer Metabolism
4982,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29727621,Mol Cell,2019,Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy,"Lundquist MR, Goncalves MD, Loughran RM, Possik E, Vijayaraghavan T, Yang A, Pauli C, Ravi A, Verma A, Yang Z, Johnson JL, Wong JCY, Ma Y, Hwang KS, Weinkove D, Divecha N, Asara JM, Elemento O, Rubin MA, Kimmelman AC, Pause A, Cantley LC, Emerling BM",U54 CA210184,,,,,,,,,U54,,,Liver,Not Applicable,Murine Model,,,,,,,Not Applicable,,Liver,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4984,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29649271,PLoS One,2018,Automated analysis of cell migration and nuclear envelope rupture in confined environments,"Elacqua JJ, McGregor AL, Lammerding J",U54 CA210184,https://github.com/Lammerding/MATLAB-CellTracking,,,,,,,,U54,,,Not Applicable,Not Applicable,Computational Tool,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4985,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29038232,Cancer Discov,2017,Tissue Force Programs Cell Fate and Tumor Aggression,"Northey JJ, Przybyla L, Weaver VM",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,microenvironment,,Not Applicable,,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
5004,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27147047,Methods Mol Biol,2017,Cell Microharpooning to Study Nucleo-Cytoskeletal Coupling,"Fedorchak G, Lammerding J",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Time Lapse Microscopy,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA210184,Center on the Physics of Cancer Metabolism
4581,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28877984,Mol Biol Cell,2017,51-Integrin promotes tension-dependent mammary epithelial cell invasion by engaging the fibronectin synergy site,"Miroshnikova YA, Rozenberg GI, Cassereau L, Pickup M, Mouw JK, Ou G, Templeman KL, Hannachi EI, Gooch KJ, Sarang-Sieminski AL, Garca AJ, Weaver VM",U54 CA210184,,,,,,,"fibronectin, collagen",,U54,,,Breast,Carcinoma in situ of Breast,"3D Cell Culture, Murine Model",,,,,,,metastasis,,Breast,,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
4582,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29284706,Clin Cancer Res,2017,"PIK3CA C2 domain deletions hyperactivate phosphoinositide 3-kinase (PI3K), generate oncogene dependence and are exquisitely sensitive to PI3Kinhibitors","Croessmann S, Sheehan JH, Lee KM, Sliwoski GR, He J, Nagy RJ, Riddle DA, Mayer IA, Balko JM, Lanman RB, Miller V, Cantley LC, Meiler J, Arteaga CL",U54 CA210184,,,,,,,breast cancer,,U54,,,Breast,Carcinoma in situ of Breast,Computational Modeling,,,,,,,drug resistance/sensitivity,,Breast,,,,Sage,3,CA210184,Center on the Physics of Cancer Metabolism
4593,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29085021,Sci Rep,2017,An Effective Model of the Retinoic Acid Induced HL-60 Differentiation Program,"Tasseff R, Jensen HA, Congleton J, Dai D, Rogers KV, Sagar A, Bunaciu RP, Yen A, Varner JD",U54 CA210184,,,,,,,"differentiation, mathematical modeling",,U54,,,Blood,Acute Myeloid Leukemia,Mathematical Modeling,,,,,,,Not Applicable,,Blood,,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
4924,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29317493,J Biol Chem,2018,"Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism","Huang Q, Stalnecker C, Zhang C, McDermott LA, Iyer P, O'Neill J, Reimer S, Cerione RA, Katt WP",U54 CA210184,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Murine Model,,,,,,,Not Applicable,,Breast,,,,Sage,2,CA210184,Center on the Physics of Cancer Metabolism
4948,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29606310,Trends Cancer,2018,Biophysical Properties of Extracellular Matrix: Linking Obesity and Cancer,"Druso JE, Fischbach C",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,1,CA210184,Center on the Physics of Cancer Metabolism
4986,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29805991,ACS Biomater Sci Eng,2018,"Genetically Encoded Toolbox for Glycocalyx Engineering: Tunable Control of Cell Adhesion, Survival, and Cancer Cell Behaviors","Shurer CR, Colville MJ, Gupta VK, Head SE, Kai F, Lakins JN, Paszek MJ",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Time Lapse Microscopy,,,,,,,Not Applicable,,Not Applicable,,,,Sage,Not Applicable,CA210184,Center on the Physics of Cancer Metabolism
4999,196,syn7349770,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29162910,Sci Rep,2017,A library of chemically defined human N-glycans synthesized from microbial oligosaccharide precursors,"Hamilton BS, Wilson JD, Shumakovich MA, Fisher AC, Brooks JC, Pontes A, Naran R, Heiss C, Gao C, Kardish R, Heimburg-Molinaro J, Azadi P, Cummings RD, Merritt JH, DeLisa MP",U54 CA210184,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,Not Applicable,CA210184,Center on the Physics of Cancer Metabolism
4718,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28959205,Front Pharmacol,2018,Furanodiene Induces Extrinsic and Intrinsic Apoptosis in Doxorubicin-Resistant MCF-7 Breast Cancer Cells via NF-B-Independent Mechanism,"Zhong ZF, Yu HB, Wang CM, Qiang WA, Wang SP, Zhang JM, Yu H, Cui L, Wu T, Li DQ, Wang YT",U54 CA193419,,,,,,,"NF-_B, breast cancer, cell apoptosis, furanodiene, intrinsic/extrinsic apoptosis, drug resistance, multidrug resistance",,U54,,,Breast,Carcinoma in situ of Breast,Colorimetric Cell Viability Assay; ELISA; Western Blotting,,,,,,,drug resistance/sensitivity,,Breast,,,"NF-_B, breast cancer, cell apoptosis, furanodiene, intrinsic/extrinsic apoptosis, drug resistance, multidrug resistance",Center,Not Applicable,CA193419,Chicago Region Physical Science Oncology Center
4735,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28536279,Cancer Res,2017,The Damaging Effect of Passenger Mutations on Cancer Progression,"McFarland CD, Yaglom JA, Wojtkowiak JW, Scott JG, Morse DL, Sherman MY, Mirny LA",U54 CA193419,,,,,,,"DNA-seq, simulation",,U54,,,Breast,Carcinoma in situ of Breast,Genotyping,,,,,,,metastasis,,Breast,,,"DNA-seq, simulation",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4971,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29610327,Proc Natl Acad Sci U S A,2018,Precise characterization of KRAS4b proteoforms in human colorectal cells and tumors reveals mutation/modification cross-talk,"Ntai I, Fornelli L, DeHart CJ, Hutton JE, Doubleday PF, LeDuc RD, van Nispen AJ, Fellers RT, Whiteley G, Boja ES, Rodriguez H, Kelleher NL",U54 CA193419,,,,,,,,,U54,,,Colon,Carcinoma in situ of Colon,High-performance Liquid Chromatography/Tandem Mass Spectrometry,,,,,,,Not Applicable,,Colon,,,,Center,Not Applicable,CA193419,Chicago Region Physical Science Oncology Center
4695,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28992434,Annu Rev Pharmacol Toxicol,2019,Targeting Epigenetics in Cancer,"Bennett RL, Licht JD",U54 CA193419,,,,,,,,,U54,,,Blood,"Leukemia, Unspecified",Not Applicable,,,,,,,Not Applicable,,Blood,,,,Center,2,CA193419,Chicago Region Physical Science Oncology Center
4715,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27477909,Mol Cell,2017,A Highly Sensitive and Robust Method for Genome-wide 5hmC Profiling of Rare Cell Populations,"Han D, Lu X, Shih AH, Nie J, You Q, Xu MM, Melnick AM, Levine RL, He C",U54 CA193419,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP070188,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77967,,"5hmC, DNA methylation, experimental method, acute myeloid leukemia, RNA-seq",,U54,,,Blood,"Leukemia, Unspecified",Nm-seq,,,,,,,Not Applicable,,Blood,,,"5hmC, DNA methylation, experimental method, acute myeloid leukemia, RNA-seq",Center,2,CA193419,Chicago Region Physical Science Oncology Center
4724,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26317460,Cell,2015,DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension,Licht JD,U54 CA193419,,,,,,,"comment, DNA methylating agents, cancer",,U54,,,Blood,"Leukemia, Unspecified",Hi-C,,,,,,,drug resistance/sensitivity,,Blood,,,"comment, DNA methylating agents, cancer",Center,2,CA193419,Chicago Region Physical Science Oncology Center
4713,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27370397,Neuro Oncol,2017,Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth,"Hashizume R, Zhang A, Mueller S, Prados MD, Lulla RR, Goldman S, Saratsis AM, Mazar AP, Stegh AH, Cheng SY, Horbinski C, Haas-Kogan DA, Sarkaria JN, Waldman T, James CD",U54 CA193419,,,,,,,,,U54,,,Brain,Malignant Neoplasm of Brain,Colorimetric Cell Viability Assay; Immunocytochemistry,,,,,,,drug resistance/sensitivity,,Brain,,,,Center,Not Applicable,CA193419,Chicago Region Physical Science Oncology Center
4968,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29212257,Oncotarget,2018,Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells,"Zhao G, Wang Q, Gu Q, Qiang W, Wei JJ, Dong P, Watari H, Li W, Yue J",U54 CA193419,,,,,,,,,U54,,,Ovary,Malignant Neoplasm of Ovary,Immunohistochemistry Staining Method; Western Blotting,,,,,,,Not Applicable,,Ovary,,,,Center,Not Applicable,CA193419,Chicago Region Physical Science Oncology Center
4694,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29045860,Biophys J,2017,Mechanics and Buckling of Biopolymeric Shells and Cell Nuclei,"Banigan EJ, Stephens AD, Marko JF",U54 CA193419,,,,,,,molecular dynamics,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,microenvironment,,Not Applicable,,,molecular dynamics,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4696,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27224481,Biophys J,2017,Chromosome Compaction by Active Loop Extrusion,"Goloborodko A, Marko JF, Mirny LA",U54 CA193419,,,,,,,"chromosome compaction, chromosome organization, active loops, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,"chromosome compaction, chromosome organization, active loops, mathematical modeling",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4697,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27111884,J Biophotonics,2017,Colocalization of cellular nanostructure using confocal fluorescence and partial wave spectroscopy,"Chandler JE, Stypula-Cyrus Y, Almassalha L, Bauer G, Bowen L, Subramanian H, Szleifer I, Backman V",U54 CA193419,,,,,,,"chromatin, confocal microscopy, hyperspectral microscopy, mitochondria, nanocytology, partial wave spectroscopic microscopy",,U54,,,Not Applicable,Not Applicable,Partial Wave Spectroscopy; Confocal Microscopy,,,,,,,Not Applicable,,Not Applicable,,,"chromatin, confocal microscopy, hyperspectral microscopy, mitochondria, nanocytology, partial wave spectroscopic microscopy",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4698,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27111891,Curr Opin Genet Dev,2017,TAD disruption as oncogenic driver,"Valton AL, Dekker J",U54 CA193419,,,,,,,"topologically associating domains, driver, gene regulation, review",,U54,,,Not Applicable,Not Applicable,Hi-C,,,,,,,Not Applicable,,Not Applicable,,,"topologically associating domains, driver, gene regulation, review",Center,2,CA193419,Chicago Region Physical Science Oncology Center
4699,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27889238,Cell,2017,Insights into Nucleosome Organization in Mouse Embryonic Stem Cells through Chemical Mapping,"Voong LN, Xi L, Sebeson AC, Xiong B, Wang JP, Wang X",U54 CA193419,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP075973,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE82127,,"CTCF, Mnase, chemical biology, chromatin, embryonic stem cells, epigenetics, nucleosomes, pioneer transcription factors, pluripotency, splicing, nucleosome organization, experimental method, DNA sequencing",,U54,,,Not Applicable,Not Applicable,MicroRNA Sequencing; Real Time PCR; Western Blotting,,,,,,,Not Applicable,,Not Applicable,,,"CTCF, Mnase, chemical biology, chromatin, embryonic stem cells, epigenetics, nucleosomes, pioneer transcription factors, pluripotency, splicing, nucleosome organization, experimental method, DNA sequencing",Center,1,CA193419,Chicago Region Physical Science Oncology Center
4700,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27145786,Chromosome Res,2017,Dependence of the structure and mechanics of metaphase chromosomes on oxidized cysteines,"Eastland A, Hornick J, Kawamura R, Nanavati D, Marko JF",U54 CA193419,,,,,,,"chromosome structure, cysteine, disulfide, metaphase chromosome, mass spectrometry, imaging",,U54,,,Not Applicable,Not Applicable,Brightfield Microscopy; Liquid Chromatography Mass Spectrometry; Western Blotting,,,,,,,Not Applicable,,Not Applicable,,,"chromosome structure, cysteine, disulfide, metaphase chromosome, mass spectrometry, imaging",Center,1,CA193419,Chicago Region Physical Science Oncology Center
4701,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29053317,Phys Rev Lett,2018,Supercoiling DNA Locates Mismatches,"Dittmore A, Brahmachari S, Takagi Y, Marko JF, Neuman KC",U54 CA193419,,,,,,,"magnetic tweezers, DNA mismatch, supercoiling",,U54,,,Not Applicable,Not Applicable,Magnetic Tweezers,,,,,,,Not Applicable,,Not Applicable,,,"magnetic tweezers, DNA mismatch, supercoiling",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4703,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29079757,Sci Rep,2018,Oligomerization and ATP stimulate condensin-mediated DNA compaction,"Keenholtz RA, Dhanaraman T, Palou R, Yu J, D'Amours D, Marko JF",U54 CA193419,,,,,,,"chromatin organization, chromatin modeling, mitosis, magnetic tweezers, condensin, ATP",,U54,,,Not Applicable,Not Applicable,Brightfield Microscopy; Flow Cytometry,,,,,,,Not Applicable,,Not Applicable,,,"chromatin organization, chromatin modeling, mitosis, magnetic tweezers, condensin, ATP",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4705,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29142071,Mol Biol Cell,2019,Chromatin histone modifications and rigidity affect nuclear morphology independent of lamins,"Stephens AD, Liu PZ, Banigan EJ, Almassalha LM, Backman V, Adam SA, Goldman RD, Marko JF",U54 CA193419,,,,,,,chromatin,,U54,,,Not Applicable,Not Applicable,Fluorescent Antibody Procedure; Western Blotting,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4706,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27044624,J Bacteriol,2017,Facilitated Dissociation of a Nucleoid Protein from the Bacterial Chromosome,"Hadizadeh N, Johnson RC, Marko JF",U54 CA193419,,,,,,,"DNA-protein interactions, binding, unbinding, wide-field fluorescence microscopy, imaging, facilitated dissociation",,U54,,,Not Applicable,Not Applicable,Brightfield Microscopy; Real Time PCR,,,,,,,Not Applicable,,Not Applicable,,,"DNA-protein interactions, binding, unbinding, wide-field fluorescence microscopy, imaging, facilitated dissociation",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4707,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27296635,Anal Biochem,2017,An assay for 26S proteasome activity based on fluorescence anisotropy measurements of dye-labeled protein substrates,"Bhattacharyya S, Renn JP, Yu H, Marko JF, Matouschek A",U54 CA193419,,,,,,,"26S proteasome, fluorescence anisotropy, high-throughput degradation assay, protein degradation, ubiquitin proteasome system (UPS), experimental method",,U54,,,Not Applicable,Not Applicable,Western Blotting; Confocal Microscopy,,,,,,,Not Applicable,,Not Applicable,,,"26S proteasome, fluorescence anisotropy, high-throughput degradation assay, protein degradation, ubiquitin proteasome system (UPS), experimental method",Center,Not Applicable,CA193419,Chicago Region Physical Science Oncology Center
4708,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27702891,Proc Natl Acad Sci U S A,2018,"Label-free imaging of the native, living cellular nanoarchitecture using partial-wave spectroscopic microscopy","Almassalha LM, Bauer GM, Chandler JE, Gladstein S, Cherkezyan L, Stypula-Cyrus Y, Weinberg S, Zhang D, Thusgaard Ruhoff P, Roy HK, Subramanian H, Chandel NS, Szleifer I, Backman V",U54 CA193419,,,,,,,"DNA damage, cell dynamics, chromatin, microscopy, mitochondrial metabolism, chromatin organization, experimental method, partial wave spectroscopic microscopy",,U54,,,Not Applicable,Not Applicable,Partial Wave Spectroscopy,,,,,,,Not Applicable,,Not Applicable,,,"DNA damage, cell dynamics, chromatin, microscopy, mitochondrial metabolism, chromatin organization, experimental method, partial wave spectroscopic microscopy",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4709,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29416042,Nat Commun,2018,Stratification of TAD boundaries reveals preferential insulation of super-enhancers by strong boundaries,"Gong Y, Lazaris C, Sakellaropoulos T, Lozano A, Kambadur P, Ntziachristos P, Aifantis I, Tsirigos A",U54 CA193419,https://github.com/NYU-BFX/hic-bench,,,,,,"HI-C, chromatin",,U54,,,Not Applicable,Not Applicable,Molecular Simulations,,,,,,,Not Applicable,,Not Applicable,,,,Center,2,CA193419,Chicago Region Physical Science Oncology Center
4710,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27670945,Innate Immun,2017,Regulation of the IL-10-driven macrophage phenotype under incoherent stimuli,"Chuang Y, Hung ME, Cangelose BK, Leonard JN",U54 CA193419,,,,,,,"Interleukin-10 (IL-10), macrophage polarization, macrophages, tumor-associated macrophages (TAM)",,U54,,,Not Applicable,Not Applicable,Real Time PCR; Western Blotting,,,,,,,Not Applicable,,Not Applicable,,,"Interleukin-10 (IL-10), macrophage polarization, macrophages, tumor-associated macrophages (TAM)",Center,Not Applicable,CA193419,Chicago Region Physical Science Oncology Center
4711,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27550448,Cancer Res,2017,The Greater Genomic Landscape: The Heterogeneous Evolution of Cancer,"Almassalha LM, Bauer GM, Chandler JE, Gladstein S, Szleifer I, Roy HK, Backman V",U54 CA193419,,,,,,,"perspective, chromatin organization, evolution, chromatin protective therapies",,U54,,,Not Applicable,Not Applicable,Brightfield Microscopy; Flow Cytometry; Molecular Simulations,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4712,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27362225,Nature,2016,Cell division: A sticky problem for chromosomes,"Brangwynne CP, Marko JF",U54 CA193419,,,,,,,comment,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,comment,Center,1,CA193419,Chicago Region Physical Science Oncology Center
4714,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27550179,Nucleic Acids Res,2017,Crossover-site sequence and DNA torsional stress control strand interchanges by the Bxb1 site-specific serine recombinase,"Keenholtz RA, Grindley ND, Hatfull GF, Marko JF",U54 CA193419,,,,,,,"serine recombinase, DNA segment exchange",,U54,,,Not Applicable,Not Applicable,Western Blotting,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4716,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29450107,Nat Biomed Eng,2018,Macrogenomic engineering via modulation of the scaling of chromatin packing density,"Almassalha LM, Bauer GM, Wu W, Cherkezyan L, Zhang D, Kendra A, Gladstein S, Chandler JE, VanDerway D, Seagle BL, Ugolkov A, Billadeau DD, O'Halloran TV, Mazar AP, Roy HK, Szleifer I, Shahabi S, Backman V",U54 CA193419,https://github.com/BiophotonicsNU/macrogenomics,,,,,,,,U54,,,Not Applicable,Not Applicable,Molecular Simulations; Partial Wave Spectroscopy; Expression Array,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4717,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29219598,Phys Rev Lett,2018,Nucleation of Multiple Buckled Structures in Intertwined DNA Double Helices,"Brahmachari S, Gunn KH, Giuntoli RD, Mondragn A, Marko JF",U54 CA193419,,,,,,,"mathematical modeling, supercoil, magnetic tweezers, DNA structure",,U54,,,Not Applicable,Not Applicable,Molecular Simulations; Magnetic Tweezers,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4719,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27032966,Sci Rep,2017,Controlled rotation mechanism of DNA strand exchange by the Hin serine recombinase,"Xiao B, McLean MM, Lei X, Marko JF, Johnson RC",U54 CA193419,,,,,,,"serine recombinase, DNA segment exchange, magnetic tweezers",,U54,,,Not Applicable,Not Applicable,Western Blotting; Magnetic Tweezers,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4720,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28228067,Crit Rev Biochem Mol Biol,2017,Epigenetic characteristics of the mitotic chromosome in 1D and 3D,"Oomen ME, Dekker J",U54 CA193419,,,,,,,"chromatin organization, cell cycle, epigenetic memory, epigenetics, histone modification, mitosis, mitotic bookmarking, review",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,"chromatin organization, cell cycle, epigenetic memory, epigenetics, histone modification, mitosis, mitotic bookmarking, review",Center,2,CA193419,Chicago Region Physical Science Oncology Center
4721,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26220077,J Mol Biol,2015,DNA-Segment-Facilitated Dissociation of Fis and NHP6A from DNA Detected via Single-Molecule Mechanical Response,"Giuntoli RD, Linzer NB, Banigan EJ, Sing CE, de la Cruz MO, Graham JS, Johnson RC, Marko JF",U54 CA193419,,,,,,,"affinity, binding kinetics, biomolecule interactions, off-rate, unbinding, magnetic tweezers, DNA-protein interactions",,U54,,,Not Applicable,Not Applicable,Magnetic Tweezers; Molecular Simulations,,,,,,,Not Applicable,,Not Applicable,,,"affinity, binding kinetics, biomolecule interactions, off-rate, unbinding, magnetic tweezers, DNA-protein interactions",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4722,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28290596,J Biomed Opt,2018,Review of interferometric spectroscopy of scattered light for the quantification of subdiffractional structure of biomaterials,"Cherkezyan L, Zhang D, Subramanian H, Capoglu I, Taflove A, Backman V",U54 CA193419,,,,,,,"review, spectroscopic microscopy",,U54,,,Not Applicable,Not Applicable,Partial Wave Spectroscopy,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4723,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26293965,Science,2015,TRANSCRIPTION Allosteric transcriptional regulation via changes in the overall topology of the core promoter,"Philips SJ, Canalizo-Hernandez M, Yildirim I, Schatz GC, Mondragn A, O'Halloran TV",U54 CA193419,,,,,,,"transcriptional regulation, DNA-protein interactions, X-ray crystallography",,U54,,,Not Applicable,Not Applicable,"Molecular Simulations, X-Ray Crystallography",,,,,,,Not Applicable,,Not Applicable,,,"transcriptional regulation, DNA-protein interactions, X-ray crystallography",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4725,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26451275,Phys Rev X,2015,Control of Stochastic and Induced Switching in Biophysical Networks,"Wells DK, Kath WL, Motter AE",U54 CA193419,,,,,,,"biological physics, complex systems, nonlinear dynamics, mathematical modeling, differentiation, anti-cancer therapeutic response",,U54,,,Not Applicable,Not Applicable,Molecular Simulations,,,,,,,drug resistance/sensitivity,,Not Applicable,,,"biological physics, complex systems, nonlinear dynamics, mathematical modeling, differentiation, anti-cancer therapeutic response",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4726,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28364020,Proc Natl Acad Sci U S A,2018,Facilitated dissociation of transcription factors from single DNA binding sites,"Kamar RI, Banigan EJ, Erbas A, Giuntoli RD, Olvera de la Cruz M, Johnson RC, Marko JF",U54 CA193419,,,,,,,"DNA-protein interactions, biomolecule binding, chemical kinetics, facilitated dissociation, transcription factor, molecular dynamics, single-cell, imaging, fluorescence microscopy",,U54,,,Not Applicable,Not Applicable,"Immunohistochemistry Staining Method, Fluorescence Microscopy, Time Lapse Microscopy, Molecular Simulations",,,,,,,Not Applicable,,Not Applicable,,,"DNA-protein interactions, biomolecule binding, chemical kinetics, facilitated dissociation, transcription factor, molecular dynamics, single-cell, imaging, fluorescence microscopy",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4727,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28117353,Sci Rep,2018,"The Global Relationship between Chromatin Physical Topology, Fractal Structure, and Gene Expression","Almassalha LM, Tiwari A, Ruhoff PT, Stypula-Cyrus Y, Cherkezyan L, Matsuda H, Dela Cruz MA, Chandler JE, White C, Maneval C, Subramanian H, Szleifer I, Roy HK, Backman V",U54 CA193419,,,,,,,"chromatin organization, chromatin accessibility, gene expression, expression microarray, partial wave spectroscopic microscopy, imaging",,U54,,,Not Applicable,Not Applicable,"Molecular Simulations, Partial Wave Spectroscopy, Transmission Electron Microscopy, Expression Array",,,,,,,Not Applicable,,Not Applicable,,,"chromatin organization, chromatin accessibility, gene expression, expression microarray, partial wave spectroscopic microscopy, imaging",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4728,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26543199,Mol Biol Cell,2016,"Forces, fluctuations, and self-organization in the nucleus","Pederson T, King MC, Marko JF",U54 CA193419,,,,,,,"nuclear organization, review",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,"nuclear organization, review",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4729,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28380910,Opt Express,2018,Stochastic fluorescence switching of nucleic acids under visible light illumination,"Dong B, Almassalha LM, Soetikno BT, Chandler JE, Nguyen TQ, Urban BE, Sun C, Zhang HF, Backman V",U54 CA193419,,,,,,,"single-molecule photo-localization microscopy, stochastic fluorescence, nucleic acid",,U54,,,Not Applicable,Not Applicable,Brightfield Microscopy; Electron Microscopy; Liquid Chromatography Mass Spectrometry,,,,,,,Not Applicable,,Not Applicable,,,"single-molecule photo-localization microscopy, stochastic fluorescence, nucleic acid",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4730,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27535934,Proc Natl Acad Sci U S A,2018,"Superresolution intrinsic fluorescence imaging of chromatin utilizing native, unmodified nucleic acids for contrast","Dong B, Almassalha LM, Stypula-Cyrus Y, Urban BE, Chandler JE, Nguyen TQ, Sun C, Zhang HF, Backman V",U54 CA193419,,,,,,,"chromatin topology, chromosome, label-free imaging, nucleic acids, superresolution fluorescence microscopy, imaging, chromatin organization",,U54,,,Not Applicable,Not Applicable,Superresolution Intrinsic Fluorescence Imaging,,,,,,,heterogeneity/evolution,,Not Applicable,,,"chromatin topology, chromosome, label-free imaging, nucleic acids, superresolution fluorescence microscopy, imaging, chromatin organization",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4731,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28414321,Nat Struct Mol Biol,2017,An orthogonal single-molecule experiment reveals multiple-attempt dynamics of type IA topoisomerases,"Gunn KH, Marko JF, Mondragn A",U54 CA193419,,,,,,,"type IA topoisomerase, single-molecule, magnetic tweezers, total internal reflection microscopy, DNA topology, DNA-protein interactions",,U54,,,Not Applicable,Not Applicable,"Atomic Force Microscopy, Magnetic Tweezers",,,,,,,Not Applicable,,Not Applicable,,,"type IA topoisomerase, single-molecule, magnetic tweezers, total internal reflection microscopy, DNA topology, DNA-protein interactions",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4732,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28435001,Methods,2018,Hi-C 20: An optimized Hi-C procedure for high-resolution genome-wide mapping of chromosome conformation,"Belaghzal H, Dekker J, Gibcus JH",U54 CA193419,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP105181,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE98161,,"HiC, experimental protocol",,U54,,,Not Applicable,Not Applicable,Hi-C,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4733,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28504680,Nat Methods,2017,Nm-seq maps 2'-O-methylation sites in human mRNA with base precision,"Dai Q, Moshitch-Moshkovitz S, Han D, Kol N, Amariglio N, Rechavi G, Dominissini D, He C",U54 CA193419,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP093757,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE90164,,,,U54,,,Not Applicable,Not Applicable,Nm-seq,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4736,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26843321,Sci Rep,2017,Role of transcription factor-mediated nucleosome disassembly in PHO5 gene expression,"Kharerin H, Bhat PJ, Marko JF, Padinhateeri R",U54 CA193419,,,,,,,"nucleosome dynamics, gene regulation, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,Not Applicable,,Not Applicable,,,"nucleosome dynamics, gene regulation, mathematical modeling",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4737,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28542912,J Cell Physiol,2017,The nucleus is irreversibly shaped by motion of cell boundaries in cancer and non-cancer cells,"Tocco VJ, Li Y, Christopher KG, Matthews JH, Aggarwal V, Paschall L, Luesch H, Licht JD, Dickinson RB, Lele TP",U54 CA193419,,,,,,,"cell forces, nuclear mechanics, nuclear shape",,U54,,,Not Applicable,Not Applicable,"Molecular Simulations, Confocal Microscopy",,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4738,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26871126,Phys Rev E,2016,Self-propulsion and interactions of catalytic particles in a chemically active medium,"Banigan EJ, Marko JF",U54 CA193419,,,,,,,"self-propulsion, mathematical modeling, Brownian dynamics",,U54,,,Not Applicable,Not Applicable,Molecular Simulations,,,,,,,Not Applicable,,Not Applicable,,,"self-propulsion, mathematical modeling, Brownian dynamics",Center,Not Applicable,CA193419,Chicago Region Physical Science Oncology Center
4739,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28618488,Phys Rev E,2018,Torque and buckling in stretched intertwined double-helix DNAs,"Brahmachari S, Marko JF",U54 CA193419,,,,,,,"magnetic tweezers, mathematical modeling, supercoiled DNA",,U54,,,Not Applicable,Not Applicable,Molecular Simulations,,,,,,,Not Applicable,,Not Applicable,,,"magnetic tweezers, mathematical modeling, supercoiled DNA",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4740,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26940867,Science,2016,Activation of proto-oncogenes by disruption of chromosome neighborhoods,"Hnisz D, Weintraub AS, Day DS, Valton AL, Bak RO, Li CH, Goldmann J, Lajoie BR, Fan ZP, Sigova AA, Reddy J, Borges-Rivera D, Lee TI, Jaenisch R, Porteus MH, Dekker J, Young RA",U54 CA193419,,,"https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP068783, https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP058436, https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP058437",,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77142 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68978 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68977 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68976 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68975",,"T cell acute lymphoblastic leukemia, chromosome organization, insulated neighborhood, ChIA-PET, RNA-seq, ChIP-seq",,U54,,,Blood,T Acute Lymphoblastic Leukemia,"ChIA-PET, ChIP-Seq, Whole Transcriptome Sequencing",,,,,,,Not Applicable,,Not Applicable,,,"T cell acute lymphoblastic leukemia, chromosome organization, insulated neighborhood, ChIA-PET, RNA-seq, ChIP-seq",Center,2,CA193419,Chicago Region Physical Science Oncology Center
4741,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26967279,Cell,2016,The 3D Genome as Moderator of Chromosomal Communication,"Dekker J, Mirny L",U54 CA193419,,,,,,,"chromosome organization, CTCF, Hi-C, biophysics, cohesin, condensin, domains, enhancer, gene expression, gene regulation, polymers, promoter, simulations",,U54,,,Not Applicable,Not Applicable,Hi-C,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4742,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27192037,Elife,2017,Compaction and segregation of sister chromatids via active loop extrusion,"Goloborodko A, Imakaev MV, Marko JF, Mirny L",U54 CA193419,,,,,,,"biophysics, chromosome, chromosomes, compaction, genes, molecular dynamics, none, polymer, simulations, structural biology, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Molecular Simulations,,,,,,,Not Applicable,,Not Applicable,,,"biophysics, chromosome, chromosomes, compaction, genes, molecular dynamics, none, polymer, simulations, structural biology, mathematical modeling",Center,3,CA193419,Chicago Region Physical Science Oncology Center
4928,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29548245,Phys Rev E,2018,Effects of electrostatic interactions on ligand dissociation kinetics,"Erba A, de la Cruz MO, Marko JF",U54 CA193419,,,,,,,,,U54,,,Not Applicable,Not Applicable,Molecular Simulations,,,,,,,Not Applicable,,Not Applicable,,,,Center,1,CA193419,Chicago Region Physical Science Oncology Center
4957,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29548184,Phys Rev E,2018,Defect-facilitated buckling in supercoiled double-helix DNA,"Brahmachari S, Dittmore A, Takagi Y, Neuman KC, Marko JF",U54 CA193419,,,,,,,,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4959,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29476478,Methods Mol Biol,2019,Measuring Nanoscale Chromatin Heterogeneity with Partial Wave Spectroscopic Microscopy,"Gladstein S, Stawarz A, Almassalha LM, Cherkezyan L, Chandler JE, Zhou X, Subramanian H, Backman V",U54 CA193419,,,,,,,,,U54,,,Not Applicable,Not Applicable,"Molecular Simulations, Partial Wave Spectroscopy",,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
5042,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30320141,IEEE Trans Control Netw Syst,2018,State observation and sensor selection for nonlinear networks,"Haber A, Molnar F, Motter AE",U54 CA193419,,,,,,,,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,Not Applicable,,Not Applicable,,,,Center,Not Applicable,CA193419,Chicago Region Physical Science Oncology Center
5131,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30181804,Oncotarget,2018,Pumilio2 regulates synaptic plasticity via translational repression of synaptic receptors in mice,"Dong H, Zhu M, Meng L, Ding Y, Yang D, Zhang S, Qiang W, Fisher DW, Xu EY",U54 CA193419,,,,,,,,,U54,,,Not Applicable,Not Applicable,Immunohistochemistry Staining Method; Electron Microscopy,,,,,,,Not Applicable,,Not Applicable,,,,Center,Not Applicable,CA193419,Chicago Region Physical Science Oncology Center
5152,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29177739,Methods Mol Biol,2018,Single-Molecule Magnetic Tweezer Analysis of Topoisomerases,"Gunn KH, Marko JF, Mondragn A",U54 CA193419,,,,,,,,,U54,,,Not Applicable,Not Applicable,"Magnetic Tweezers, Brightfield Microscopy",,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
5209,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30192578,Phys Rev Lett,2018,Bend-Induced Twist Waves and the Structure of Nucleosomal DNA,"Skoruppa E, Nomidis SK, Marko JF, Carlon E",U54 CA193419,,,,,,,,,U54,,,Not Applicable,Not Applicable,Molecular Simulations,,,,,,,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
5222,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/28525758,Cell,2017,Targeted Degradation of CTCF Decouples Local Insulation of Chromosome Domains from Genomic Compartmentalization,"Nora EP, Goloborodko A, Valton AL, Gibcus JH, Uebersohn A, Abdennur N, Dekker J, Mirny LA, Bruneau BG",U54 CA193419,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP106652,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE98671,,"CTCF, chromosomal structure",,U54,syn12976723,syn12976719,Not Applicable,Not Applicable,Fluorescent Antibody Procedure; Whole Transcriptome Sequencing; Western Blotting; Flow Cytometry; Molecular Simulations; Hi-C; ChIP-Seq; 5C,,GSE98671,Targeted Degradation of CTCF,10.1016/j.cell.2017.05.004,embryo,University of Chicago,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
5226,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/29348367,Science,2018,A pathway for mitotic chromosome formation,"Gibcus JH, Samejima K, Goloborodko A, Samejima I, Naumova N, Nuebler J, Kanemaki MT, Xie L, Paulson JR, Earnshaw WC, Mirny LA, Dekker J",U54 CA193419,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP115572,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE102740,,"chromatin formation, condensin",,U54,syn13857535,syn13857585,Not Applicable,Not Applicable,Fluorescent Antibody Procedure; Hi-C; LC-MSMS; Mathematical Modeling;  ,,GSE102740,Mitotic chromosome formation,10.1126/science.aao6135,Bursa of Fabricius,University of Chicago,Not Applicable,,Not Applicable,,,,Center,3,CA193419,Chicago Region Physical Science Oncology Center
4702,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27182590,Phys Rev E,2016,"Erratum: Torque correlation length and stochastic twist dynamics of DNA [Phys Rev E 89, 062706 (2014)]","Banigan EJ, Marko JF",U54 CA193419,,,,,,,erraturm,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,Not Applicable,,Not Applicable,,,erraturm,Sage,3,CA193419,Chicago Region Physical Science Oncology Center
4704,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=25368422,Mol Biol Cell,2014,"Nuclear physics (of the cell, not the atom)","Pederson T, Marko JF",U54 CA193419,,,,,,,"nuclear organization, physics, review",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,3,CA193419,Chicago Region Physical Science Oncology Center
4734,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28057760,Mol Biol Cell,2017,Chromatin and lamin A determine two different mechanical response regimes of the cell nucleus,"Stephens AD, Banigan EJ, Adam SA, Goldman RD, Marko JF",U54 CA193419,,,,,,,"lamin A, lamin C, chromatin, nucleus, stiffness, molecular dynamics, imaging, wide-field microscopy",,U54,,,Not Applicable,Not Applicable,"Molecular Simulations, Fluorescence Microscopy",,,,,,,Not Applicable,,Not Applicable,,,,Sage,3,CA193419,Chicago Region Physical Science Oncology Center
4797,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29263839,NPJ Genom Med,2018,Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas,"Madubata CJ, Roshan-Ghias A, Chu T, Resnick S, Zhao J, Arnes L, Wang J, Rabadan R",U54 CA193313,https://github.com/RabadanLab/TOBI,,,,,,,,U54,,,Not Applicable,Pan-cancer,Not Applicable,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4931,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29625057,Cell,2019,Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer,"Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, Chua CW, Barlow LJ, Kandoth C, Williams AB, Bergren SK, Pietzak EJ, Anderson CB, Benson MC, Coleman JA, Taylor BS, Abate-Shen C, McKiernan JM, Al-Ahmadie H, Solit DB, Shen MM",U54 CA193313,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP118077,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103990,,,,U54,,,Bladder,Carcinoma in situ of Bladder,"Organoid, Whole Transcriptome Sequencing, Whole Exome Sequencing, High-throughput Drug Screen, Targeted Genome Sequencing",,,,,,,drug resistance/sensitivity,,Bladder,,,,Center,1,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4811,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27890785,J Invest Dermatol,2017,Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis ofMelanoma,"Melamed RD, Aydin IT, Rajan GS, Phelps R, Silvers DN, Emmett KJ, Brunner G, Rabadan R, Celebi JT",U54 CA193313,,,,,,,"melanoma, exome sequencing",,U54,,,Skin,Carcinoma in situ of Skin,"Whole Exome Sequencing, Targeted Genome Sequencing",,,,,,,heterogeneity/evolution,,Skin,,,,Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4927,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29467127,Cancer Immunol Res,2018,Quantitative Analysis of Immune Infiltrates in Primary Melanoma,"Gartrell RD, Marks DK, Hart TD, Li G, Davari DR, Wu A, Blake Z, Lu Y, Askin KN, Monod A, Esancy CL, Stack EC, Jia DT, Armenta PM, Fu Y, Izaki D, Taback B, Rabadan R, Kaufman HL, Drake CG, Horst BA, Saenger YM",U54 CA193313,,,,,,,,,U54,,,Skin,Carcinoma in situ of Skin,Quantitative Multiplex Immunofluorescence,,,,,,,"microenvironment, tumor-immune",,Skin,,,,Sage,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4802,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29323298,Nature,2018,A metabolic function of FGFR3-TACC3 gene fusions in cancer,"Frattini V, Pagnotta SM, Tala, Fan JJ, Russo MV, Lee SB, Garofano L, Zhang J, Shi P, Lewis G, Sanson H, Frederick V, Castano AM, Cerulo L, Rolland DCM, Mall R, Mokhtari K, Elenitoba-Johnson KSJ, Sanson M, Huang X, Ceccarelli M, Lasorella A, Iavarone A",U54 CA193313,,E-MTAB-6037,,,,,"gene fusion, glioblastoma",,U54,,,Brain,Glioblastoma,"Mass Spectrometry, Expression Array, Xenograft",,,,,,,Not Applicable,,Brian,,,"gene fusion, glioblastoma",Sage,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4997,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29748285,Science,2018,An anatomic transcriptional atlas of human glioblastoma,"Puchalski RB, Shah N, Miller J, Dalley R, Nomura SR, Yoon JG, Smith KA, Lankerovich M, Bertagnolli D, Bickley K, Boe AF, Brouner K, Butler S, Caldejon S, Chapin M, Datta S, Dee N, Desta T, Dolbeare T, Dotson N, Ebbert A, Feng D, Feng X, Fisher M, Gee G, Goldy J, Gourley L, Gregor BW, Gu G, Hejazinia N, Hohmann J, Hothi P, Howard R, Joines K, Kriedberg A, Kuan L, Lau C, Lee F, Lee H, Lemon T, Long F, Mastan N, Mott E, Murthy C, Ngo K, Olson E, Reding M, Riley Z, Rosen D, Sandman D, Shapovalova N, Slaughterbeck CR, Sodt A, Stockdale G, Szafer A, Wakeman W, Wohnoutka PE, White SJ, Marsh D, Rostomily RC, Ng L, Dang C, Jones A, Keogh B, Gittleman HR, Barnholtz-Sloan JS, Cimino PJ, Uppin MS, Keene CD, Farrokhi FR, Lathia JD, Berens ME, Iavarone A, Bernard A, Lein E, Phillips JW, Rostad SW, Cobbs C, Hawrylycz MJ, Foltz GD",U54 CA193313,,,,,,,,,U54,,,Brian,Glioblastoma,"Hematoxylin and Eosin Staining Method, Whole Transcriptome Sequencing, In Situ Hybridization",,,,,,,Not Applicable,,Brian,,,,Sage,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4817,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27852792,Neuro Oncol,2017,FGFR-TACC gene fusions in human glioma,"Lasorella A, Sanson M, Iavarone A",U54 CA193313,,,,,,,"chromosomal translocations, FGFR-TACC, glioma, personalized therapy, review",,U54,,,Brain,Glioma,Not Applicable,,,,,,,drug resistance/sensitivity,,Brain,,,"chromosomal translocations, FGFR-TACC, glioma, personalized therapy, review",Sage,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4800,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27655895,Proc Natl Acad Sci U S A,2018,"Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia","Oshima K, Khiabanian H, da Silva-Almeida AC, Tzoneva G, Abate F, Ambesi-Impiombato A, Sanchez-Martin M, Carpenter Z, Penson A, Perez-Garcia A, Eckert C, Nicolas C, Balbin M, Sulis ML, Kato M, Koh K, Paganin M, Basso G, Gastier-Foster JM, Devidas M, Loh ML, Kirschner-Schwabe R, Palomero T, Rabadan R, Ferrando AA",U54 CA193313,,,,,,,"acute lymphoblastic leukemia, chemotherapy resistance, genome sequencing, relapsed leukemia, whole-exome sequencing, whole-genome sequencing, clonal evolution, mutational landscape",,U54,,,Blood,Acute Lymphoblastic Leukemia,"Whole Exome Sequencing, Whole Genome Sequencing",,,,,,,heterogeneity/evolution,,Blood,,,"acute lymphoblastic leukemia, chemotherapy resistance, genome sequencing, relapsed leukemia, whole-exome sequencing, whole-genome sequencing, clonal evolution, mutational landscape",Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4805,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27335277,Blood,2017,The genetics of nodal marginal zone lymphoma,"Spina V, Khiabanian H, Messina M, Monti S, Cascione L, Bruscaggin A, Spaccarotella E, Holmes AB, Arcaini L, Lucioni M, Tabb F, Zairis S, Diop F, Cerri M, Chiaretti S, Marasca R, Ponzoni M, Deaglio S, Ramponi A, Tiacci E, Pasqualucci L, Paulli M, Falini B, Inghirami G, Bertoni F, Fo R, Rabadan R, Gaidano G, Rossi D",U54 CA193313,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP059441,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68078,,"nodal marginal zone lymphoma, splenic marginal zone lymphoma, mutational landscape, whole-exome sequencing, targeted sequencing, RNA-seq, SNP array",,U54,,,Blood,Marginal Zone Lymphoma,"Whole Exome Sequencing, Targeted Genome Sequencing, Whole Transcriptome Sequencing, Single Nucleotide Polymorphism Array",,,,,,,Not Applicable,,Blood,,,"nodal marginal zone lymphoma, splenic marginal zone lymphoma, mutational landscape, whole-exome sequencing, targeted sequencing, RNA-seq, SNP array",Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4810,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26883104,Oncotarget,2017,Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes,"Messina M, Chiaretti S, Wang J, Fedullo AL, Peragine N, Gianfelici V, Piciocchi A, Brugnoletti F, Di Giacomo F, Pauselli S, Holmes AB, Puzzolo MC, Ceglie G, Apicella V, Mancini M, Te Kronnie G, Testi AM, Vitale A, Vignetti M, Guarini A, Rabadan R, Fo R",U54 CA193313,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67405,,"acute lymphoblastic leukemia, copy number aberrations, genetic-driven targeted therapy, next generation sequencing, novel prognostic markers, mutational landscape, whole-exome sequencing, microarray expression",,U54,,,Blood,B Acute Lymphoblastic Leukemia,"Whole Exome Sequencing, Single Nucleotide Polymorphism Array",,,,,,,drug resistance/sensitivity,,Blood,,,"acute lymphoblastic leukemia, copy number aberrations, genetic-driven targeted therapy, next generation sequencing, novel prognostic markers, mutational landscape, whole-exome sequencing, microarray expression",Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4813,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26819056,Haematologica,2017,"Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia","Rasi S, Khiabanian H, Ciardullo C, Terzi-di-Bergamo L, Monti S, Spina V, Bruscaggin A, Cerri M, Deambrogi C, Martuscelli L, Biasi A, Spaccarotella E, De Paoli L, Gattei V, Fo R, Rabadan R, Gaidano G, Rossi D",U54 CA193313,,,,,,,"BIRC3, NOTCH1, SF3B1,TP53, chronic lymphocytic leukemia, evolution, frequency, prognostic impact, subclones, DNA sequencing",,U54,,,Blood,Chronic Lymphocytic Leukemia,Targeted Genome Sequencing,,,,,,,heterogeneity/evolution,,Blood,,,"BIRC3, NOTCH1, SF3B1,TP53, chronic lymphocytic leukemia, evolution, frequency, prognostic impact, subclones, DNA sequencing",Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
5027,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30034030,J Stat Phys,2018,On statistical modeling of sequencing noise in high depth data to assess tumor evolution,"Rabadan R, Bhanot G, Marsilio S, Chiorazzi N, Pasqualucci L, Khiabanian H",U54 CA193313,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP126272,,,,,,U54,,,Blood,Diffuse Large B-Cell Lymphoma,Whole Genome Sequencing,,,,,,,heterogeneity/evolution,,Blood,,,,Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4803,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27304073,Elife,2016,Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors,"Yamamoto K, Wang J, Sprinzen L, Xu J, Haddock CJ, Li C, Lee BJ, Loredan DG, Jiang W, Vindigni A, Wang D, Rabadan R, Zha S",U54 CA193313,,,,,,,"ATM, DNA damage, Topo-isomerase-I inhibitor",,U54,,,"Lymph node, Thymus","Pan-cancer, Lymphoma",Murine Model,,,,,,,drug resistance/sensitivity,,"Lymph node, Thymus",,,"ATM, DNA damage, Topo-isomerase-I inhibitor",Sage,3,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4807,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26824661,Cell,2016,Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma,"Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh A, Pagnotta SM, Anjum S, Wang J, Manyam G, Zoppoli P, Ling S, Rao AA, Grifford M, Cherniack AD, Zhang H, Poisson L, Carlotti CG Jr, Tirapelli DP, Rao A, Mikkelsen T, Lau CC, Yung WK, Rabadan R, Huse J, Brat DJ, Lehman NL, Barnholtz-Sloan JS, Zheng S, Hess K, Rao G, Meyerson M, Beroukhim R, Cooper L, Akbani R, Wrensch M, Haussler D, Aldape KD, Laird PW, Gutmann DH, TCGA Research Network, Noushmehr H, Iavarone A, Verhaak RG",U54 CA193313,,,,,,,"diffuse glioma, disease classification, progression, mutational landscape, whole-genome sequencing, whole-exome sequencing, RNA-seq, DNA copy number arrays, SNP arrays, gene expression microarray, DNA methylation array, reverse phase protein array, miRNA-seq, miRNA expression array",,U54,,,Brain,Glioma,"Whole Genome Sequencing, Whole Exome Sequencing, Whole Transcriptome Sequencing, Single Nucleotide Polymorphism Array, Expression Array, Methylation Profiling by Array, MicroRNA Sequencing, MicroRNA Expression Array",,,,,,,Not Applicable,,Brain,,,"diffuse glioma, disease classification, progression, mutational landscape, whole-genome sequencing, whole-exome sequencing, RNA-seq, DNA copy number arrays, SNP arrays, gene expression microarray, DNA methylation array, reverse phase protein array, miRNA-seq, miRNA expression array",Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4812,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28263318,Nat Genet,2017,Spatiotemporal genomic architecture informs precision oncology in glioblastoma,"Lee JK, Wang J, Sa JK, Ladewig E, Lee HO, Lee IH, Kang HJ, Rosenbloom DS, Camara PG, Liu Z, van Nieuwenhuizen P, Jung SW, Choi SW, Kim J, Chen A, Kim KT, Shin S, Seo YJ, Oh JM, Shin YJ, Park CK, Kong DS, Seol HJ, Blumberg A, Lee JI, Iavarone A, Park WY, Rabadan R, Nam DH",U54 CA193313,,EGAS00001001880,,,,,,,U54,,,Brain,Glioblastoma,"Single Cell RNA-Sequencing, Whole Exome Sequencing",,,,,,,"heterogeneity/evolution, drug resistance/sensitivity",,Brain,,,,Center,3,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4917,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29440233,Gut,2019,Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma,"Arnes L, Liu Z, Wang J, Carlo Maurer H, Sagalovskiy I, Sanchez-Martin M, Bommakanti N, Garofalo DC, Balderes DA, Sussel L, Olive KP, Rabadan R",U54 CA193313,https://github.com/RabadanLab/NORI,,"https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP096338, https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP102315",,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE96931, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE93326",,,,U54,,,Pancreas,Malignant Neoplasm of Pancreas,Whole Transcriptome Sequencing,,,,,,,drug resistance/sensitivity,,Pancreas,,,,Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4798,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28459448,Nat Biotechnol,2017,Single-cell topological RNA-seq analysis reveals insights into cellular differentiation and development,"Rizvi AH, Camara PG, Kandror EK, Roberts TJ, Schieren I, Maniatis T, Rabadan R",U54 CA193313,https://github.com/RabadanLab/scTDA,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP099648,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE94883,,"scRNA-seq, transcriptional regulation",,U54,,,Not Applicable,Not Applicable,Single Cell RNA-Sequencing,,,,,,,heterogeneity/evolution,,Not Applicable,,,"scRNA-seq, transcriptional regulation",Center,Core,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4799,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28483946,Mol Cancer Res,2018,p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes,"Pappas K, Xu J, Zairis S, Resnick-Silverman L, Abate F, Steinbach N, Ozturk S, Saal LH, Su T, Cheung P, Schmidt H, Aaronson S, Hibshoosh H, Manfredi J, Rabadan R, Parsons R",U54 CA193313,,,,,,,ChIP-seq,,U54,,,Not Applicable,Not Applicable,ChIP-Seq,,,,,,,Not Applicable,,Not Applicable,,,ChIP-seq,Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4806,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27345159,Cell Syst,2019,"Topological Data Analysis Generates High-Resolution, Genome-wide Maps of Human Recombination","Camara PG, Rosenbloom DI, Emmett KJ, Levine AJ, Rabadan R",U54 CA193313,,,,,,,"topological data analysis, recombination, mathematical modeling, computational model",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,"topological data analysis, recombination, mathematical modeling, computational model",Center,Core,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4808,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27270107,Nat Genet,2017,Clonal evolution of glioblastoma under therapy,"Wang J, Cazzato E, Ladewig E, Frattini V, Rosenbloom DI, Zairis S, Abate F, Liu Z, Elliott O, Shin YJ, Lee JK, Lee IH, Park WY, Eoli M, Blumberg AJ, Lasorella A, Nam DH, Finocchiaro G, Iavarone A, Rabadan R",U54 CA193313,,"EGAS00001000579, EGAD00001001113, EGAD00001001213, and EGAD00001001424, EGAS00001001800",https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP074425,,,,"glioblastoma, clonal evolution, whole-exome sequencing, RNA-seq",,U54,,,Brain,Glioblastoma,"Whole Exome Sequencing, Whole Transcriptome Sequencing",,,,,,,heterogeneity/evolution,,Brian,,,"glioblastoma, clonal evolution, whole-exome sequencing, RNA-seq",Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4809,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27532298,PLoS Comput Biol,2017,Inference of Ancestral Recombination Graphs through Topological Data Analysis,"Cmara PG, Levine AJ, Rabadn R",U54 CA193313,https://github.com/RabadanLab/TARGet,,,,,,"methods, ancestral recombination graphs, topological data analysis, computational method",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,Core,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4815,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26999002,Nat Methods,2017,Reprogramming eukaryotic translation with ligand-responsive synthetic RNA switches,"Anzalone AV, Lin AJ, Zairis S, Rabadan R, Cornish VW",U54 CA193313,,,,,,,"experimental method, reprogramming translation, synthetic biology, biotechnology/methods, cellular reprogramming/genetics, directed molecular evolution, frameshifting, ribosomal/genetics, gene expression regulation, fungal, ligands, protein biosynthesis/genetics, rna; fungal/chemistry, rna; fungal/genetics, rna; messenger/chemistry, riboswitch/genetics, saccharomyces cerevisiae/genetics, saccharomyces cerevisiae/metabolism",,U54,,,Not Applicable,Not Applicable,In Vitro Selection,,,,,,,Not Applicable,,Not Applicable,,,,Center,Not Applicable,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4818,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27923679,Biochim Biophys Acta,2017,Evolutionary scalpels for dissecting tumor ecosystems,"Rosenbloom DIS, Camara PG, Chu T, Rabadan R",U54 CA193313,,,,,,,"review, tumor heterogeneity, Darwinian evolution, single-cell, scRNA-seq, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,"heterogeneity/evolution, drug resistance/sensitivity",,Not Applicable,,,"review, tumor heterogeneity, Darwinian evolution, single-cell, scRNA-seq, mathematical modeling",Center,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4907,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29213056,Sci Rep,2019,A Random Categorization Model for Hierarchical Taxonomies,"D'Amico G, Rabadan R, Kleban M",U54 CA193313,,,,,,,,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,Not Applicable,,Not Applicable,,,,Center,Not Applicable,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4937,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29606308,Trends Cancer,2018,Single-Cell Transcriptomic Analysis of Tumor Heterogeneity,"Levitin HM, Yuan J, Sims PA",U54 CA193313,,,,,,,,,U54,,,Not Applicable,Not Applicable,Single Cell Sequencing,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Sage,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4804,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27357673,Proc Natl Acad Sci U S A,2016,Algorithmic methods to infer the evolutionary trajectories in cancer progression,"Caravagna G, Graudenzi A, Ramazzotti D, Sanz-Pamplona R, De Sano L, Mauri G, Moreno V, Antoniotti M, Mishra B",U54 CA193313,https://sites.google.com/site/troncopackage/picnic,,,,,,"Bayesian structural inference, cancer evolution, causality, next generation sequencing, selective advantage, colorectal cancer, computational method, progression",,U54,,,"Colon, Rectum","Carcinoma in situ of Colon, Rectal Adenocarcinoma",Computational Tool,,,,,,,heterogeneity/evolution,,"Colon, Rectum",,,"Bayesian structural inference, cancer evolution, causality, next generation sequencing, selective advantage, colorectal cancer, computational method, progression",Sage,Core,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4801,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27275544,Oncotarget,2016,Cancer megafunds with in silico and in vitro validation: accelerating cancer drug discovery via financial engineering without financial crisis,"Yang X, Debonneuil E, Zhavoronkov A, Mishra B",U54 CA193313,,,,,,,"RBO, cancer megafund, in silico validation, megafund, research-backed obligation, mathematical modeling",,U54,,,Not Applicable,Pan-cancer,Mathematical Modeling,,,,,,,drug resistance/sensitivity,,Not Applicable,,,"RBO, cancer megafund, in silico validation, megafund, research-backed obligation, mathematical modeling",Sage,Not Applicable,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4814,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26047807,Genome Biol,2015,Scalable microfluidics for single-cell RNA printing and sequencing,"Bose S, Wan Z, Carr A, Rizvi AH, Vieira G, Pe'er D, Sims PA",U54 CA193313,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP055569,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66357,,"scRNA-seq, experimental method",,U54,,,Not Applicable,Not Applicable,Single Cell Sequencing,,,,,,,Not Applicable,,Not Applicable,,,"scRNA-seq, experimental method",Sage,2,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4816,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28983521,Curr Opin Syst Biol,2017,Topological methods for genomics: present and future directions,Cmara PG,U54 CA193313,,,,,,,"review, topological methods, genomics",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,Not Applicable,,Not Applicable,,,"review, topological methods, genomics",Sage,Core,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4819,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26861821,Bioinformatics,2016,TRONCO: an R package for the inference of cancer progression models from heterogeneous genomic data,"De Sano L, Caravagna G, Ramazzotti D, Graudenzi A, Mauri G, Mishra B, Antoniotti M",U54 CA193313,http://bimib.disco.unimib.it/,,,,,,"algorithms, disease progression, epigenesis, genomics, humans, theoretical models, neoplasms/genetics, software, user-computer interface",,U54,,,Not Applicable,Not Applicable,Computational Tool,,,,,,,heterogeneity/evolution,,Not Applicable,,,"algorithms, disease progression, epigenesis, genomics, humans, theoretical models, neoplasms/genetics, software, user-computer interface",Sage,Core,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4918,196,syn7349759,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29556884,J Clin Monit Comput,2018,Predicting delayed cerebral ischemia after subarachnoid hemorrhage using physiological time series data,"Park S, Megjhani M, Frey HP, Grave E, Wiggins C, Terilli KL, Roh DJ, Velazquez A, Agarwal S, Connolly ES Jr., Schmidt JM, Claassen J, Elhadad N",U54 CA193313,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,Not Applicable,CA193313,Columbia University Center for Topology of Cancer Evolution and Heterogeneity
4649,196,syn7315805,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27851913,Immunity,2016,Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer,"Plitas G, Konopacki C, Wu K, Bos PD, Morrow M, Putintseva EV, Chudakov DM, Rudensky AY",U54 CA209975,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP092158,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89225,,"breast cancer, immunology",,U54,,,Breast,Carcinoma in situ of Breast,Whole Transcriptome Sequencing,,,,,,,tumor-immune,,Breast,,,"breast cancer, immunology",Sage,1,CA209975,CSBC Research Center for Cancer Systems Immunology at MSKCC
5227,196,syn7315805,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/29961579,Cell,2018,Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment,"Azizi E, Carr AJ, Plitas G, Cornish AE, Konopacki C, Prabhakaran S, Nainys J, W u K, Kiseliovas V, Setty M, Choi K, Fromme RM, Dao P, McKenney PT, Wasti RC, Ka daveru K, Mazutis L, Rudensky AY, Peer D",CA209975,"https://github.com/ambrosejcarr/seqc.git, https://github.com/sandhya212/BISCUIT_SingleCell_IMM_ICML_2016",,https://www.ncbi.nlm.nih.gov//bioproject/PRJNA472383,,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114724, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114725",,"scRNAseq, immune cells, breast cancer",,U54,"syn18475750,syn18475749",syn18475808,Breast,Carcinoma in situ of Breast,Single Cell Sequencing,,"GSE114724 ,GSE114725",Immune phenotype map in breast tumor,,breast,Memorial Sloan Kettering Cancer Center,tumor-immune,,Breast,Ductal Carcinoma,scRNAseq,"scRNAseq, immune cells, breast cancer",Sage,1,CA209975,CSBC Research Center for Cancer Systems Immunology at MSKCC
5002,196,syn7315805,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29038367,J Exp Med,2017,A nonimmune function of T cells in promoting lung tumor progression,"Green JA, Arpaia N, Schizas M, Dobrin A, Rudensky AY",U54 CA209975,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP116599,,,,,,U54,,,Lung,Carcinoma in situ of Bronchus and Lung,Whole Transcriptome Sequencing,,,,,,,tumor-immune,,Lung,,,,Sage,2,CA209975,CSBC Research Center for Cancer Systems Immunology at MSKCC
5096,196,syn7315805,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30224821,Nat Immunol,2018,The effect of cellular context on miR-155-mediated gene regulation in four major immune cell types,"Hsin JP, Lu Y, Loeb GB, Leslie CS, Rudensky AY",U54 CA209975,,,"https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP151684, https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP151681, https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP151472",,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116561 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116468 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116466 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116348",,,,U54,,,Not Applicable,Not Applicable,"Whole Transcriptome Sequencing, Cross-linking Immunoprecipitation High-throughput Sequencing",,,,,,,tumor-immune,,Not Applicable,,,,Sage,2,CA209975,CSBC Research Center for Cancer Systems Immunology at MSKCC
5219,196,syn7315805,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/28246332,Proc Natl Acad Sci U S A,2017,Metabolic origins of spatial organization in the tumor microenvironment,"Carmona-Fontaine C, Deforet M, Akkari L, Thompson CB, Joyce JA, Xavier JB",U54 CA209975,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP096883,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE93702,,"cancer metabolism, tumor microenvironment, morphogens, positional information, tumor-associated macrophages",,U54,syn12976504,syn12976496,Not Applicable,Not Applicable,"Whole Transcriptome Sequencing, Mathematical Modeling",,GSE93702,Spatial organization in the tumor microenvironment,10.1073/pnas.1700600114,bone marrow,Memorial Sloan Kettering Cancer Center,microenvironment,,Not Applicable,,,,Sage,2,CA209975,CSBC Research Center for Cancer Systems Immunology at MSKCC
4648,196,syn7315805,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28514453,Nature,2017,Chromatin states define tumour-specific T cell dysfunction and reprogramming,"Philip M, Fairchild L, Sun L, Horste EL, Camara S, Shakiba M, Scott AC, Viale A, Lauer P, Merghoub T, Hellmann MD, Wolchok JD, Leslie CS, Schietinger A",U54 CA209975,,,"https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP092280, https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP092279",https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001680.v1.p1,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89309 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89308 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89307",syn10916005,"chromatin structure, ATAC-Seq, immunology",,U54,"syn8415612,syn8415608",syn10916005,"Skin, Lung","Melanoma, Lung Non-Small Cell Carcinoma","ATAC-Seq, Whole Transcriptome Sequencing",,"ATAC-Seq, RNA-Seq",T Cell Chromatin States,,,,tumor-immune,,"Skin, Lung",,,"chromatin structure, ATAC-Seq, immunology",Sage,1,CA209975,CSBC Research Center for Cancer Systems Immunology at MSKCC
4874,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=25012997,Cancer Epidemiol Biomarkers Prev,2014,Metabolic health reduces risk of obesity-related cancer in framingham study adults,"Moore LL, Chadid S, Singer MR, Kreger BE, Denis GV",U01 CA182898,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,,,,,,,,microenvironment,,Breast,,,,Sage,1,CA182898,CSBC U01 Project Boston University
4876,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=24343304,Cancer Causes Control,2014,A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium,"Palmer JR, Ambrosone CB, Olshan AF",U01 CA182898,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Questionnaire,,,,,,,,,Breast,,,,Sage,1,CA182898,CSBC U01 Project Boston University
4878,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27756774,Cancer Epidemiol Biomarkers Prev,2017,Differential Patterns of Risk Factors for Early-Onset Breast Cancer by ER Status in African American Women,"Bertrand KA, Bethea TN, Adams-Campbell LL, Rosenberg L, Palmer JR",U01 CA182898,,,,,,,"epidemiology, breast cancer, metabolism",,U01,,,Breast,Carcinoma in situ of Breast,,,,,,,,microenvironment,,Breast,,,"epidemiology, breast cancer, metabolism",Sage,1,CA182898,CSBC U01 Project Boston University
4880,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=25809092,Breast Cancer Res Treat,2015,"Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium","Bandera EV, Chandran U, Hong CC, Troester MA, Bethea TN, Adams-Campbell LL, Haiman CA, Park SY, Olshan AF, Ambrosone CB, Palmer JR, Rosenberg L",U01 CA182898,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,,,,,,,,microenvironment,,Breast,,,,Sage,1,CA182898,CSBC U01 Project Boston University
4882,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29437854,Mol Cancer Res,2018,BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-mesenchymal Transition,"Andrieu GP, Denis GV",U01 CA182898,,,,,,,"EMT, breast cancer",,U01,,,Breast,Carcinoma in situ of Breast,Real Time PCR,,,,,,,metastasis,,Breast,,,"EMT, breast cancer",Sage,1,CA182898,CSBC U01 Project Boston University
4892,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27491296,Cell Mol Life Sci,2017,BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer,"Nicholas DA, Andrieu G, Strissel KJ, Nikolajczyk BS, Denis GV",U01 CA182898,,,,,,,"epigenetics, breast cancer, metabolism",,U01,,,Breast,Carcinoma in situ of Breast,,,,,,,,metastasis,,Breast,,,"epigenetics, breast cancer, metabolism",Sage,1,CA182898,CSBC U01 Project Boston University
4897,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26743380,Breast Cancer Res Treat,2016,Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium,"Ruiz-Narvez EA, Haddad SA, Lunetta KL, Yao S, Bensen JT, Sucheston-Campbell LE, Hong CC, Haiman CA, Olshan AF, Ambrosone CB, Palmer JR",U01 CA182898,,,,,,,breast cancer,,U01,,,Breast,Carcinoma in situ of Breast,Targeted Transcriptome Sequencing,,,,,,,microenvironment,,Breast,,,breast cancer,Sage,1,CA182898,CSBC U01 Project Boston University
4898,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26721669,Cancer Epidemiol Biomarkers Prev,2016,Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women,"Bethea TN, Rosenberg L, Castro-Webb N, Lunetta KL, Sucheston-Campbell LE, Ruiz-Narvez EA, Charlot M, Park SY, Bandera EV, Troester MA, Ambrosone CB, Palmer JR",U01 CA182898,,,,,,,"breast cancer, epidemiology",,U01,,,Breast,Carcinoma in situ of Breast,,,,,,,,microenvironment,,Breast,,,"breast cancer, epidemiology",Sage,1,CA182898,CSBC U01 Project Boston University
4861,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=25224496,J Natl Cancer Inst,2014,"Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium","Palmer JR, Viscidi E, Troester MA, Hong CC, Schedin P, Bethea TN, Bandera EV, Borges V, McKinnon C, Haiman CA, Lunetta K, Kolonel LN, Rosenberg L, Olshan AF, Ambrosone CB",U01 CA182898,,,,,,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4868,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=23171873,Am J Epidemiol,2012,Individual and neighborhood socioeconomic status in relation to breast cancer incidence in African-American women,"Palmer JR, Boggs DA, Wise LA, Adams-Campbell LL, Rosenberg L",U01 CA182898,,,,,,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4870,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=25103823,Cancer Epidemiol Biomarkers Prev,2014,A prospective study of physical activity and breast cancer incidence in African-American women,"Rosenberg L, Palmer JR, Bethea TN, Ban Y, Kipping-Ruane K, Adams-Campbell LL",U01 CA182898,,,,,,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4872,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=23411594,J Natl Cancer Inst,2013,Validation of a breast cancer risk prediction model developed for Black women,"Boggs DA, Rosenberg L, Pencina MJ, Adams-Campbell LL, Palmer JR",U01 CA182898,,,,,,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4873,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=23136140,Cancer Epidemiol Biomarkers Prev,2013,Genetic susceptibility loci for subtypes of breast cancer in an African American population,"Palmer JR, Ruiz-Narvaez EA, Rotimi CN, Cupples LA, Cozier YC, Adams-Campbell LL, Rosenberg L",U01 CA182898,,,,,,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4877,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=24852375,Hum Mol Genet,2014,A comprehensive examination of breast cancer risk loci in African American women,"Feng Y, Stram DO, Rhie SK, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Deming SL, Rodriguez-Gil JL, Palmer JR, Olopade OI, Huo D, Adebamowo CA, Ogundiran T, Chen GK, Stram A, Park K, Rand KA, Chanock SJ, Le Marchand L, Kolonel LN, Conti DV, Easton D, Henderson BE, Haiman CA",U01 CA182898,,,,,,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4879,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=25624428,J Clin Oncol,2015,Prospective approach to breast cancer risk prediction in African American women: the black women's health study model,"Boggs DA, Rosenberg L, Adams-Campbell LL, Palmer JR",U01 CA182898,,,,,,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4881,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=22710709,Breast Cancer Res Treat,2012,Cardiometabolic factors and breast cancer risk in US black women,"Bosco JL, Palmer JR, Boggs DA, Hatch EE, Rosenberg L",U01 CA182898,,,,,,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4883,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29141994,Cancer Res,2017,Type II Diabetes and Incidence of Estrogen Receptor Negative Breast Cancer in African American Women,"Palmer JR, Castro-Webb N, Bertrand K, Bethea TN, Denis GV",U01 CA182898,,,,,,,"breast cancer, epidemiology, diabetes, metabolism",,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,"breast cancer, epidemiology, diabetes, metabolism",,1,CA182898,CSBC U01 Project Boston University
4885,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28408379,Cancer Prev Res (Phila),2017,"""Obesity-Associated"" Breast Cancer in Lean Women: Metabolism and Inflammation as Critical Modifiers of Risk","Denis GV, Palmer JR",U01 CA182898,,,,,,,"diabetes, breast cancer, epidemiology",,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4886,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28377418,Cancer Epidemiol Biomarkers Prev,2017,Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry,"Feng Y, Rhie SK, Huo D, Ruiz-Narvaez EA, Haddad SA, Ambrosone CB, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Deming SL, Rodriguez-Gil JL, Zheng Y, Yao S, Han YJ, Ogundiran TO, Rebbeck TR, Adebamowo C, Ojengbede O, Falusi AG, Hennis A, Nemesure B, Ambs S, Blot W, Cai Q, Signorello L, Nathanson KL, Lunetta KL, Sucheston-Campbell LE, Bensen JT, Chanock SJ, Marchand LL, Olshan AF, Kolonel LN, Conti DV, Coetzee GA, Stram DO, Olopade OI, Palmer JR, Haiman CA",U01 CA182898,,,,,,,"breast cancer, epidemiology",,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,"breast cancer, epidemiology",,1,CA182898,CSBC U01 Project Boston University
4888,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27995352,Cancer Causes Control,2017,Diabetes and breast cancer mortality in Black women,"Charlot M, Castro-Webb N, Bethea TN, Bertrand K, Boggs DA, Denis GV, Adams-Campbell LL, Rosenberg L, Palmer JR",U01 CA182898,,,,,,,"diabetes, breast cancer",,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,"diabetes, breast cancer",,1,CA182898,CSBC U01 Project Boston University
4891,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27651315,Cancer Res,2016,BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling,"Andrieu G, Tran AH, Strissel KJ, Denis GV",U01 CA182898,,,,,,,"breast cancer, chromatin activity",,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,"breast cancer, chromatin activity",,1,CA182898,CSBC U01 Project Boston University
4899,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26650177,Int J Cancer,2016,Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium,"Yao S, Haddad SA, Hu Q, Liu S, Lunetta KL, Ruiz-Narvaez EA, Hong CC, Zhu Q, Sucheston-Campbell L, Cheng TY, Bensen JT, Johnson CS, Trump DL, Haiman CA, Olshan AF, Palmer JR, Ambrosone CB",U01 CA182898,,,,,,,breast cancer,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,breast cancer,,1,CA182898,CSBC U01 Project Boston University
4901,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26458823,Breast Cancer Res Treat,2015,Hormone-related pathways and risk of breast cancer subtypes in African American women,"Haddad SA, Lunetta KL, Ruiz-Narvez EA, Bensen JT, Hong CC, Sucheston-Campbell LE, Yao S, Bandera EV, Rosenberg L, Haiman CA, Troester MA, Ambrosone CB, Palmer JR",U01 CA182898,,,,,,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4908,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29493812,J Leukoc Biol,2018,"BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment","Andrieu GP, Shafran JS, Deeney JT, Bharadwaj KR, Rangarajan A, Denis GV",U01 CA182898,,,,,,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4894,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27106577,Cancer Causes Control,2016,Predictors of biospecimen donation in the Black Women's Health Study,"Adams-Campbell LL, Dash C, Palmer JR, Wiedemeier MV, Russell CW, Rosenberg L, Cozier YC",U01 CA182898,,,,,,,"breast cancer, metabolism, epidemiology",,U01,,,,"Intraductal carcinoma in situ of breast, Carcinoma in situ of Colon, Carcinoma in situ of Cervix Uteri",,,,,,,,,,,,,"breast cancer, metabolism, epidemiology",,1,CA182898,CSBC U01 Project Boston University
4865,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=23068072,Mol Aspects Med,2013,'Metabolically healthy obesity': origins and implications,"Denis GV, Obin MS",U01 CA182898,,,,,,,,,U01,,,Unspecified,Not Applicable,,,,,,,,microenvironment,,Unspecified,,,,Sage,1,CA182898,CSBC U01 Project Boston University
4871,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=23420887,J Immunol,2013,BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses,"Belkina AC, Nikolajczyk BS, Denis GV",U01 CA182898,,,,,,,,,U01,,,Unspecified,Not Applicable,,,,,,,,microenvironment,,Unspecified,,,,Sage,1,CA182898,CSBC U01 Project Boston University
4887,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28178278,PLoS One,2017,Advances in the quantification of mitochondrial function in primary human immune cells through extracellular flux analysis,"Nicholas D, Proctor EA, Raval FM, Ip BC, Habib C, Ritou E, Grammatopoulos TN, Steenkamp D, Dooms H, Apovian CM, Lauffenburger DA, Nikolajczyk BS",U01 CA182898,,,,,,,"immunology, metabolism,",,U01,,,Blood,Not Applicable,,,,,,,,microenvironment,,Blood,,,"immunology, metabolism,",Sage,,CA182898,CSBC U01 Project Boston University
4900,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26576827,Obesity (Silver Spring),2016,Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNF production,"Ip B, Cilfone NA, Belkina AC, DeFuria J, Jagannathan-Bogdan M, Zhu M, Kuchibhatla R, McDonnell ME, Xiao Q, Kepler TB, Apovian CM, Lauffenburger DA, Nikolajczyk BS",U01 CA182898,,,,,,,"diabetes, inflammation",,U01,,,Unspecified,Not Applicable,Flow Cytometry,,,,,,,microenvironment,,Unspecified,,,"diabetes, inflammation",Sage,,CA182898,CSBC U01 Project Boston University
4902,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=20585247,Curr Opin Endocrinol Diabetes Obes,2010,Obesity genes and insulin resistance,"Belkina AC, Denis GV",U01 CA182898,,,,,,,,,U01,,,Unspecified,Not Applicable,,,,,,,,microenvironment,,Unspecified,,,,Sage,1,CA182898,CSBC U01 Project Boston University
4896,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26900131,BMC Cancer,2016,Associations between metabolic disorders and risk of cancer in Danish men and women--a nationwide cohort study,"Berger SM, Gislason G, Moore LL, Andersson C, Torp-Pedersen C, Denis GV, Schmiegelow MD",U01 CA182898,,,,,,,"metabolism, epidemiology",,U01,,,Not Applicable,Pan-cancer,Statistical Modeling,,,,,,,Not Applicable,,Not Applicable,,,"metabolism, epidemiology",Sage,1,CA182898,CSBC U01 Project Boston University
4858,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=24915044,PLoS One,2014,Metabolic disease risk in children by salivary biomarker analysis,"Goodson JM, Kantarci A, Hartman ML, Denis GV, Stephens D, Hasturk H, Yaskell T, Vargas J, Wang X, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F",U01 CA182898,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4859,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=24962433,J Cell Physiol,2015,Intrinsic Sex-Linked Variations in Osteogenic and Adipogenic Differentiation Potential of Bone Marrow Multipotent Stromal Cells,"Bragdon B, Burns R, Baker AH, Belkina AC, Morgan EF, Denis GV, Gerstenfeld LC, Schlezinger JJ",U01 CA182898,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4860,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=24487726,Cancer Causes Control,2014,Bilateral oophorectomy and risk of cancer in African American women,"Boggs DA, Palmer JR, Rosenberg L",U01 CA182898,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4862,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=22722403,Nat Rev Cancer,2012,"BET domain co-regulators in obesity, inflammation and cancer","Belkina AC, Denis GV",U01 CA182898,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4863,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=22889227,Immunol Rev,2012,The outliers become a stampede as immunometabolism reaches a tipping point,"Nikolajczyk BS, Jagannathan-Bogdan M, Denis GV",U01 CA182898,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4864,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=25106001,Curr Opin Endocrinol Diabetes Obes,2014,Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease,"Strissel KJ, Denis GV, Nikolajczyk BS",U01 CA182898,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4866,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=23374712,Vitam Horm,2013,"Brd2 gene disruption causes ""metabolically healthy"" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes","Wang F, Deeney JT, Denis GV",U01 CA182898,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4867,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=24319289,J Leukoc Biol,2014,The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis,"Belkina AC, Blanton WP, Nikolajczyk BS, Denis GV",U01 CA182898,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4869,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=23974763,Curr Opin Endocrinol Diabetes Obes,2013,Healthy obese persons: how can they be identified and do metabolic profiles stratify risk?,"Denis GV, Hamilton JA",U01 CA182898,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4875,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=23479618,Proc Natl Acad Sci U S A,2013,B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile,"DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, Markham D, Strissel KJ, Watkins AA, Zhu M, Allen J, Bouchard J, Toraldo G, Jasuja R, Obin MS, McDonnell ME, Apovian C, Denis GV, Nikolajczyk BS",U01 CA182898,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4884,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28840653,Obesity (Silver Spring),2017,"Relationships Among Obesity, Type 2 Diabetes, and Plasma Cytokines in African American Women","Denis GV, Sebastiani P, Andrieu G, Tran AH, Strissel KJ, Lombardi FL, Palmer JR",U01 CA182898,,,,,,,"diabetes, epidemiology",,U01,,,,,,,,,,,,,,,,,"diabetes, epidemiology",,1,CA182898,CSBC U01 Project Boston University
4889,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27942580,NPJ Breast Cancer,2016,"Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium","Ruiz-Narvez EA, Lunetta KL, Hong CC, Haddad S, Yao S, Cheng TD, Bensen JT, Bandera EV, Haiman CA, Troester MA, Ambrosone CB, Rosenberg L, Palmer JR",U01 CA182898,,,,,,,"breast cancer, epidemiology",,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4890,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27769357,Drug Discov Today Technol,2016,Clinical trials for BET inhibitors run ahead of the science,"Andrieu G, Belkina AC, Denis GV",U01 CA182898,,,,,,,chromatin activity,,U01,,,,,,,,,,,,,,,,,chromatin activity,,1,CA182898,CSBC U01 Project Boston University
4893,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27441007,Clin Med Insights Womens Health,2016,Barriers to Obtaining Sera and Tissue Specimens of African-American Women for the Advancement of Cancer Research,"Strissel KJ, Nicholas DA, Castagne-Charlotin M, Ko N, Denis GV",U01 CA182898,,,,,,,"breast cancer, metabolism, epidemiology",,U01,,,,,,,,,,,,,,,,,,,1,CA182898,CSBC U01 Project Boston University
4895,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27008626,PLoS One,2016,"BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic -Cell","Deeney JT, Belkina AC, Shirihai OS, Corkey BE, Denis GV",U01 CA182898,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77450,,"metabolism, chromatin activity",,U01,,,,,,,,,,,,,,,,,"metabolism, chromatin activity",Sage,1,CA182898,CSBC U01 Project Boston University
4824,196,syn9775704,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26181325,PLoS One,2015,Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer,"Korkola JE, Collisson EA, Heiser M, Oates C, Bayani N, Itani S, Esch A, Thompson W, Griffith OL, Wang NJ, Kuo WL, Cooper B, Billig J, Ziyad S, Hung JL, Jakkula L, Feiler H, Lu Y, Mills GB, Spellman PT, Tomlin C, Mukherjee S, Gray JW",U01 CA195469,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Mathematical Modeling,,,,,,,drug resistance/sensitivity,,Breast,,,,Sage,1,CA195469,CSBC U01 Project DFCI
4825,196,syn9775704,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29184166,Sci Rep,2017,"Quantitative, in situ analysis of mRNAs and proteins with subcellular resolution","Kwon S, Chin K, Nederlof M, Gray JW",U01 CA195469,,,,,,,immunoFISH,,U01,,,Breast,Carcinoma in situ of Breast,FISH,,,,,,,heterogeneity/evolution,,Breast,,,immunoFISH,Sage,1,CA195469,CSBC U01 Project DFCI
4826,196,syn9775704,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26894975,Oncotarget,2016,Therapeutic siRNA for drug-resistant HER2-positive breast cancer,"Gu S, Hu Z, Ngamcherdtrakul W, Castro DJ, Morry J, Reda MM, Gray JW, Yantasee W",U01 CA195469,,,,,,,"breast cancer, siRNA",,U01,,,Breast,Carcinoma in situ of Breast,,,,,,,,drug resistance/sensitivity,,Breast,,,"breast cancer, siRNA",Sage,1,CA195469,CSBC U01 Project DFCI
4823,196,syn9775704,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26248648,Mol Cancer Res,2016,Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics,"Goodspeed A, Heiser LM, Gray JW, Costello JC",U01 CA195469,,,,,,,"pharmacogenomics, computational biology",,U01,,,Not Applicable,Pan-cancer,Not Applicable,,,,,,,drug resistance/sensitivity,,Not Applicable,,,,Sage,1,CA195469,CSBC U01 Project DFCI
4967,196,syn9775704,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29550255,Cell Syst,2018,Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes,"Watson SS, Dane M, Chin K, Tatarova Z, Liu M, Liby T, Thompson W, Smith R, Nederlof M, Bucher E, Kilburn D, Whitman M, Sudar D, Mills GB, Heiser LM, Jonas O, Gray JW, Korkola JE",U01 CA195469,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA195469,CSBC U01 Project DFCI
4848,196,syn9775689,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26811325,Cancer Discov,2016,Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression,"Oudin MJ, Jonas O, Kosciuk T, Broye LC, Guido BC, Wyckoff J, Riquelme D, Lamar JM, Asokan SB, Whittaker C, Ma D, Langer R, Cima MJ, Wisinski KB, Hynes RO, Lauffenburger DA, Keely PJ, Bear JE, Gertler FB",U01 CA184897,,,,,,,"breast cancer, migration, microenvironment",,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,microenvironment,,,,,,Sage,1,CA184897,CSBC U01 Project MIT BIMDC MGH
4851,196,syn9775689,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=25380226,Elife,2014,Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state,"Katz Y, Li F, Lambert NJ, Sokol ES, Tam WL, Cheng AW, Airoldi EM, Lengner CJ, Gupta PB, Yu Z, Jaenisch R, Burge CB",U01 CA184897,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58423,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,Sage,1,CA184897,CSBC U01 Project MIT BIMDC MGH
4847,196,syn9775689,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26437589,Trends Cell Biol,2015,Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression,"Ye X, Weinberg RA",U01 CA184897,,,,,,,,,U01,,,Unspecified,Not Applicable,,,,,,,,metastasis,,Unspecified,,,,Sage,1,CA184897,CSBC U01 Project MIT BIMDC MGH
4845,196,syn9775689,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=25617416,Bioinformatics,2015,Quantitative visualization of alternative exon expression from RNA-seq data,"Katz Y, Wang ET, Silterra J, Schwartz S, Wong B, Thorvaldsdttir H, Robinson JT, Mesirov JP, Airoldi EM, Burge CB",U01 CA184897,http://miso.readthedocs.org/en/fastmiso/sashimi.html,,,,,,,,U01,,,Not Applicable,Not Applicable,Computational Tool,,,,,,,Not Applicable,,Not Applicable,,,,Sage,1,CA184897,CSBC U01 Project MIT BIMDC MGH
4846,196,syn9775689,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26331542,Nature,2015,Distinct EMT programs control normal mammary stem cells and tumour-initiating cells,"Ye X, Tam WL, Shibue T, Kaygusuz Y, Reinhardt F, Ng Eaton E, Weinberg RA",U01 CA184897,https://www.ncbi.nlm.nih.gov/sra?LinkName=pubmed_sra&from_uid=26331542,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61198,,,,U01,,,Breast,Carcinoma in situ of Breast,ChIP-Seq,,,,,,,metastasis,,Breast,,,,Sage,1,CA184897,CSBC U01 Project MIT BIMDC MGH
4849,196,syn9775689,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28735747,Neuron,2017,"A Requirement for Mena, an Actin Regulator, in Local mRNA Translation in Developing Neurons","Vidaki M, Drees F, Saxena T, Lanslots E, Taliaferro MJ, Tatarakis A, Burge CB, Wang ET, Gertler FB",U01 CA184897,,,,,,,local translation,,U01,,,Not Applicable,Not Applicable,"Mass Spectrometry, Cross-linking Immunoprecipitation High-throughput Sequencing",,,,,,,Not Applicable,,Not Applicable,,,local translation,Sage,1,CA184897,CSBC U01 Project MIT BIMDC MGH
4850,196,syn9775689,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26907613,Mol Cell,2016,Distal Alternative Last Exons Localize mRNAs to Neural Projections,"Taliaferro JM, Vidaki M, Oliveira R, Olson S, Zhan L, Saxena T, Wang ET, Graveley BR, Gertler FB, Swanson MS, Burge CB",U01 CA184897,,https://www.ncbi.nlm.nih.gov/sra/?Db=sra&DbFrom=pmc&Cmd=Link&LinkName=pmc_sra&IdsFromResult=4798900,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67828,,"mRNA translation, mRNA splicing",,U01,,,Not Applicable,Not Applicable,Whole Transcriptome Sequencing,,,,,,,Not Applicable,,Not Applicable,,,"mRNA translation, mRNA splicing",Sage,1,CA184897,CSBC U01 Project MIT BIMDC MGH
4820,196,syn9774783,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29339479,Proc Natl Acad Sci U S A,2018,HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice,"Devignes CS, Aslan Y, Brenot A, Devillers A, Schepers K, Fabre S, Chou J, Casbon AJ, Werb Z, Provot S",U01 CA199315,,,,,,,"hypoxia, metastasis, breast cancer",,U01,,,,Bone Tumor,,,,,,,,metastasis,,,,,,Sage,1,CA199315,CSBC U01 Project UCSF
5188,196,syn9774783,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29795293,Nat Commun,2018,Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity,"Nguyen QH, Pervolarakis N, Blake K, Ma D, Davis RT, James N, Phung AT, Willey E, Kumar R, Jabart E, Driver I, Rock J, Goga A, Khan SA, Lawson DA, Werb Z, Kessenbrock K",U01 CA199315,,,,,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113198 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113197 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113196 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113127 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113099",,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,Sage,1,CA199315,CSBC U01 Project UCSF
4822,196,syn9774783,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29131550,FEBS J,2017,Innate and acquired immune surveillance in the postdissemination phase of metastasis,"Gonzalez H, Robles I, Werb Z",U01 CA199315,,,,,,,"immunology, metastasis, microenvironment,",,U01,,,Unspecified,Not Applicable,,,,,,,,metastasis,,Unspecified,,,"immunology, metastasis, microenvironment,",Sage,1,CA199315,CSBC U01 Project UCSF
4821,196,syn9774783,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27725631,Nat Commun,2016,Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers,"Allaoui R, Bergenfelz C, Mohlin S, Hagerling C, Salari K, Werb Z, Anderson RL, Ethier SP, Jirstrm K, Phlman S, Bexell D, Tahin B, Johansson ME, Larsson C, Leandersson K",U01 CA199315,,,,,,,"breast cancer, microenvironment, inflammation",,U01,,,Breast,Carcinoma in situ of Breast,PDX,,,,,,,"tumor-immune, microenvironment",,Carcinoma in situ of Breast,,,"breast cancer, microenvironment, inflammation",Sage,1,CA199315,CSBC U01 Project UCSF
4926,196,syn9774783,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29541388,Oncotarget,2017,Single-cell RNA sequencing reveals gene expression signatures of breast cancer-associated endothelial cells,"Sun Z, Wang CY, Lawson DA, Kwek S, Velozo HG, Owyong M, Lai MD, Fong L, Wilson M, Su H, Werb Z, Cooke DL",U01 CA199315,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA199315,CSBC U01 Project UCSF
5012,196,syn9774959,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29907681,Cancer Res,2018,"Case Studies of Gastric, Lung, and Oral Cancer Connect Etiologic Agent Prevalence to Cancer Incidence","Brouwer AF, Eisenberg MC, Meza R",U01 CA182915,,,,,,,,,U01,,,Stomach,Gastric Adenocarcinoma,Not Applicable,,,,,,,,,Stomach,,,,Sage,1,CA182915,CSBC U01 Project University of Michigan
5032,196,syn9774959,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29978468,Int J Cancer,2018,DNA Concentration from self samples for HPV testing,"Meza R, Lau YK, Thomas TB, Carey TE, Walline HM, Eisenberg MC",U01 CA182915,,,,,,,,,U01,,,Unspecified,Human Papillomavirus,,,,,,,,microenvironment,,Unspecified,,,,Sage,1,CA182915,CSBC U01 Project University of Michigan
4852,196,syn9774959,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28288156,PLoS Comput Biol,2017,Parameter estimation for multistage clonal expansion models from cancer incidence data: A practical identifiability analysis,"Brouwer AF, Meza R, Eisenberg MC",U01 CA182915,,,,,,,"mathematicalModels,epidemiology",,U01,,,,Malignant Neoplasm of Pancreas,,,,,,,,,,,,,"mathematicalModels,epidemiology",,1,CA182915,CSBC U01 Project University of Michigan
4856,196,syn9774959,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26963717,PLoS One,2016,Age Effects and Temporal Trends in HPV-Related and HPV-Unrelated Oral Cancer in the United States: A Multistage Carcinogenesis Modeling Analysis,"Brouwer AF, Eisenberg MC, Meza R",U01 CA182915,,,,,,,"oral squamous cell carcinoma, epidemiology",,U01,,,,Squamous Cell Cancer,,,,,,,,,,,,,"oral squamous cell carcinoma, epidemiology",,1,CA182915,CSBC U01 Project University of Michigan
4853,196,syn9774959,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26689203,BMC Infect Dis,2015,Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003-2012,"Brouwer AF, Eisenberg MC, Carey TE, Meza R",U01 CA182915,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,1,CA182915,CSBC U01 Project University of Michigan
4854,196,syn9774959,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29094082,J Glob Oncol,2017,Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala,"Gottschlich A, Rivera-Andrade A, Grajeda E, Alvarez C, Mendoza Montano C, Meza R",U01 CA182915,,,,,,,epidemiology,,U01,,,Cervix Uteri,Carcinoma in situ of Cervix Uteri,Not Applicable,,,,,,,Not Applicable,,Cervix Uteri,,,,Sage,1,CA182915,CSBC U01 Project University of Michigan
4855,196,syn9774959,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27612302,Risk Anal,2017,A Systematic Approach to Determining the Identifiability of Multistage Carcinogenesis Models,"Brouwer AF, Meza R, Eisenberg MC",U01 CA182915,,,,,,,differential algebra,,U01,,,Not Applicable,Pan-cancer,Mathematical Modeling,,,,,,,heterogeneity/evolution,,Not Applicable,,,differential algebra,Sage,1,CA182915,CSBC U01 Project University of Michigan
4857,196,syn9774959,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26518265,Math Biosci,2015,Transmission heterogeneity and autoinoculation in a multisite infection model of HPV,"Brouwer AF, Meza R, Eisenberg MC",U01 CA182915,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182915,CSBC U01 Project University of Michigan
4960,196,syn9774959,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28733187,J Theor Biol,2017,A confidence building exercise in data and identifiability: Modeling cancer chemotherapy as a case study,"Eisenberg MC, Jain HV",U01 CA182915,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182915,CSBC U01 Project University of Michigan
5177,196,syn9774959,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30282679,BMJ Open,2018,Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study,"Eisenberg MC, Campredon LP, Brouwer AF, Walline HM, Marinelli BM, Lau YK, Thomas TB, Delinger RL, Sullivan TS, Yost ML, Goudsmit CM, Carey TE, Meza R",U01 CA182915,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA182915,CSBC U01 Project University of Michigan
4691,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28360138,Cancer Res,2017,Mathematical Modeling Links Pregnancy-Associated Changes and Breast Cancer Risk,"Temko D, Cheng YK, Polyak K, Michor F",U54 CA193461,,,,,,,"mathematical modeling, breast cancer",,U54,,,Breast,Carcinoma in situ of Breast,,,,,,,,,,Breast,,,"mathematical modeling, breast cancer",Center,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4916,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28333954,PLoS One,2018,Distance in cancer gene expression from stem cells predicts patient survival,"Riester M, Wu HJ, Zehir A, Gnen M, Moreira AL, Downey RJ, Michor F",U54 CA193461,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,,,,,,,,,,Breast,,,,Center,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
5221,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/28652380,Cancer Discov,2018,Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition,"Gil Del Alcazar CR, Huh SJ, Ekram MB, Trinh A, Liu LL, Beca F, Zi X, Kwak M, Bergholtz H, Su Y, Ding L, Russnes HG, Richardson AL, Babski K, Min Hui Kim E, McDonnell CH 3rd, Wagner J, Rowberry R, Freeman GJ, Dillon D, Sorlie T, Coussens LM, Garber JE, Fan R, Bobolis K, Allred DC, Jeong J, Park SY, Michor F, Polyak K",U54 CA193461,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87517,,"immune escape, breast tumor progression, invasive ductal carcinomas",,U54,syn12976694,syn12976693,Breast,Carcinoma in situ of Breast,,,GSE87517,Immune Escape in Breast Cancer,10.1158/2159-8290.CD-17-0222,breast,Dana-Farber Cancer Institute,Tumor-immune,,Breast,,,,Center,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4689,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29293494,PLoS Comput Biol,2018,Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients,"Stein S, Zhao R, Haeno H, Vivanco I, Michor F",U54 CA193461,,,,,,,"glioblastoma, mathematical modeling, lapatinib, treatment schedule optimisation",,U54,,,,Glioblastoma,,,,,,,,,,,,,"glioblastoma, mathematical modeling, lapatinib, treatment schedule optimisation",,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4921,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28774478,Trends Mol Med,2017,Putting Glioblastoma in Its Place: IRF3 Inhibits Invasion,"Pattwell SS, Holland EC",U54 CA193461,,,,,,,,,U54,,,,Glioblastoma,,,,,,,,,,,,,,,2,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4963,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29632085,Genes Dev,2018,Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in IDH wild-type glioblastoma,"Cimino PJ, Kim Y, Wu HJ, Alexander J, Wirsching HG, Szulzewsky F, Pitter K, Ozawa T, Wang J, Vazquez J, Arora S, Rabadan R, Levine R, Michor F, Holland EC","U54 CA193461, U54 CA193313",,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89409,,,,U54,,,,Glioblastoma,,,,,,,,,,,,,,Sage,2,"CA193461, CA193313",Dana-Farber Cancer Institute Physical Sciences-Oncology Center
5111,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28614736,Nanomedicine,2017,Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma,"Kievit FM, Wang K, Ozawa T, Tarudji AW, Silber JR, Holland EC, Ellenbogen RG, Zhang M",U54 CA193461,,,,,,,,,U54,,,Brain,Glioblastoma,Unspecified,,,,,,,drug resistance/sensitivity,,Brain,,,,Sage,2,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4913,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28465358,Genes Dev,2017,Mutant IDH1 regulates the tumor-associated immune system in gliomas,"Amankulor NM, Kim Y, Arora S, Kargl J, Szulzewsky F, Hanke M, Margineantu DH, Rao A, Bolouri H, Delrow J, Hockenbery D, Houghton AM, Holland EC",U54 CA193461,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE96979,,,,U54,,,,Glioma,,,,,,,,,,,,,,Sage,2,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
5009,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29949764,Cell Rep,2018,A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-B,"Ozawa T, Arora S, Szulzewsky F, Juric-Sekhar G, Miyajima Y, Bolouri H, Yasui Y, Barber J, Kupp R, Dalton J, Jones TS, Nakada M, Kumabe T, Ellison DW, Gilbertson RJ, Holland EC",U54 CA193461,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE93765,,,,U54,,,Brain,Glioma,Not Applicable,,,,,,,heterogeneity/evolution,,Brain,,,,Sage,2,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
5218,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/28465358,Genes Dev,2017,Mutant IDH1 regulates the tumor-associated immune system in gliomas,"Nduka M. Amankulor, Youngmi Kim, Sonali Arora, Julia Kargl, Frank Szulzewsky, Mark Hanke, Daciana H. Margineantu, Aparna Rao1, Hamid Bolouri, Jeff Delrow, David Hockenbery, A. McGarry Houghton and Eric C. Holland","CA143798, CA163167, CA193461",,,,,,,"glioma, expression profiling, CpG island",,U54,syn12976490,syn12976486,Brain,Glioma,Expression Array,,GSE96979,Tumor-associated immune system in gliomas,10.1101/gad.294991.116,brain,Dana-Farber Cancer Institute,,,Brain,,,,Sage,,"CA143798, CA163167, CA193461",Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4923,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28068180,J Clin Oncol,2017,Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma,"Gibson CJ, Lindsley RC, Tchekmedyian V, Mar BG, Shi J, Jaiswal S, Bosworth A, Francisco L, He J, Bansal A, Morgan EA, Lacasce AS, Freedman AS, Fisher DC, Jacobsen E, Armand P, Alyea EP, Koreth J, Ho V, Soiffer RJ, Antin JH, Ritz J, Nikiforow S, Forman SJ, Michor F, Neuberg D, Bhatia R, Bhatia S, Ebert BL",U54 CA193461,,,,,,,,,U54,,,,"Hodgkin Lymphoma, Myelodysplastic syndromes, Acute Myeloblastic Leukemia, Non-Hodgkin Lymphoma",,,,,,,,,,,,,,,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4685,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27526321,Nat Genet,2016,Punctuated copy number evolution and clonal stasis in triple-negative breast cancer,"Gao R, Davis A, McDonald TO, Sei E, Shi X, Wang Y, Tsai PC, Casasent A, Waters J, Zhang H, Meric-Bernstam F, Michor F, Navin NE",U54 CA193461,,,,,,,"triple-negative breast cancer, tumor evolution, copy number aberrations, single cell, single-cell sequencing, experimental method, mathematical modeling",,U54,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,"triple-negative breast cancer, tumor evolution, copy number aberrations, single cell, single-cell sequencing, experimental method, mathematical modeling",,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4677,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28073786,Ann Oncol,2017,Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers,"Yu HA, Sima C, Feldman D, Liu LL, Vaitheesvaran B, Cross J, Rudin CM, Kris MG, Pao W, Michor F, Riely GJ",U54 CA193461,,,,,,,"EGFR-mutant lung cancer, acquired resistance, evolutionary modeling, EGFR T790M, pulse dose erlotinib, clinical study",,U54,,,,Lung Carcinoma,,,,,,,,,,,,,,,3,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4690,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28566331,Cancer Res,2017,Pharmacokinetics and Drug Interactions Determine Optimum Combination Strategies in Computational Models of Cancer Evolution,"Chakrabarti S, Michor F",U54 CA193461,,,,,,,"mathematical modeling, pharmacokinetics",,U54,,,,Lung Carcinoma,,,,,,,,,,,,,"mathematical modeling, pharmacokinetics",,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
5225,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/28963352,Cancer Discov,2017,mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors,"Malone CF, Emerson C, Ingraham R, Barbosa W, Guerra S, Yoon H, Liu LL, Michor F, Haigis M, Macleod KF, Maertens O, Cichowski K",U54 CA193461,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE84205,,"kinases, oxidative stress, combination therapy",,U54,syn12976748,syn12976747,Nervous system,Malignant Peripheral Nerve Tissue Tumor,MicroRNA Sequencing,,GSE84205,Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors,10.1158/2159-8290.CD-17-0177,nerve,Dana-Farber Cancer Institute,,,Nervous system,,,,Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4681,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27006493,Clin Cancer Res,2016,Myeloma Cell Dynamics in Response to Treatment Supports a Model of Hierarchical Differentiation and Clonal Evolution,"Tang M, Zhao R, van de Velde H, Tross JG, Mitsiades C, Viselli S, Neuwirth R, Esseltine DL, Anderson K, Ghobrial IM, San Miguel JF, Richardson PG, Tomasson MH, Michor F",U54 CA193461,,,,,,,"multiple myeloma, clonal evolution, mathematical modeling, selective pressure",,U54,,,,Multiple Myeloma,,,,,,,,,,,,,"multiple myeloma, clonal evolution, mathematical modeling, selective pressure",,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4911,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28380360,Cell Rep,2017,The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma,"Mishima Y, Paiva B, Shi J, Park J, Manier S, Takagi S, Massoud M, Perilla-Glen A, Aljawai Y, Huynh D, Roccaro AM, Sacco A, Capelletti M, Detappe A, Alignani D, Anderson KC, Munshi NC, Prosper F, Lohr JG, Ha G, Freeman SS, Van Allen EM, Adalsteinsson VA, Michor F, San Miguel JF, Ghobrial IM",U54 CA193461,,,,,,,,,U54,,,Blood,Multiple Myeloma,Whole Exome Sequencing,,,,,,,microenvironment,,Blood,,,,Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4915,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28723910,PLoS One,2017,Estimating mono- and bi-phasic regression parameters using a mixture piecewise linear Bayesian hierarchical model,"Zhao R, Catalano P, DeGruttola VG, Michor F",U54 CA193461,,,,,,,,,U54,,,,Multiple Myeloma,,,,,,,,,,,,,,,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4692,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28765841,Analyst,2017,"Capture, amplification, and global profiling of microRNAs from low quantities of whole cell lysate","Wang N, Cheng J, Fan R, Lu J",U54 CA193461,,,,,,,"miRNA, expression profiling, library preparation, experimental protocol",,U54,,,Unspecified,Not Applicable,MicroRNA Sequencing,,,,,,,heterogeneity/evolution,,Unspecified,,,"miRNA, expression profiling, library preparation, experimental protocol",Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4932,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28334409,Bioinformatics,2017,SIApopr: a computational method to simulate evolutionary branching trees for analysis of tumor clonal evolution,"McDonald TO, Michor F",U54 CA193461,,,,,,,,,U54,,,Unspecified,Not Applicable,Single Cell Sequencing,,,,,,,heterogeneity/evolution,,Unspecified,,,,Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
5224,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/28126923,Nucleic Acids Res,2017,Bisulfite-independent analysis of CpG island methylation enables genome-scale stratification of single cells,"Han L, Wu HJ, Zhu H, Kim KY, Marjani SL, Riester M, Euskirchen G, Zi X, Yang J, Han J, Snyder M, Park IH, Irizarry R, Weissman SM, Michor F, Fan R, Pan X",U54 CA193461,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75346,,"chromatin, epigenetics",,U54,syn12976746,syn12976745,Not Applicable,Not Applicable,scCGIseq,,GSE75346,Genome-scale stratification of single cells,10.1093/nar/gkx026,Not Applicable,Dana-Farber Cancer Institute,heterogeneity/evolution,,Not Applicable,,,,Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4675,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28548090,Nat Commun,2017,Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration,"Jayatilaka H, Tyle P, Chen JJ, Kwak M, Ju J, Kim HJ, Lee JSH, Wu PH, Gilkes DM, Fan R, Wirtz D","U54 CA193461, U54 CA210173",,,,,,,"imaging, microscopy, migration, metastasis, motility, fibrosarcoma, breast carcinoma, glioblastoma",,U54,,,,"Sarcoma, Epithelial Carcinoma",,,,,,,,,,,,,"imaging, microscopy, migration, metastasis, motility, fibrosarcoma, breast carcinoma, glioblastoma",,,"CA193461, CA210173",Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4682,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27299299,Am J Hematol,2016,Mathematical modeling of erythrocyte chimerism informs genetic intervention strategies for sickle cell disease,"Altrock PM, Brendel C, Renella R, Orkin SH, Williams DA, Michor F",U54 CA193461,,,,,,,"mathematical modeling, sickle cell disease",,U54,,,Bone marrow,Sickle Cell Anemia,,,,,,,,drug resistance/sensitivity,,Bone marrow,,,"mathematical modeling, sickle cell disease",Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4684,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26379039,PLoS Comput Biol,2015,An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer,"Foo J, Liu LL, Leder K, Riester M, Iwasa Y, Lengauer C, Michor F",U54 CA193461,,,,,,,"mathematical modeling, colorectal cancer, driver mutation, evolution",,U54,,,,Tumor of the Large Bowel,,,,,,,,,,,,,,,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4678,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28235203,Cell,2017,Epigenetic Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells,"Yu VW, Yusuf RZ, Oki T, Wu J, Saez B, Wang X, Cook C, Baryawno N, Ziller MJ, Lee E, Gu H, Meissner A, Lin CP, Kharchenko PV, Scadden DT",U54 CA193461,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87527,,erratum,,U54,,,Not Applicable,Not Applicable,"ATAC-Seq, Whole Transcriptome Sequencing, Single Cell Sequencing, Bisulfite Sequencing",,,,,,,heterogeneity/evolution,,Not Applicable,,,erratum,Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4679,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28085223,Mol Oncol,2017,Circulating and disseminated tumor cells: harbingers or initiators of metastasis?,"Dasgupta A, Lim AR, Ghajar CM",U54 CA193461,,,,,,,"review, circulating tumor cells, disseminated tumor cells",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,"microenvironment, heterogeneity/evolution",,Not Applicable,,,"review, circulating tumor cells, disseminated tumor cells",Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4680,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26349637,Small,2015,Interfacing Inorganic Nanowire Arrays and Living Cells for Cellular Function Analysis,"Kwak M, Han L, Chen JJ, Fan R",U54 CA193461,,,,,,,"cell-substrate interactions, cellular function analysis, intracellular delivery, nanowire arrays, rare cell analysis, revie",,U54,,,Not Applicable,Not Applicable,Nanowire,,,,,,,tumor-immune,,Not Applicable,,,"cell-substrate interactions, cellular function analysis, intracellular delivery, nanowire arrays, rare cell analysis, revie",Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4683,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26590416,Cell,2015,Improving Cancer Treatment via Mathematical Modeling: Surmounting the Challenges Is Worth the Effort,"Michor F, Beal K",U54 CA193461,,,,,,,"cancer treatment, mathematical modeling, perspective",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,drug resistance/sensitivity,,Not Applicable,,,,Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4686,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27531101,Bioinformatics,2016,A computational strategy to adjust for copy number in tumor Hi-C data,"Wu HJ, Michor F",U54 CA193461,https://bitbucket.org/mthjwu/hicapp,,,,,,"Hi-C, copy number, computational method",,U54,,,"Breast, Bone marrow","Carcinoma in situ of Breast, Chronic myeloid leukemia","Computational Tool, Hi-C",,,,,,,Not Applicable,,"Breast, Bone marrow",,,"Hi-C, copy number, computational method",Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4687,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28967881,Nat Struct Mol Biol,2017,Nuclear topology modulates the mutational landscapes of cancer genomes,"Smith KS, Liu LL, Ganesan S, Michor F, De S",U54 CA193461,,,,,,,"DNA damage, DNA repair, lamina, nucleus, nuclear organization, mutational landscape",,U54,,,Not Applicable,Pan-cancer,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4688,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28303905,Nat Rev Cancer,2017,Pre-metastatic niches: organ-specific homes for metastases,"Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, Bissell MJ, Cox TR, Giaccia AJ, Erler JT, Hiratsuka S, Ghajar CM, Lyden D",U54 CA193461,,,,,,,"review, metastasis, seed-and-soil hypothesis",,U54,,,Not Applicable,Pan-cancer,Not Applicable,,,,,,,microenvironment,,Not Applicable,,,"review, metastasis, seed-and-soil hypothesis",Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4693,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28959968,Nature,2017,Epigenetic restriction of extraembryonic lineages mirrors the somatic transition to cancer,"Smith ZD, Shi J, Gu H, Donaghey J, Clement K, Cacchiarelli D, Gnirke A, Michor F, Meissner A",U54 CA193461,,"https://www.ncbi.nlm.nih.gov/sra/?Db=sra&DbFrom=pmc&Cmd=Link&LinkName=pmc_sra&IdsFromResult=5789792, https://www.ncbi.nlm.nih.gov/bioproject/?Db=bioproject&DbFrom=pmc&Cmd=Link&LinkName=pmc_bioproject&IdsFromResult=5789792",,,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE98963 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE98960 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE84236 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE84235 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE84234 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE84232 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58889",,,,U54,,,Not Applicable,Pan-cancer,"Bisulfite Sequencing, Whole Transcriptome Sequencing, ATAC-Seq",,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
4910,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28097472,Cancer Causes Control,2017,Proceedings of the third international molecular pathological epidemiology (MPE) meeting,"Campbell PT, Rebbeck TR, Nishihara R, Beck AH, Begg CB, Bogdanov AA, Cao Y, Coleman HG, Freeman GJ, Heng YJ, Huttenhower C, Irizarry RA, Kip NS, Michor F, Nevo D, Peters U, Phipps AI, Poole EM, Qian ZR, Quackenbush J, Robins H, Rogan PK, Slattery ML, Smith-Warner SA, Song M, VanderWeele TJ, Xia D, Zabor EC, Zhang X, Wang M, Ogino S",U54 CA193461,,,,,,,,,U54,,,,,,,,,,,,,,,,,,,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
5149,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28043968,J Cell Sci,2017,"Tissue mechanics regulate brain development, homeostasis and disease","Barnes JM, Przybyla L, Weaver VM",U01 CA202241,,,,,,,,,U01,,,Unspecified,Glioblastoma,,,,,,,,microenvironment,,Unspecified,,,,Sage,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5172,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=25959051,Integr Biol (Camb),2015,Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration,"Acerbi I, Cassereau L, Dean I, Shi Q, Au A, Park C, Chen YY, Liphardt J, Hwang ES, Weaver VM",U01 CA202241,,,,,,,,,U01,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5201,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28025167,Matrix Biol,2017,Force-dependent breaching of the basement membrane,"Chang TT, Thakar D, Weaver VM",U01 CA202241,,,,,,,,,U01,,,,"Intraductal carcinoma in situ of breast, Malignant Neoplasm of Pancreas, Hepatoma",,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5100,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27089513,Nat Med,2016,Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression,"Laklai H, Miroshnikova YA, Pickup MW, Collisson EA, Kim GE, Barrett AS, Hill RC, Lakins JN, Schlaepfer DD, Mouw JK, LeBleu VS, Roy N, Novitskiy SV, Johansen JS, Poli V, Kalluri R, Iacobuzio-Donahue CA, Wood LD, Hebrok M, Hansen K, Moses HL, Weaver VM",U01 CA202241,,,,,,,,,U01,,,,Malignant Neoplasm of Pancreas,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5072,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29866846,Proc Natl Acad Sci U S A,2018,Spatially modulated ephrinA1:EphA2 signaling increases local contractility and global focal adhesion dynamics to promote cell motility,"Chen Z, Oh D, Biswas KH, Yu CH, Zaidel-Bar R, Groves JT",U01 CA202241,,,,,,,,,U01,,,Not Applicable,Not Applicable,,,,,,,,metastasis,,Not Applicable,,,,Sage,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5153,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26812279,J Am Chem Soc,2016,Covalent Ras Dimerization on Membrane Surfaces through Photosensitized Oxidation,"Chung JK, Lee YK, Lam HY, Groves JT",U01 CA202241,,,,,,,,,U01,,,Unspecified,Not Applicable,Spectroscopy,,,,,,,drug resistance/sensitivity,,Unspecified,,,,Sage,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5198,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30075851,Biophys J,2018,Spatiomechanical Modulation of EphB4-Ephrin-B2 Signaling in Neural Stem Cell Differentiation,"Dong M, Spelke DP, Lee YK, Chung JK, Yu CH, Schaffer DV, Groves JT",U01 CA202241,,,,,,,,,U01,,,Nervous system,Not Applicable,Not Applicable,,,,,,,heterogeneity/evolution,,Nervous system,,,,Sage,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5043,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27334548,Integr Biol (Camb),2016,Visualizing mechanical modulation of nanoscale organization of cell-matrix adhesions,"Ou G, Thakar D, Tung JC, Miroshnikova YA, Dufort CC, Gutierrez E, Groisman A, Weaver VM",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5056,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30053426,Cell,2018,Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding,"Sibener LV, Fernandes RA, Kolawole EM, Carbone CB, Liu F, McAffee D, Birnbaum ME, Yang X, Su LF, Yu W, Dong S, Gee MH, Jude KM, Davis MM, Groves JT, Goddard WA 3rd, Heath JR, Evavold BD, Vale RD, Garcia KC",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5057,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27056543,Trends Cell Biol,2016,Force Matters: Biomechanical Regulation of Cell Invasion and Migration in Disease,"Kai F, Laklai H, Weaver VM",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5069,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26378258,Mol Biol Cell,2015,Diffusion of GPI-anchored proteins is influenced by the activity of dynamic cortical actin,"Saha S, Lee IH, Polley A, Groves JT, Rao M, Mayor S",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5078,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28684606,Mol Biol Cell,2017,Cell and tissue mechanics: the new cell biology frontier,Weaver VM,U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5081,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28495700,Science,2017,Visualizing dynamic microvillar search and stabilization during ligand detection by T cells,"Cai E, Marchuk K, Beemiller P, Beppler C, Rubashkin MG, Weaver VM, Grard A, Liu TL, Chen BC, Betzig E, Bartumeus F, Krummel MF",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5093,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27298087,Annu Rev Cell Dev Biol,2016,Mechanical Control of Epithelial-to-Mesenchymal Transitions in Development and Cancer,"Przybyla L, Muncie JM, Weaver VM",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5112,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28424337,Cold Spring Harb Symp Quant Biol,2016,"Physical and Chemical Gradients in the Tumor Microenvironment Regulate Tumor Cell Invasion, Migration, and Metastasis","Oudin MJ, Weaver VM",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5114,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29182244,J Am Chem Soc,2017,"Allosteric Modulation of Grb2 Recruitment to the Intrinsically Disordered Scaffold Protein, LAT, by Remote Site Phosphorylation","Huang WYC, Ditlev JA, Chiang HK, Rosen MK, Groves JT",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5116,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26439949,Bioessays,2015,"Tumor-induced solid stress activates -catenin signaling to drive malignant behavior in normal, tumor-adjacent cells","Ou G, Weaver VM",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5135,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30055167,J Mol Biol,2018,Modeling Tissue Polarity in Context,"Tharp KM, Weaver VM",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5140,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28452363,Nat Commun,2017,Mechanism of SOS PR-domain autoinhibition revealed by single-molecule assays on native protein from lysate,"Lee YK, Low-Nam ST, Chung JK, Hansen SD, Lam HYM, Alvarez S, Groves JT",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5142,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29320680,Biophys J,2018,K-Ras4B Remains Monomeric on Membranes over aWide Range ofSurface Densities and Lipid Compositions,"Chung JK, Lee YK, Denson JP, Gillette WK, Alvarez S, Stephen AG, Groves JT",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5157,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27452175,Cell Stem Cell,2016,Tissue Mechanics Orchestrate Wnt-Dependent Human Embryonic Stem Cell Differentiation,"Przybyla L, Lakins JN, Weaver VM",U01 CA202241,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83584,,,,U01,,,,,,,,,,,,,,,,,,Sage,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5162,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29045874,Biophys J,2017,Dynamic Scaling Analysis of Molecular Motion within the LAT:Grb2:SOS Protein Network onMembranes,"Huang WYC, Chiang HK, Groves JT",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5169,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27203736,Langmuir,2016,Site-Specific Modulation of Charge Controls the Structure and Stimulus Responsiveness of Intrinsically Disordered Peptide Brushes,"Bhagawati M, Rubashkin MG, Lee JP, Ananthanarayanan B, Weaver VM, Kumar S",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5194,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26668364,Proc Natl Acad Sci U S A,2015,Negative membrane curvature catalyzes nucleation of endosomal sorting complex required for transport (ESCRT)-III assembly,"Lee IH, Kai H, Carlson LA, Groves JT, Hurley JH",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
5195,196,syn7416710,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29266001,Elife,2017,A bulky glycocalyx fosters metastasis formation by promoting G1 cell cycle progression,"Woods EC, Kai F, Barnes JM, Pedram K, Pickup MW, Hollander MJ, Weaver VM, Bertozzi CR",U01 CA202241,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA202241,ECM geometrical and mechanical properties modulate RTK signaling
4837,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27354287,Sci Rep,2016,Network Modeling Identifies Patient-specific Pathways in Glioblastoma,"Tuncbag N, Milani P, Pokorny JL, Johnson H, Sio TT, Dalin S, Iyekegbe DO, White FM, Sarkaria JN, Fraenkel E",U01 CA184898,,,,,,,"networks, computational biology",,U01,,,,Glioblastoma,,,,,,,,,,,,,,,1,CA184898,Embryonal Brain Tumor Networks
4839,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27479327,Nat Methods,2016,Revealing disease-associated pathways by network integration of untargeted metabolomics,"Pirhaji L, Milani P, Leidl M, Curran T, Avila-Pacheco J, Clish CB, White FM, Saghatelian A, Fraenkel E",U01 CA184898,,,,,,,"networks, computational biology",,U01,,,,Huntingon's Disease,Not Applicable,,,,,,,,,,,,"networks, computational biology",Sage,1,CA184898,Embryonal Brain Tumor Networks
4831,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27096930,PLoS Comput Biol,2016,Network-Based Interpretation of Diverse High-Throughput Datasets through the Omics Integrator Software Package,"Tuncbag N, Gosline SJ, Kedaigle A, Soltis AR, Gitter A, Fraenkel E",U01 CA184898,,,,,,syn9898746,"networks, computational biology",,U01,,,,Lung Carcinoma,,,,,,,,,,,,,"networks, computational biology",,1,CA184898,Embryonal Brain Tumor Networks
4919,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29478614,Handb Clin Neurol,2018,Brain cancer genomics and epigenomics,"Archer TC, Sengupta S, Pomeroy SL",U01 CA184898,,,,,,,,,U01,,,,Malignant Neoplasm of Brain,,,,,,,,,,,,,,,1,CA184898,Embryonal Brain Tumor Networks
4840,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29023490,PLoS One,2017,Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens,"Ursu O, Gosline SJC, Beeharry N, Fink L, Bhattacharjee V, Huang SC, Zhou Y, Yen T, Fraenkel E",U01 CA184898,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70810,,"pancreatic cancer, protein interaction network, computational biology, epigenetics, kinase specificity",,U01,,,,Malignant Neoplasm of Pancreas,,,,,,,,,,,,,"pancreatic cancer, protein interaction network, computational biology, epigenetics, kinase specificity",Sage,1,CA184898,Embryonal Brain Tumor Networks
5200,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30205044,Cancer Cell,2018,"Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups","Archer TC, Ehrenberger T, Mundt F, Gold MP, Krug K, Mah CK, Mahoney EL, Daniel CJ, LeNail A, Ramamoorthy D, Mertins P, Mani DR, Zhang H, Gillette MA, Clauser K, Noble M, Tang LC, Pierre-Franois J, Silterra J, Jensen J, Tamayo P, Korshunov A, Pfister SM, Kool M, Northcott PA, Sears RC, Lipton JO, Carr SA, Mesirov JP, Pomeroy SL, Fraenkel E","U54 CA209988, U01 CA184898",,,,,,,,,"U01, U54",,,Brain,Medulloblastoma,,,,,,,,heterogeneity/evolution,,Brain,,,,Center,1,"CA209988, CA184898",Embryonal Brain Tumor Networks
4841,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29018056,Mol Cancer Res,2017,Functional Genomics Approach Identifies Novel Signaling Regulators of TGF Ectodomain Shedding,"Wilson JL, Kefaloyianni E, Stopfer L, Harrison C, Sabbisetti VS, Fraenkel E, Lauffenburger DA, Herrlich A",U01 CA184898,,,,,,,"protein interaction network, computational biology, shRNA screen",,U01,,,Blood,Not Applicable,shRNA,,,,,,,microenvironment,,Blood,,,"protein interaction network, computational biology, shRNA screen",Sage,1,CA184898,Embryonal Brain Tumor Networks
5097,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30257219,Cell Rep,2018,Synthesizing Signaling Pathways from Temporal Phosphoproteomic Data,"Kksal AS, Beck K, Cronin DR, McKenna A, Camp ND, Srivastava S, MacGilvray ME, Bodk R, Wolf-Yadlin A, Fraenkel E, Fisher J, Gitter A",U01 CA184898,,,,,,,,,U01,,,Unspecified,Not Applicable,Proteomics Assay,,,,,,,heterogeneity/evolution,,Unspecified,,,,Sage,1,CA184898,Embryonal Brain Tumor Networks
4832,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27315426,Integr Biol (Camb),2016,Pathway-based network modeling finds hidden genes in shRNA screen for regulators of acute lymphoblastic leukemia,"Wilson JL, Dalin S, Gosline S, Hemann M, Fraenkel E, Lauffenburger DA",U01 CA184898,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77570,,"networks, computational biology",,U01,,,Blood,T Acute Lymphoblastic Leukemia,shRNA,,,,,,,drug resistance/sensitivity,,Blood,,,"networks, computational biology",Sage,1,CA184898,Embryonal Brain Tumor Networks
4836,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28386677,Neurotherapeutics,2017,Medulloblastoma: Molecular Classification-Based Personal Therapeutics,"Archer TC, Mahoney EL, Pomeroy SL",U01 CA184898,,,,,,,"DNA methylation, medulloblastoma",,U01,,,,Tumor of Cerebellum,,,,,,,,,,,,,"DNA methylation, medulloblastoma",,1,CA184898,Embryonal Brain Tumor Networks
4994,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29753700,Lancet Oncol,2018,Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort,"Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugires L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, Brabetz S, Hain M, Zichner T, Segura-Wang M, Weischenfeldt J, Rausch T, Mardin BR, Zhou X, Baciu C, Lawerenz C, Chan JA, Varlet P, Guerrini-Rousseau L, Fults DW, Grajkowska W, Hauser P, Jabado N, Ra YS, Zitterbart K, Shringarpure SS, De La Vega FM, Bustamante CD, Ng HK, Perry A, MacDonald TJ, Herniz Driever P, Bendel AE, Bowers DC, McCowage G, Chintagumpala MM, Cohn R, Hassall T, Fleischhack G, Eggen T, Wesenberg F, Feychting M, Lannering B, Schz J, Johansen C, Andersen TV, Rsli M, Kuehni CE, Grotzer M, Kjaerheim K, Monoranu CM, Archer TC, Duke E, Pomeroy SL, Shelagh R, Frank S, Sumerauer D, Scheurlen W, Ryzhova MV, Milde T, Kratz CP, Samuel D, Zhang J, Solomon DA, Marra M, Eils R, Bartram CR, von Hoff K, Rutkowski S, Ramaswamy V, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P, Malkin D, Gajjar A, Korbel JO, Pfister SM",U01 CA184898,,,,,,,,,U01,,,,Tumor of Cerebellum,,,,,,,,,,,,,,,1,CA184898,Embryonal Brain Tumor Networks
4833,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27088724,Nat Biotechnol,2016,Characterizing genomic alterations in cancer by complementary functional associations,"Kim JW, Botvinnik OB, Abudayyeh O, Birger C, Rosenbluh J, Shrestha Y, Abazeed ME, Hammerman PS, DiCara D, Konieczkowski DJ, Johannessen CM, Liberzon A, Alizad-Rahvar AR, Alexe G, Aguirre A, Ghandi M, Greulich H, Vazquez F, Weir BA, Van Allen EM, Tsherniak A, Shao DD, Zack TI, Noble M, Getz G, Beroukhim R, Garraway LA, Ardakani M, Romualdi C, Sales G, Barbie DA, Boehm JS, Hahn WC, Mesirov JP, Tamayo P",U01 CA184898,REVEALER is available in GenePattern (www.genepattern.org).,,,,,,computational biology,,U01,,,Not Applicable,Pan-cancer,Computational Tool,,,,,,,Not Applicable,,Not Applicable,,,,Sage,1,CA184898,Embryonal Brain Tumor Networks
4834,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27146274,Sci Rep,2016,Cell freezing protocol suitable for ATAC-Seq on motor neurons derived from human induced pluripotent stem cells,"Milani P, Escalante-Chong R, Shelley BC, Patel-Murray NL, Xin X, Adam M, Mandefro B, Sareen D, Svendsen CN, Fraenkel E",U01 CA184898,,"https://www.ncbi.nlm.nih.gov/gap/?LinkName=pubmed_gap&from_uid=27146274, https://www.ncbi.nlm.nih.gov/sra?LinkName=pubmed_sra&from_uid=27146274",,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78036,,"ATAC-Seq, iPSCs",,U01,,,Not Applicable,Not Applicable,ATAC-Seq,,,,,,,Not Applicable,,Not Applicable,,,"ATAC-Seq, iPSCs",Sage,1,CA184898,Embryonal Brain Tumor Networks
4835,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26748710,Cell Rep,2016,"Elucidating MicroRNA Regulatory Networks Using Transcriptional, Post-transcriptional, and Histone Modification Measurements","Gosline SJ, Gurtan AM, JnBaptiste CK, Bosson A, Milani P, Dalin S, Matthews BJ, Yap YS, Sharp PA, Fraenkel E",U01 CA184898,,,,,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61035 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61034 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61033",,"networks, computational biology, miRNA",,U01,,,Not Applicable,Not Applicable,"Whole Transcriptome Sequencing, ChIP-Seq",,,,,,,Not Applicable,,Not Applicable,,,,Sage,1,CA184898,Embryonal Brain Tumor Networks
4838,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28131823,Cell Syst,2017,In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons,"Chung CY, Khurana V, Yi S, Sahni N, Loh KH, Auluck PK, Baru V, Udeshi ND, Freyzon Y, Carr SA, Hill DE, Vidal M, Ting AY, Lindquist S",U01 CA184898,,,,,,,,,U01,,,Not Applicable,Not Applicable,Mass Spectrometry,,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA184898,Embryonal Brain Tumor Networks
4842,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28759592,PLoS Comput Biol,2017,PCSF: An R-package for network-based interpretation of high-throughput data,"Akhmedov M, Kedaigle A, Chong RE, Montemanni R, Bertoni F, Fraenkel E, Kwee I",U01 CA184898,https://github.com/IOR-Bioinformatics/PCSF,,,,,,"protein interaction network, computational biology",,U01,,,Not Applicable,Not Applicable,Computational Tool,,,,,,,Not Applicable,,Not Applicable,,,"protein interaction network, computational biology",Sage,1,CA184898,Embryonal Brain Tumor Networks
4843,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28726821,Nature,2017,The whole-genome landscape of medulloblastoma subtypes,"Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Grbner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz HJ, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, Waszak SM, Erkek S, Jones DTW, Worst BC, Kool M, Zapatka M, Jger N, Chavez L, Hutter B, Bieg M, Paramasivam N, Heinold M, Gu Z, Ishaque N, Jger-Schmidt C, Imbusch CD, Jugold A, Hbschmann D, Risch T, Amstislavskiy V, Gonzalez FGR, Weber UD, Wolf S, Robinson GW, Zhou X, Wu G, Finkelstein D, Liu Y, Cavalli FMG, Luu B, Ramaswamy V, Wu X, Koster J, Ryzhova M, Cho YJ, Pomeroy SL, Herold-Mende C, Schuhmann M, Ebinger M, Liau LM, Mora J, McLendon RE, Jabado N, Kumabe T, Chuah E, Ma Y, Moore RA, Mungall AJ, Mungall KL, Thiessen N, Tse K, Wong T, Jones SJM, Witt O, Milde T, Von Deimling A, Capper D, Korshunov A, Yaspo ML, Kriwacki R, Gajjar A, Zhang J, Beroukhim R, Fraenkel E, Korbel JO, Brors B, Schlesner M, Eils R, Marra MA, Pfister SM, Taylor MD, Lichter P",U01 CA184898,,https://www.ebi.ac.uk/ega/studies/EGAS00001001953,,,,,"medulloblastoma, cancer subtypes,",,U01,,,Brain,Medulloblastoma,"Whole Genome Sequencing, Whole Transcriptome Sequencing, Whole Exome Sequencing, Expression Array, Methylation Profiling by Array",,,,,,,heterogeneity/evolution,,Brain,,,"medulloblastoma, cancer subtypes,",Sage,1,CA184898,Embryonal Brain Tumor Networks
4844,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28131822,Cell Syst,2017,Genome-Scale Networks Link Neurodegenerative Disease Genes to -Synuclein through Specific Molecular Pathways,"Khurana V, Peng J, Chung CY, Auluck PK, Fanning S, Tardiff DF, Bartels T, Koeva M, Eichhorn SW, Benyamini H, Lou Y, Nutter-Upham A, Baru V, Freyzon Y, Tuncbag N, Costanzo M, San Luis BJ, Schndorf DC, Barrasa MI, Ehsani S, Sanjana N, Zhong Q, Gasser T, Bartel DP, Vidal M, Deleidi M, Boone C, Fraenkel E, Berger B, Lindquist S",U01 CA184898,http://transposenet.csail.mit.edu,,,,,,"protein interaction network, computational biology",,U01,,,Not Applicable,Not Applicable,Computational Tool,,,,,,,Not Applicable,,Not Applicable,,,,Sage,1,CA184898,Embryonal Brain Tumor Networks
5088,196,syn9772917,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29344883,Methods Mol Biol,2018,"Discovering Altered Regulation and Signaling Through Network-based Integration of Transcriptomic, Epigenomic, and Proteomic Tumor Data","Kedaigle AJ, Fraenkel E",U01 CA184898,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA184898,Embryonal Brain Tumor Networks
5074,196,syn17083789,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29984313,Tomography,2018,Enhanced Bone Metastases in Skeletally Immature Mice,"Haley HR, Shen N, Qyli T, Buschhaus JM, Pirone M, Luker KE, Luker GD",U01 CA210152,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Imaging,,,,,,,metastasis,,Breast,,,,Center,,CA210152,Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis
5082,196,syn17083789,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29416611,Oncotarget,2019,Three-dimensional tumor model mimics stromal - breast cancer cells signaling,"Ham SL, Thakuri PS, Plaster M, Li J, Luker KE, Luker GD, Tavana H",U01 CA210152,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,3D Cell Culture,,,,,,,,,Breast,,,,Center,,CA210152,Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis
5122,196,syn17083789,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30414485,Acta Biomater,2018,Mammary fibroblasts remodel fibrillar collagen microstructure in a biomimetic nanocomposite hydrogel,"Liu C, Chiang B, Lewin Mejia D, Luker KE, Luker GD, Lee A",U01 CA210152,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Hydrogels,,,,,,,,,Breast,,,,Center,,CA210152,Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis
5134,196,syn17083789,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29484715,Adv Mater,2019,3D Jet Writing: Functional Microtissues Based on Tessellated Scaffold Architectures,"Jordahl JH, Solorio L, Sun H, Ramcharan S, Teeple CB, Haley HR, Lee KJ, Eyster TW, Luker GD, Krebsbach PH, Lahann J",U01 CA210152,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Tissue Engineering,,,,,,,"metastasis, microenvironment",,Breast,,,,Center,1,CA210152,Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis
5154,196,syn17083789,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29879553,Acta Biomater,2019,Hybrid collagen alginate hydrogel as a platform for 3D tumor spheroid invasion,"Liu C, Lewin Mejia D, Chiang B, Luker KE, Luker GD",U01 CA210152,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Hydrogels,,,,,,,,,Breast,,,,Center,,CA210152,Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis
5165,196,syn17083789,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29972798,Cell Metab,2019,Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling,"Luo M, Shang L, Brooks MD, Jiagge E, Zhu Y, Buschhaus JM, Conley S, Fath MA, Davis A, Gheordunescu E, Wang Y, Harouaka R, Lozier A, Triner D, McDermott S, Merajver SD, Luker GD, Spitz DR, Wicha MS",U01 CA210152,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Unspecified,,,,,,,heterogeneity/evolution,,Breast,,,,Center,1,CA210152,Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis
5174,196,syn17083789,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29144754,Nano Lett,2018,Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy,"Fan Y, Kuai R, Xu Y, Ochyl LJ, Irvine DJ, Moon JJ",U01 CA210152,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Unspecified,,,,,,,tumor-immune,,Breast,,,,Center,,CA210152,Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis
5191,196,syn17083789,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29858782,Methods Mol Biol,2019,Dual Reporter Bioluminescence Imaging with NanoLuc and Firefly Luciferase,"Gibbons AE, Luker KE, Luker GD",U01 CA210152,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Imaging,,,,,,,drug resistance/sensitivity,,Breast,,,,Center,,CA210152,Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis
5206,196,syn17083789,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29030823,Methods Mol Biol,2018,"A Facile, In Vitro 384-Well Plate System to Model Disseminated Tumor Cells in the Bone Marrow Microenvironment","Buschhaus JM, Luker KE, Luker GD",U01 CA210152,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,3D Cell Culture,,,,,,,microenvironment,,Breast,,,,Center,,CA210152,Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis
5079,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28871147,Sci Rep,2019,Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment,"Reynolds DS, Tevis KM, Blessing WA, Colson YL, Zaman MH, Grinstaff MW",U01 CA202123,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Brightfield Microscopy; Fluorescent Antibody Procedure; Immunocytochemistry; Western Blotting,,,,,,,drug resistance/sensitivity,,Breast,,,,Center,,CA202123,Epithelial layer jamming in breast cancer cell migration
5084,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30079253,Converg Sci Phys Oncol,2018,"Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression","Seager RJ, Hajal C, Spill F, Kamm RD, Zaman MH","U01 CA202177, U01 CA202123",,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Brightfield Microscopy; Western Blotting,,,,,,,,,Breast,,,,Center,,"CA202177, CA202123",Epithelial layer jamming in breast cancer cell migration
5101,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29620778,Integr Biol (Camb),2019,Characterization of the mechanical properties of cancer cells in 3D matrices in response to collagen concentration and cytoskeletal inhibitors,"Kim JE, Reynolds DS, Zaman MH, Mak M",U01 CA202123,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Brightfield Microscopy; Western Blotting,,,,,,,,,Breast,,,,Center,,CA202123,Epithelial layer jamming in breast cancer cell migration
5105,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29210480,Adv Mater,2019,Dimeric Drug Polymeric Micelles with Acid-Active Tumor Targeting and FRET-Traceable Drug Release,"Guo X, Wang L, Duval K, Fan J, Zhou S, Chen Z",U01 CA202123,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Not Applicable,,,,,,,,,Breast,,,,Center,,CA202123,Epithelial layer jamming in breast cancer cell migration
5120,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27276271,Biophys J,2017,A Computational Model of YAP/TAZ Mechanosensing,"Sun M, Spill F, Zaman MH",U01 CA202123,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Not Applicable,,,,,,,,,Breast,,,,Center,,CA202123,Epithelial layer jamming in breast cancer cell migration
5137,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27398083,J Nanomater,2019,Design of Nanoparticle-Based Carriers for Targeted Drug Delivery,"Yu X, Trase I, Ren M, Duval K, Guo X, Chen Z",U01 CA202123,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Atomic Force Microscopy; Brightfield Microscopy; Western Blotting,,,,,,,,,Breast,,,,Center,,CA202123,Epithelial layer jamming in breast cancer cell migration
5055,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30151030,Nat Phys,2018,Geometric constraints during epithelial jamming,"Atia L, Bi D, Sharma Y, Mitchel JA, Gweon B, Koehler S, DeCamp SJ, Lan B, Kim JH, Hirsch R, Pegoraro AF, Lee KH, Starr JR, Weitz DA, Martin AC, Park JA, Butler JP, Fredberg JJ",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,microenvironment,,Not Applicable,,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5062,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27863122,Wiley Interdiscip Rev Syst Biol Med,2017,"Modeling, signaling and cytoskeleton dynamics: integrated modeling-experimental frameworks in cell migration","Sun M, Zaman MH",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Center,,CA202123,Epithelial layer jamming in breast cancer cell migration
5065,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=25953078,Integr Biol (Camb),2016,High-throughput screening for modulators of cellular contractile force,"Park CY, Zhou EH, Tambe D, Chen B, Lavoie T, Dowell M, Simeonov A, Maloney DJ, Marinkovic A, Tschumperlin DJ, Burger S, Frykenberg M, Butler JP, Stamer WD, Johnson M, Solway J, Fredberg JJ, Krishnan R",U01 CA202123,,,,,,,,,U01,,,"Lung, NOS",Not Applicable,Not Applicable,,,,,,,,,"Lung, NOS",,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5073,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26546401,Exp Cell Res,2017,Problems in biology with many scales of length: Cell-cell adhesion and cell jamming in collective cellular migration,"Pegoraro AF, Fredberg JJ, Park JA",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5080,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26651416,Trends Pharmacol Sci,2016,Cellular Biomechanics in Drug Screening and Evaluation: Mechanopharmacology,"Krishnan R, Park JA, Seow CY, Lee PV, Stewart AG",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Center,,CA202123,Epithelial layer jamming in breast cancer cell migration
5098,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28945485,Connect Tissue Res,2018,Contact guidance and collective migration in the advancing epithelial monolayer,"Lee G, Atia L, Lan B, Sharma Y, Nissim L, Wu MR, Pery E, Lu TK, Park CY, Butler JP, Fredberg JJ",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,,,,,,,,,,Not Applicable,,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5099,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=25652451,Am J Physiol Cell Physiol,2015,"Fluid shear, intercellular stress, and endothelial cell alignment","Steward R Jr, Tambe D, Hardin CC, Krishnan R, Fredberg JJ",U01 CA202123,,,,,,,,,U01,,,"Lung, NOS",Not Applicable,Not Applicable,,,,,,,,,"Lung, NOS",,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5124,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27342210,J Exp Clin Cancer Res,2018,Erratum to: Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma,"Huang XY, Huang ZL, Xu B, Chen Z, Re TJ, Zheng Q, Tang ZY, Huang XY",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Center,,CA202123,Epithelial layer jamming in breast cancer cell migration
5129,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28374776,Sci Rep,2018,Homogenizing cellular tension by hepatocyte growth factor in expanding epithelial monolayer,"Jang H, Notbohm J, Gweon B, Cho Y, Park CY, Kee SH, Fredberg JJ, Shin JH, Park Y",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Brightfield Microscopy,,,,,,,,,Not Applicable,,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5139,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29461895,Ann Am Thorac Soc,2019,"Scaling Physiologic Function from Cell to Tissue in Asthma, Cancer, and Development","Sharma Y, Atia L, Rhodes CS, DeCamp SJ, Mitchel J, Fredberg JJ",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5143,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27550520,J Cell Sci,2017,"Collective migration and cell jamming in asthma, cancer and development","Park JA, Atia L, Mitchel JA, Fredberg JJ, Butler JP",U01 CA202123,,,,,,,,,U01,,,"Lung, NOS",Not Applicable,Not Applicable,,,,,,,,,"Lung, NOS",,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5145,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29345194,Am J Physiol Lung Cell Mol Physiol,2019,Transient stretch induces cytoskeletal fluidization through the severing action of cofilin,"Lan B, Krishnan R, Park CY, Watanabe RA, Panganiban R, Butler JP, Lu Q, Cole WC, Fredberg JJ",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,microenvironment,,Not Applicable,,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5150,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28615311,Physiology (Bethesda),2018,Modeling Physiological Events in 2D vs 3D Cell Culture,"Duval K, Grover H, Han LH, Mou Y, Pegoraro AF, Fredberg J, Chen Z",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5163,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29618614,Proc Natl Acad Sci U S A,2018,Cell contraction induces long-ranged stress stiffening in the extracellular matrix,"Han YL, Ronceray P, Xu G, Malandrino A, Kamm RD, Lenz M, Broedersz CP, Guo M",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,microenvironment,,Not Applicable,,,,Center,,CA202123,Epithelial layer jamming in breast cancer cell migration
5171,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28973866,Proc Natl Acad Sci U S A,2018,Cell volume change through water efflux impacts cell stiffness and stem cell fate,"Guo M, Pegoraro AF, Mao A, Zhou EH, Arany PR, Han Y, Burnette DT, Jensen MH, Kasza KE, Moore JR, Mackintosh FC, Fredberg JJ, Mooney DJ, Lippincott-Schwartz J, Weitz DA",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5187,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28892054,Nat Mater,2019,Long-lived force patterns and deformation waves at repulsive epithelial boundaries,"Rodrguez-Franco P, Brugus A, Marn-Llaurad A, Conte V, Solanas G, Batlle E, Fredberg JJ, Roca-Cusachs P, Sunyer R, Trepat X",U01 CA202123,,,,,,,,,U01,,,Kidney,Not Applicable,Brightfield Microscopy; Western Blotting,,,,,,,microenvironment,,Kidney,,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5205,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26820546,Nat Methods,2016,Hidden in the mist no more: physical force in cell biology,"Wang K, Cai LH, Lan B, Fredberg JJ",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5207,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30206629,Integr Biol (Camb),2019,Computational model of wound healing: EGF secreted by fibroblasts promotes delayed re-epithelialization of epithelial keratinocytes,"Andasari V , L D , Swat M , Feng S , Spill F , Chen L , Luo X , Zaman M , Long M ",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,metastasis,,Not Applicable,,,,Center,,CA202123,Epithelial layer jamming in breast cancer cell migration
5208,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27332131,Biophys J,2017,Cellular Contraction and Polarization Drive Collective Cellular Motion,"Notbohm J, Banerjee S, Utuje KJC, Gweon B, Jang H, Park Y, Shin J, Butler JP, Fredberg JJ, Marchetti MC",U01 CA202123,,,,,,,,,U01,,,"Lung, NOS",Not Applicable,Not Applicable,,,,,,,,,"Lung, NOS",,,,Center,1,CA202123,Epithelial layer jamming in breast cancer cell migration
5213,196,syn7416702,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30030173,Acta Biomater,2019,Mechanical confinement via a PEG/Collagen interpenetrating network inhibits behavior characteristic of malignant cells in the triple negative breast cancer cell line MDAMB231,"Reynolds DS, Bougher KM, Letendre JH, Fitzgerald SF, Gisladottir UO, Grinstaff MW, Zaman MH",U01 CA202123,,,,,,,,,U01,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,microenvironment,,Not Applicable,,,,Center,,CA202123,Epithelial layer jamming in breast cancer cell migration
4663,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27009166,Cancer Res,2017,Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces,"Lloyd MC, Cunningham JJ, Bui MM, Gillies RJ, Brown JS, Gatenby RA",U54 CA193489,,,,,,,"darwinian evolution, breast cancer, intratumoral heterogeneity, IHC, imaging, mathematical modeling, biomarkers",,U54,,,Breast,Carcinoma in situ of Breast,Immunohistochemistry Staining Method,,,,,,,,,Breast,,,,Center,,CA193489,H Lee Moffitt Cancer Center and Research Institute
5017,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30056557,J Mammary Gland Biol Neoplasia,2019,In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ,"Brock EJ, Ji K, Shah S, Mattingly RR, Sloane BF",U54 CA193489,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Not Applicable,,,,,,,,,Breast,,,,Center,,CA193489,H Lee Moffitt Cancer Center and Research Institute
5094,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30144784,Neoplasia,2018,Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation,"Shah S, Brock EJ, Jackson RM, Ji K, Boerner JL, Sloane BF, Mattingly RR",U54 CA193489,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Immunohistochemistry Staining Method,,,,,,,,,Breast,,,,Center,,CA193489,H Lee Moffitt Cancer Center and Research Institute
4674,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28249898,Cancer Res,2017,Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution,"Ibrahim-Hashim A, Robertson-Tessi M, Enriquez-Navas PM, Damaghi M, Balagurunathan Y, Wojtkowiak JW, Russell S, Yoonseok K, Lloyd MC, Bui MM, Brown JS, Anderson ARA, Gillies RJ, Gatenby RA",U54 CA193489,,,,,,,"mathematical modeling, oxygen consumption, acidification",,U54,,,Prostate Gland,Carcinoma in situ of Prostate,Immunohistochemistry Staining Method,,,,,,,,,Prostate Gland,,,,Center,,CA193489,H Lee Moffitt Cancer Center and Research Institute
4661,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26276155,Mol Imaging Biol,2016,Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia,"Tafreshi NK, Lloyd MC, Proemsey JB, Bui MM, Kim J, Gillies RJ, Morse DL",U54 CA193489,,,,,,,"breast cancer, carbonic anhydrase IX, carbonic anhydrase XII, non-invasive imaging of hypoxia, targeted agents, imaging, IHC, fluorescence microscopy",,U54,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,"breast cancer, carbonic anhydrase IX, carbonic anhydrase XII, non-invasive imaging of hypoxia, targeted agents, imaging, IHC, fluorescence microscopy",,1,CA193489,H Lee Moffitt Cancer Center and Research Institute
4665,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26912903,Sci Transl Med,2016,Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer,"Enriquez-Navas PM, Kam Y, Das T, Hassan S, Silva A, Foroutan P, Ruiz E, Martinez G, Minton S, Gillies RJ, Gatenby RA",U54 CA193489,,,,,,,"breast cancer, darwinian evolution, xenograft",,U54,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,"breast cancer, darwinian evolution, xenograft",,,CA193489,H Lee Moffitt Cancer Center and Research Institute
4664,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27689717,Eur J Cancer,2016,Phase i trials in melanoma: A framework to translate preclinical findings to the clinic,"Kim E, Rebecca VW, Smalley KS, Anderson AR",U54 CA193489,,,,,,,"clinical trials, heterogeneity of patient responses, mathematical model, stratification, treatment schedule optimisation",,U54,,,,Melanoma,,,,,,,,,,,,,"clinical trials, heterogeneity of patient responses, mathematical model, stratification, treatment schedule optimisation",,,CA193489,H Lee Moffitt Cancer Center and Research Institute
4667,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28578393,Sci Rep,2017,MTI-101 treatment inducing activation of Stim1 and TRPC1 expression is a determinant of response in multiple myeloma,"Emmons MF, Anreddy N, Cuevas J, Steinberger K, Yang S, McLaughlin M, Silva A, Hazlehurst LA",U54 CA193489,,,,,,,"multiple myeloma, gene expression arrays",,U54,,,,Multiple Myeloma,,,,,,,,,,,,,"multiple myeloma, gene expression arrays",,,CA193489,H Lee Moffitt Cancer Center and Research Institute
4669,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28400475,Cancer Res,2017,An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma,"Silva A, Silva MC, Sudalagunta P, Distler A, Jacobson T, Collins A, Nguyen T, Song J, Chen DT, Chen L, Cubitt C, Baz R, Perez L, Rebatchouk D, Dalton W, Greene J, Gatenby R, Gillies R, Sontag E, Meads MB, Shain KH",U54 CA193489,,,,,,,"multiple myeloma, mathematical modeling, therapeutic response, drug screen",,U54,,,,Multiple Myeloma,,,,,,,,,,,,,"multiple myeloma, mathematical modeling, therapeutic response, drug screen",,,CA193489,H Lee Moffitt Cancer Center and Research Institute
4658,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29423880,Bull Math Biol,2018,Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue,"Karolak A, Rejniak KA","U54 CA193489, U54 CA193489",,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Sage,,"CA193489, CA193489",H Lee Moffitt Cancer Center and Research Institute
4668,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28341421,Biochim Biophys Acta,2017,"Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer","Gatenby RA, Brown J",U54 CA193489,,,,,,,"Darwinian evolution, review",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,"Darwinian evolution, review",Center,2,CA193489,H Lee Moffitt Cancer Center and Research Institute
4671,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28113286,IEEE Trans Biomed Eng,2017,Aggregation Effects and Population-Based Dynamics as a Source of Therapy Resistance in Cancer,"Brown JS, Cunningham JJ, Gatenby RA",U54 CA193489,,,,,,,"mathematical modeling, Darwinian evolution, drug resistance",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,"mathematical modeling, Darwinian evolution, drug resistance",Center,2,CA193489,H Lee Moffitt Cancer Center and Research Institute
4676,196,syn7349753,"PS-ON, CSBC",https://www.ncbi.nlm.nih.gov/pubmed/?term=28912577,Nat Rev Cancer,2017,Classifying the evolutionary and ecological features of neoplasms,"Maley CC, Aktipis A, Graham TA, Sottoriva A, Boddy AM, Janiszewska M, Silva AS, Gerlinger M, Yuan Y, Pienta KJ, Anderson KS, Gatenby R, Swanton C, Posada D, Wu CI, Schiffman JD, Hwang ES, Polyak K, Anderson ARA, Brown JS, Greaves M, Shibata D","U54 CA193461, U54 CA193489, U01 CA195469",,,,,,,,,"U01, U54",,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Center,2,"CA193461, CA193489, CA195469",H Lee Moffitt Cancer Center and Research Institute
4990,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29621614,Semin Cancer Biol,2019,Ras and Rap1: A tale of two GTPases,"Shah S, Brock EJ, Ji K, Mattingly RR",U54 CA193489,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Center,,CA193489,H Lee Moffitt Cancer Center and Research Institute
4662,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27888521,Int J Cancer,2017,Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-B activation,"Avnet S, Di Pompo G, Chano T, Errani C, Ibrahim-Hashim A, Gillies RJ, Donati DM, Baldini N",U54 CA193489,,,,,,,"osteosarcoma, RNA-seq",,U54,,,,Sarcoma,,,,,,,,,,,,,,,1,CA193489,H Lee Moffitt Cancer Center and Research Institute
4659,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27097301,Cell Cycle,2016,Lysosomal protein relocation as an adaptation mechanism to extracellular acidosis,"Damaghi M, Gillies RJ",U54 CA193489,,,,,,,"spotlight, proteomics, breast cancer, acidosis",,U54,,,Breast,Carcinoma in situ of Breast,Mass Spectrometry,,,,,,,"microenvironment, heterogeneity/evolution",,Breast,,,"spotlight, proteomics, breast cancer, acidosis",Sage,1,CA193489,H Lee Moffitt Cancer Center and Research Institute
4660,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27770034,Genetics,2016,Stochasticity in the Genotype-Phenotype Map: Implications for the Robustness and Persistence of Bet-Hedging,"Nichol D, Robertson-Tessi M, Jeavons P, Anderson AR",U54 CA193489,,,,,,,"bacterial persistence, bet-hedging, drug resistance, evolution, genotype?phenotype map, computational modeling",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,"drug resistance/sensitivity, heterogeneity/evolution",,Not Applicable,,,"bacterial persistence, bet-hedging, drug resistance, evolution, genotype?phenotype map, computational modeling",Sage,,CA193489,H Lee Moffitt Cancer Center and Research Institute
4666,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29167448,Sci Rep,2017,Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer Immunotherapy,"Yagawa Y, Robertson-Tessi M, Zhou SL, Anderson ARA, Mul JJ, Mailloux AW",U54 CA193489,,,,,,,"mathematical modeling, chemotaxis, migration",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,tumor-immune,,Not Applicable,,,"mathematical modeling, chemotaxis, migration",Sage,,CA193489,H Lee Moffitt Cancer Center and Research Institute
4670,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26719539,Cancer Res,2016,Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy,"Pilon-Thomas S, Kodumudi KN, El-Kenawi AE, Russell S, Weber AM, Luddy K, Damaghi M, Wojtkowiak JW, Mul JJ, Ibrahim-Hashim A, Gillies RJ",U54 CA193489,,,,,,,"tumor acidity, immunotherapy, adoptive T cell therapy",,U54,,,"Pancreas, Skin","Malignant Neoplasm of Pancreas, Melanoma",Murine Model,,,,,,,"tumor-immune, drug resistance/sensitivity",,"Pancreas, Skin",,,,Sage,1,CA193489,H Lee Moffitt Cancer Center and Research Institute
4672,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28416797,Nat Commun,2017,Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma,"Zhao X, Lwin T, Silva A, Shah B, Tao J, Fang B, Zhang L, Fu K, Bi C, Li J, Jiang H, Meads MB, Jacobson T, Silva M, Distler A, Darville L, Zhang L, Han Y, Rebatchouk D, Di Liberto M, Moscinski LC, Koomen JM, Dalton WS, Shain KH, Wang M, Sotomayor E, Tao J",U54 CA193489,,,,,,,"mantle cell lymphoma, LC-MS/MS, PDX, drug screen",,U54,,,Lymph node,Mantle cell lymphoma,"High-throughput Drug Screen, PDX",,,,,,,"microenvironment, heterogeneity/evolution, drug resistance/sensitivity",,Lymph node,,,"mantle cell lymphoma, LC-MS/MS, PDX, drug screen",Sage,,CA193489,H Lee Moffitt Cancer Center and Research Institute
4673,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28113244,IEEE Trans Biomed Eng,2017,Stem Cell Plasticity and Niche Dynamics in Cancer Progression,"Picco N, Gatenby RA, Anderson ARA",U54 CA193489,,,,,,,"mathematical modeling, simulation, ductal carcinoma",,U54,,,Breast,Carcinoma in situ of Breast,Mathematical Modeling,,,,,,,microenvironment,,Breast,,,"mathematical modeling, simulation, ductal carcinoma",Sage,2,CA193489,H Lee Moffitt Cancer Center and Research Institute
4912,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29544886,J Theor Biol,2018,Evolutionary advantage of directional symmetry breaking in self-replicating polymers,"Subramanian H, Gatenby RA",U54 CA193489,,,,,,,,,U54,,,,,,,,,,,,,,,,,,,2,CA193489,H Lee Moffitt Cancer Center and Research Institute
4945,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29382708,Cancer Res,2018,Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies,"Gallaher JA, Enriquez-Navas PM, Luddy KA, Gatenby RA, Anderson ARA",U54 CA193489,,,,,,,,,U54,,,,,,,,,,,,,,,,,,,2,CA193489,H Lee Moffitt Cancer Center and Research Institute
4991,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29725703,J Mol Evol,2018,Chiral Monomers Ensure Orientational Specificity of Monomer Binding During Polymer Self-Replication,"Subramanian H, Gatenby RA",U54 CA193489,,,,,,,,,U54,,,,,,,,,,,,,,,,,,,2,CA193489,H Lee Moffitt Cancer Center and Research Institute
5133,196,syn7349753,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29774168,Converg Sci Phys Oncol,2017,Evaluating the potential for maximized T cell redistribution entropy to improve abscopal responses to radiotherapy,"Walker R, Schoenfeld JD, Pilon-Thomas S, Poleszczuk J, Enderling H",U54 CA193489,,,,,,,,,U54,,,,,,,,,,,,,,,,,,,,CA193489,H Lee Moffitt Cancer Center and Research Institute
4622,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28821574,J Cell Sci,2018,Mosaic loss of non-muscle myosin IIA and IIB is sufficient to induce mammary epithelial proliferation,"Nguyen-Ngoc KV, Silvestri VL, Georgess D, Fairchild AN, Ewald AJ",U54 CA210173,,,,,,,"non-muscle myosin, proliferation, imaging, differential interference contrast microscopy, confocal microscopy",,U54,,,Breast,Carcinoma in situ of Breast,,,,,,,,heterogeneity/evolution,,Breast,,,"non-muscle myosin, proliferation, imaging, differential interference contrast microscopy, confocal microscopy",Center,,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4996,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29634937,Dev Cell,2018,Coordination of Receptor Tyrosine Kinase Signaling and Interfacial Tension Dynamics Drives Radial Intercalation and Tube Elongation,"Neumann NM, Perrone MC, Veldhuis JH, Huebner RJ, Zhan H, Devreotes PN, Brodland GW, Ewald AJ",U54 CA210173,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,,,,,,,,metastasis,,Breast,,,,Center,,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
5058,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28213554,Mol Cancer Res,2018,Hypoxia Selectively Enhances Integrin 51 Receptor Expression in Breast Cancer to Promote Metastasis,"Ju JA, Godet I, Ye IC, Byun J, Jayatilaka H, Lee SJ, Xiang L, Samanta D, Lee MH, Wu PH, Wirtz D, Semenza GL, Gilkes DM",U54 CA210173,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,"IHC, PCR, Real Time PCR, Western Blotting",,,,,,,,,Breast,,,,Center,,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4621,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28747635,Nat Commun,2017,AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination,"Haffner MC, Esopi DM, Chaux A, Grel M, Ghosh S, Vaghasia AM, Tsai H, Kim K, Castagna N, Lam H, Hicks J, Wyhs N, Biswal Shinohara D, Hurley PJ, Simons BW, Schaeffer EM, Lotan TL, Isaacs WB, Netto GJ, De Marzo AM, Nelson WG, An SS, Yegnasubramanian S",U54 CA210173,,,,,,,"prostate cancer, metastasis, mass spectrometry",,U54,,,,Carcinoma in situ of Prostate,,,,,,,,,,,,,"prostate cancer, metastasis, mass spectrometry",,,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
5158,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30390333,J Cell Biochem,2018,Optimization of prostate cancer cell detection using multiplex tyramide signal amplification,"Roy S, Axelrod HD, Valkenburg KC, Amend S, Pienta KJ",U54 CA210173,,,,,,,,,U54,,,Prostate Gland,Carcinoma in situ of Prostate,Expression Array,,,,,,,metastasis,,Prostate Gland,,,,Sage,,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
5083,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29144730,ACS Nano,2017,Cancer Protrusions on a Tightrope: Nanofiber Curvature Contrast Quantitates Single Protrusion Dynamics,"Koons B, Sharma P, Ye Z, Mukherjee A, Lee MH, Wirtz D, Behkam B, Nain AS",U54 CA210173,,,,,,,,,U54,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,2,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
5090,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30061414,Proc Natl Acad Sci U S A,2018,Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain,"Grither WR, Longmore GD",U54 CA210173,,,,,,,,,U54,,,,Intraductal carcinoma in situ of breast,,,,,,,,,,,,,,,2,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
5125,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30038020,Proc Natl Acad Sci U S A,2018,Cytoskeletal tension regulates mesodermal spatial organization and subsequent vascular fate,"Smith Q, Rochman N, Carmo AM, Vig D, Chan XY, Sun S, Gerecht S",U54 CA210173,,,,,,,,,U54,,,Not Applicable,Not Applicable,,,,,,,,,,Not Applicable,,,,Sage,1,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4618,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27909339,Nat Rev Cancer,2017,Cancer cell motility: lessons from migration in confined spaces,"Paul CD, Mistriotis P, Konstantopoulos K",U54 CA210173,,,,,,,"review, migration, motility, engineered substrate",,U54,,,Not Applicable,Pan-cancer,,,,,,,,,,Not Applicable,,,"review, migration, motility, engineered substrate",Center,3,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4905,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29423593,Target Oncol,2018,Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies,"DiGiacomo JW, Gilkes DM",U54 CA210173,,,,,,,"hypoxia, metastasis",,U54,,,Not Applicable,Pan-cancer,Not Applicable,,,,,,,metastasis,,Not Applicable,,,,Center,,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4920,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29385717,Genes (Basel),2018,RhoB: Team Oncogene or Team Tumor Suppressor?,"Ju JA, Gilkes DM",U54 CA210173,,,,,,,,,U54,,,Not Applicable,Pan-cancer,Not Applicable,,,,,,,,,Not Applicable,,,,Center,,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4619,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28974764,Sci Rep,2017,Cancer-associated fibroblasts support vascular growth through mechanical force,"Sewell-Loftin MK, Bayer SVH, Crist E, Hughes T, Joison SM, Longmore GD, George SC",U54 CA210173,,,,,,,vascularization,,U54,,,Breast,Carcinoma in situ of Breast,3D Cell Culture,,,,,,,microenvironment,,Breast,,,vascularization,Sage,2,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4620,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29321819,Genes Cancer,2017,The induction of endoreduplication and polyploidy by elevated expression of 14-3-3,"Gomes CJ, Centuori SM, Harman MW, Putnam CW, Wolgemuth CW, Martinez JD",U54 CA210173,,,,,,,,,U54,,,Lung,Lung Non-Small Cell Carcinoma,Not Applicable,,,,,,,Not Applicable,,Lung,,,,Sage,,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4623,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28978451,Biophys J,2017,Cellular Contraction Can Drive Rapid Epithelial Flows,"Vig DK, Hamby AE, Wolgemuth CW",U54 CA210173,,,,,,,"mathematical modeling, motility",,U54,,,Kidney,Not Applicable,"Microscopy, Traction Force Microscopy",,,,,,,metastasis,,Kidney,,,"mathematical modeling, motility",Sage,,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4624,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28129208,Rep Prog Phys,2017,Cell mechanics: a dialogue,"Tao J, Li Y, Vig DK, Sun SX",U54 CA210173,,,,,,,"motility, cell morphology, review",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,metastasis,,Not Applicable,,,,Sage,,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4625,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28918264,Biomaterials,2017,Past matrix stiffness primes epithelial cells and regulates their future collective migration through a mechanical memory,"Nasrollahi S, Walter C, Loza AJ, Schimizzi GV, Longmore GD, Pathak A",U54 CA210173,,,,,,,"migration, atomic force microscopy, imaging",,U54,,,Breast,Carcinoma in situ of Breast,"Atomic Force Microscopy, Confocal Microscopy, Fluorescence Microscopy",,,,,,,"microenvironment, metastasis",,Breast,,,,Sage,2,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4934,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29461250,Phys Biol,2018,"Ergodicity, hidden bias and the growth rate gain","Rochman ND, Popescu DM, Sun SX",U54 CA210173,,,,,,,,,U54,,,,,,,,,,,,,,,,,,,,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
4974,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28726849,Nat Protoc,2017,O2-controllable hydrogels for studying cellular responses to hypoxic gradients in three dimensions in vitro and in vivo,"Lewis DM, Blatchley MR, Park KM, Gerecht S",U54 CA210173,,,,,,,,,U54,,,,,,,,,,,,,,,,,,,1,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
5028,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27109101,Oncogene,2017,MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents,"Shah MY, Martinez-Garcia E, Phillip JM, Chambliss AB, Popovic R, Ezponda T, Small EC, Will C, Phillip MP, Neri P, Bahlis NJ, Wirtz D, Licht JD",U54 CA210173,,,,,,,,,U54,,,,,,,,,,,,,,,,,,Center,2,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
5186,196,syn7349766,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30044986,Cell Rep,2018,Differential HDAC6 Activity Modulates Ciliogenesis and Subsequent Mechanosensing of Endothelial Cells Derived from Pluripotent Stem Cells,"Smith Q, Macklin B, Chan XY, Jones H, Trempel M, Yoder MC, Gerecht S",U54 CA210173,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE115870,,,,U54,,,,,,,,,,,,,,,,,,Sage,1,CA210173,Johns Hopkins Physical Sciences Oncology Center (PS-OC)
5089,196,syn9773345,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30364881,Proc IEEE Int Symp Biomed Imaging,2018,BREAST CANCER HISTOPATHOLOGY IMAGE ANALYSIS PIPELINE FOR TUMOR PURITY ESTIMATION,"Azimi V, Chang YH, Thibault G, Smith J, Tsujikawa T, Kukull B, Jensen B, Corless C, Margolin A, Gray JW",U54 CA209988,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Not Applicable,,,,,,,,,Breast,,,,Center,3,CA209988,"Measuring, Modeling and Controlling Heterogeneity (M2CH)"
5148,196,syn9773345,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30364524,Proc IEEE Int Symp Biomed Imaging,2018,A METHOD FOR QUANTIFICATION OF CALPONIN EXPRESSION IN MYOEPITHELIAL CELLS IN IMMUNOHISTOCHEMICAL IMAGES OF DUCTAL CARCINOMA IN SITU,"Gray E, Mitchell E, Jindal S, Schedin P, Chang YH",U54 CA209988,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Not Applicable,,,,,,,,,Breast,,,,Center,3,CA209988,"Measuring, Modeling and Controlling Heterogeneity (M2CH)"
5123,196,syn9773345,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30224753,Sci Rep,2018,Computational measurement of tumor immune microenvironment in gastric adenocarcinomas,"Chang YH, Heo YJ, Cho J, Song SY, Lee J, Kim KM",U54 CA209988,,,,,,,,,U54,,,Stomach,Gastric Adenocarcinoma,Not Applicable,,,,,,,,,Stomach,,,,Center,3,CA209988,"Measuring, Modeling and Controlling Heterogeneity (M2CH)"
4646,196,syn9773345,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28380359,Cell Rep,2017,Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis,"Tsujikawa T, Kumar S, Borkar RN, Azimi V, Thibault G, Chang YH, Balter A, Kawashima R, Choe G, Sauer D, El Rassi E, Clayburgh DR, Kulesz-Martin MF, Lutz ER, Zheng L, Jaffee EM, Leyshock P, Margolin AA, Mori M, Gray JW, Flint PW, Coussens LM",U54 CA209988,,,,,,,"pancreatic cancer, digital pathology, immunohistochemistry, immunology,",,U54,,,Pancreas,Malignant Neoplasm of Pancreas,Not Applicable,,,,,,,,,Pancreas,,,"pancreatic cancer, digital pathology, immunohistochemistry, immunology,",Center,3,CA209988,"Measuring, Modeling and Controlling Heterogeneity (M2CH)"
5050,196,syn9773345,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30389701,Cancer Res,2019,Activation of PP2A and inhibition of mTOR synergistically reduce MYC signaling and decrease tumor growth in pancreatic ductal adenocarcinoma,"Allen-Petersen BL, Risom T, Feng Z, Wang Z, Jenny ZP, Thoma MC, Pelz KR, Morton JP, Sansom OJ, Lopez CD, Sheppard B, Christensen DJ, Ohlmeyer M, Narla G, Sears RC",U54 CA209988,,,,,,,,,U54,,,Pancreas,Malignant Neoplasm of Pancreas,Unspecified,,,,,,,,,Pancreas,,,,Center,1,CA209988,"Measuring, Modeling and Controlling Heterogeneity (M2CH)"
5087,196,syn9773345,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30364826,Proc SPIE Int Soc Opt Eng,2018,Integrative Analysis on Histopathological Image for Identifying Cellular Heterogeneity,"Chang YH, Thibault G, Johnson B, Margolin A, Gray JW",U54 CA209988,,,,,,,,,U54,,,Pancreas,Malignant Neoplasm of Pancreas,Not Applicable,,,,,,,,,Pancreas,,,,Center,3,CA209988,"Measuring, Modeling and Controlling Heterogeneity (M2CH)"
5167,196,syn9773345,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30283195,Proc SPIE Int Soc Opt Eng,2018,SHIFT: speedy histopathological-to-immunofluorescent translation of whole slide images using conditional generative adversarial networks,"Burlingame EA, Margolin AA, Gray JW, Chang YH",U54 CA209988,,,,,,,,,U54,,,Pancreas,Malignant Neoplasm of Pancreas,Not Applicable,,,,,,,,,Pancreas,,,,Center,3,CA209988,"Measuring, Modeling and Controlling Heterogeneity (M2CH)"
5035,196,syn9773345,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29735700,Proc Natl Acad Sci U S A,2018,Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism,"Davis RJ, Gnen M, Margineantu DH, Handeli S, Swanger J, Hoellerbauer P, Paddison PJ, Gu H, Raftery D, Grim JE, Hockenbery DM, Margolin AA, Clurman BE",U54 CA209988,,,,,,,,,U54,,,Not Applicable,Not Applicable,,,,,,,,,,Not Applicable,,,,Center,,CA209988,"Measuring, Modeling and Controlling Heterogeneity (M2CH)"
5204,196,syn9773345,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30366908,Genes Dev,2018,Post-translational modification localizes MYC to the nuclear pore basket to regulate a subset of target genes involved in cellular responses to environmental signals,"Su Y, Pelz C, Huang T, Torkenczy K, Wang X, Cherry A, Daniel CJ, Liang J, Nan X, Dai MS, Adey A, Impey S, Sears RC",U54 CA209988,,,,,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121094 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109459 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109458 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109457",,,,U54,,,Not Applicable,Not Applicable,Imaging,,,,,,,,,Not Applicable,,,,Center,,CA209988,"Measuring, Modeling and Controlling Heterogeneity (M2CH)"
5110,196,syn17083914,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29540687,Nat Commun,2018,Compression force sensing regulates integrin IIb3 adhesive function on diabetic platelets,"Ju L, McFadyen JD, Al-Daher S, Alwis I, Chen Y, Tnnesen LL, Maiocchi S, Coulter B, Calkin AC, Felner EI, Cohen N, Yuan Y, Schoenwaelder SM, Cooper ME, Zhu C, Jackson SP",U01 CA214354,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA214354,Mechanisms of Impaired T-Cell Mechanosensing of Melanoma Antiagents
5128,196,syn17083914,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28954860,Mol Biol Cell,2017,Receptor-mediated cell mechanosensing,"Chen Y, Ju L, Rushdi M, Ge C, Zhu C",U01 CA214354,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA214354,Mechanisms of Impaired T-Cell Mechanosensing of Melanoma Antiagents
5141,196,syn7349764,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29608279,Anal Chem,2018,In Vitro Liquid Extraction Surface Analysis Mass Spectrometry (ivLESA-MS) for Direct Metabolic Analysis of Adherent Cells in Culture,"Basu SS, Randall EC, Regan MS, Lopez BGC, Clark AR, Schmitt ND, Agar JN, Dillon DA, Agar NYR",U54 CA210180,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,Microscopy,,,,,,,,,Breast,,,,Sage,,CA210180,MIT Mayo Physical Sciences Center for Drug Distribution and Drug Efficacy in Brain Tumors
4615,196,syn7349764,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28847917,J Pharmacol Exp Ther,2017,Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma,"Laramy JK, Kim M, Gupta SK, Parrish KE, Zhang S, Bakken KK, Carlson BL, Mladek AC, Ma DJ, Sarkaria JN, Elmquist WF",U54 CA210180,,,,,,,"glioblastoma, pharmacology",,U54,,,,Glioblastoma,,,,,,,,,,,,,"glioblastoma, pharmacology",,,CA210180,MIT Mayo Physical Sciences Center for Drug Distribution and Drug Efficacy in Brain Tumors
4953,196,syn7349764,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29724813,Mol Cancer Res,2018,EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival,"Roos A, Dhruv HD, Peng S, Inge LJ, Tuncali S, Pineda M, Millard N, Mayo Z, Eschbacher JM, Loftus JC, Winkles JA, Tran NL",U54 CA210180,,,,,,,,,U54,,,,Glioblastoma,,,,,,,,,,,,,,,,CA210180,MIT Mayo Physical Sciences Center for Drug Distribution and Drug Efficacy in Brain Tumors
5011,196,syn7349764,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29970480,Mol Cancer Ther,2018,Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain Barrier,"Kim M, Ma DJ, Calligaris D, Zhang S, Feathers RW, Vaubel RA, Meaux I, Mladek AC, Parrish KE, Jin F, Barriere C, Debussche L, Watters J, Tian S, Decker PA, Eckel-Passow JE, Kitange GJ, Johnson AJ, Parney IF, Anastasiadis PZ, Agar NYR, Elmquist WF, Sarkaria JN",U54 CA210180,,,,,,,,,U54,,,Brain,Glioblastoma,,,,,,,,drug resistance/sensitivity,,Brain,,,,Sage,,CA210180,MIT Mayo Physical Sciences Center for Drug Distribution and Drug Efficacy in Brain Tumors
5216,196,syn7349764,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30464169,Nat Commun,2018,Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma,"Randall EC, Emdal KB, Laramy JK, Kim M, Roos A, Calligaris D, Regan MS, Gupta SK, Mladek AC, Carlson BL, Johnson AJ, Lu FK, Xie XS, Joughin BA, Reddy RJ, Peng S, Abdelmoula WM, Jackson PR, Kolluri A, Kellersberger KA, Agar JN, Lauffenburger DA, Swanson KR, Tran NL, Elmquist WF, White FM, Sarkaria JN, Agar NYR",U54 CA210180,,,,,,,,,U54,,,Brain,Glioblastoma,Proteomics Assay,,,,,,,drug resistance/sensitivity,,Brain,,,,Sage,,CA210180,MIT Mayo Physical Sciences Center for Drug Distribution and Drug Efficacy in Brain Tumors
4616,196,syn7349764,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28830985,Mol Cancer Ther,2017,"Characterization of In Vivo Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of Resistance","Emdal KB, Dittmann A, Reddy RJ, Lescarbeau RS, Moores SL, Laquerre S, White FM",U54 CA210180,,,,,,,"NSCLC, mass spectrometry, xenograft, cell viability, (small-scale) drug screen",,U54,,,,Lung Non-Small Cell Carcinoma,,,,,,,,,,,,,"NSCLC, mass spectrometry, xenograft, cell viability, (small-scale) drug screen",,2,CA210180,MIT Mayo Physical Sciences Center for Drug Distribution and Drug Efficacy in Brain Tumors
4617,196,syn7349764,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28634084,Pharmacol Res,2017,Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?,"Gampa G, Vaidhyanathan S, Sarkaria JN, Elmquist WF",U54 CA210180,,,,,,,"melanoma, review",,U54,,,,"Malignant Neoplasm of Brain, Melanoma",,,,,,,,,,,,,,,,CA210180,MIT Mayo Physical Sciences Center for Drug Distribution and Drug Efficacy in Brain Tumors
5044,196,syn17084080,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28762750,Antioxid Redox Signal,2018,Genome-Scale Modeling of NADPH-Driven -Lapachone Sensitization in Head and Neck Squamous Cell Carcinoma,"Lewis JE, Costantini F, Mims J, Chen X, Furdui CM, Boothman DA, Kemp ML",U01 CA215848,,,,,,,,,U01,,,,Head and Neck Carcinoma,,,,,,,,,,,,,,Center,1,CA215848,Model-based Prediction of Redox-Modulated Responses to Cancer Treatments
5132,196,syn17084080,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29113454,Antioxid Redox Signal,2018,Modulators of Redox Metabolism in Head and Neck Cancer,"Chen X, Mims J, Huang X, Singh N, Motea E, Planchon SM, Beg M, Tsang AW, Porosnicu M, Kemp ML, Boothman DA, Furdui CM",U01 CA215848,,,,,,,,,U01,,,,Head and Neck Carcinoma,,,,,,,,,,,,,,Center,1,CA215848,Model-based Prediction of Redox-Modulated Responses to Cancer Treatments
5127,196,syn9775595,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29997286,JCI Insight,2018,Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival,"Markowitz GJ, Havel LS, Crowley MJ, Ban Y, Lee SB, Thalappillil JS, Narula N, Bhinder B, Elemento O, Wong ST, Gao D, Altorki NK, Mittal V",U01 CA188388,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114300,,,,U01,,,Lung,Carcinoma in situ of Bronchus and Lung,"Whole Transcriptome Sequencing, Whole Exome Sequencing",,,,,,,"microenvironment, tumor-immune",,Lung,,,,Sage,1,CA188388,Modeling and targeting stroma-tumor crosstalk in non small cell lung cancer
4828,196,syn9775595,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26560033,Nature,2015,Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance,"Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, Schwabe RF, Vahdat LT, Altorki NK, Mittal V, Gao D",U01 CA188388,,,,,,,,,U01,,,,Lung Carcinoma,,,,,,,,,,,,,,,1,CA188388,Modeling and targeting stroma-tumor crosstalk in non small cell lung cancer
4950,196,syn9775595,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29086544,J Biomed Opt,2017,Combining deep learning and coherent anti-Stokes Raman scattering imaging for automated differential diagnosis of lung cancer,"Weng S, Xu X, Li J, Wong STC",U01 CA188388,,,,,,,,,U01,,,,Lung Carcinoma,,,,,,,,,,,,,,,1,CA188388,Modeling and targeting stroma-tumor crosstalk in non small cell lung cancer
4830,196,syn9775595,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26751490,Biomolecules,2016,Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment,"Yeung TL, Leung CS, Li F, Wong SS, Mok SC",U01 CA188388,,,,,,,"ovarian cancer, microenvironment",,U01,,,,Malignant Neoplasm of Ovary,,,,,,,,microenvironment,,,,,,Sage,1,CA188388,Modeling and targeting stroma-tumor crosstalk in non small cell lung cancer
4939,196,syn9775595,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29251630,J Clin Invest,2018,Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance,"Leung CS, Yeung TL, Yip KP, Wong KK, Ho SY, Mangala LS, Sood AK, Lopez-Berestein G, Sheng J, Wong ST, Birrer MJ, Mok SC",U01 CA188388,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE106519,,,,U01,,,,Malignant Neoplasm of Ovary,,,,,,,,,,,,,,Sage,,CA188388,Modeling and targeting stroma-tumor crosstalk in non small cell lung cancer
4827,196,syn9775595,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=25781964,IEEE J Biomed Health Inform,2015,Optimal drug prediction from personal genomics profiles,"Sheng J, Li F, Wong ST",U01 CA188388,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Computational Tool,,,,,,,drug resistance/sensitivity,,Not Applicable,,,,Sage,1,CA188388,Modeling and targeting stroma-tumor crosstalk in non small cell lung cancer
4829,196,syn9775595,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26893478,Cancer Res,2016,In Vivo Visualization and Characterization of Epithelial-Mesenchymal Transition in Breast Tumors,"Zhao Z, Zhu X, Cui K, Mancuso J, Federley R, Fischer K, Teng G, Mittal V, Gao D, Zhao H, Wong ST",U01 CA188388,,,,,,,"imaging, metastasis, single-cell",,U01,,,Not Applicable,"Carcinoma in situ of Breast, Chronic myeloid leukemia","Time Lapse Microscopy, Murine Model, Multiphoton Microscopy",,,,,,,Not Applicable,,Not Applicable,,,"imaging, metastasis, single-cell",Sage,1,CA188388,Modeling and targeting stroma-tumor crosstalk in non small cell lung cancer
5211,196,syn7416712,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27798635,PLoS One,2016,Platform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral Decomposition,"Aiello KA, Alter O",U01 CA202144,,,,,,,,,U01,,,,Astrocytoma,,,,,,,,,,,,,,,1,CA202144,Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
5136,196,syn7416712,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30397684,APL Bioeng,2018,Mathematically universal and biologically consistent astrocytoma genotype encodes for transformation and predicts survival phenotype,"Aiello KA, Ponnapalli SP, Alter O",U01 CA202144,,,,,,,,,U01,,,Brain,Malignant Neoplasm of Brain,Mathematical Modeling,,,,,,,,,Brain,,,,Center,1,CA202144,Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
5070,196,syn17084070,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28396217,Biochim Biophys Acta Rev Cancer,2017,Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!,"Wooten DJ, Quaranta V",U01 CA215845,,,,,,,,,U01,,,"Lung, NOS",Carcinoma in situ of Bronchus and Lung,,,,,,,,,,"Lung, NOS",,,,Center,1,CA215845,Phenotype Transitions in Small Cell Lung Cancer - CA215845
5166,196,syn17084070,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29432467,PLoS One,2018,A drift-diffusion checkpoint model predicts a highly variable and growth-factor-sensitive portion of the cell cycle G1 phase,"Jones ZW, Leander R, Quaranta V, Harris LA, Tyson DR",U01 CA215845,,,,,,,,,U01,,,"Lung, NOS",Carcinoma in situ of Bronchus and Lung,Mathematical Modeling,,,,,,,microenvironment,,"Lung, NOS",,,,Center,1,CA215845,Phenotype Transitions in Small Cell Lung Cancer - CA215845
5095,196,syn17084070,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29590606,Biophys J,2019,"A Nonquiescent ""Idling"" Population State in Drug-Treated, BRAF-Mutated Melanoma","Paudel BB, Harris LA, Hardeman KN, Abugable AA, Hayford CE, Tyson DR, Quaranta V",U01 CA215845,,,,,,,,,U01,,,Skin,Melanoma,Confocal Microscopy,,,,,,,drug resistance/sensitivity,,Skin,,,,Center,1,CA215845,Phenotype Transitions in Small Cell Lung Cancer - CA215845
5164,196,syn17084070,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28666314,Bioinformatics,2018,GPU-powered model analysis with PySB/cupSODA,"Harris LA, Nobile MS, Pino JC, Lubbock ALR, Besozzi D, Mauri G, Cazzaniga P, Lopez CF",U01 CA215845,,,,,,,,,U01,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,,Center,1,CA215845,Phenotype Transitions in Small Cell Lung Cancer - CA215845
5180,196,syn17084070,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26392530,Proc Natl Acad Sci U S A,2016,Competition and allostery govern substrate selectivity of cyclooxygenase-2,"Mitchener MM, Hermanson DJ, Shockley EM, Brown HA, Lindsley CW, Reese J, Rouzer CA, Lopez CF, Marnett LJ",U01 CA215845,,,,,,,,,U01,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,,Center,1,CA215845,Phenotype Transitions in Small Cell Lung Cancer - CA215845
5066,196,syn7416714,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29483578,Sci Rep,2018,Targeting Ligand Specificity Linked to Tumor Tissue Topological Heterogeneity via Single-Cell Micro-Pharmacological Modeling,"Karolak A, Estrella VC, Huynh AS, Chen T, Vagner J, Morse DL, Rejniak KA",U01 CA202229,,,,,,,,,U01,,,Pancreas,Malignant Neoplasm of Pancreas,Mathematical Modeling,,,,,,,,,Pancreas,,,,Center,1,CA202229,Physical Dynamics of Cancer Response to Chemotherapy in 3D Microenvironments
5061,196,syn7416714,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28594557,J Phys Chem Lett,2017,Long-Lived 13C2 Nuclear Spin States Hyperpolarized by Parahydrogen in Reversible Exchange at Microtesla Fields,"Zhou Z, Yu J, Colell JFP, Laasner R, Logan A, Barskiy DA, Shchepin RV, Chekmenev EY, Blum V, Warren WS, Theis T",U01 CA202229,,,,,,,,,U01,,,Unspecified,Not Applicable,,,,,,,,,,Unspecified,,,,Sage,,CA202229,Physical Dynamics of Cancer Response to Chemotherapy in 3D Microenvironments
5121,196,syn7416714,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27775375,Math Biosci Eng,2017,Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases,"Shah AB, Rejniak KA, Gevertz JL",U01 CA202229,,,,,,,,,U01,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,drug resistance/sensitivity,,Not Applicable,,,,Center,1,CA202229,Physical Dynamics of Cancer Response to Chemotherapy in 3D Microenvironments
5161,196,syn7416714,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27739047,Adv Exp Med Biol,2017,Microenvironmental Niches and Sanctuaries: A Route to Acquired Resistance,"Prez-Velzquez J, Gevertz JL, Karolak A, Rejniak KA",U01 CA202229,,,,,,,,,U01,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,,Center,1,CA202229,Physical Dynamics of Cancer Response to Chemotherapy in 3D Microenvironments
5175,196,syn7416714,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29367239,J R Soc Interface,2019,"Towards personalized computational oncology: from spatial models of tumour spheroids, to organoids, to tissues","Karolak A, Markov DA, McCawley LJ, Rejniak KA",U01 CA202229,,,,,,,,,U01,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,,Center,1,CA202229,Physical Dynamics of Cancer Response to Chemotherapy in 3D Microenvironments
5059,196,syn7416714,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28392884,J Phys Chem C Nanomater Interfaces,2017,"Generalizing, Extending, and Maximizing Nitrogen-15 Hyperpolarization Induced by Parahydrogen in Reversible Exchange","Colell JF, Logan AW, Zhou Z, Shchepin RV, Barskiy DA, Ortiz GX Jr, Wang Q, Malcolmson SJ, Chekmenev EY, Warren WS, Theis T",U01 CA202229,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,,CA202229,Physical Dynamics of Cancer Response to Chemotherapy in 3D Microenvironments
5092,196,syn7416714,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29790649,Chem Asian J,2018,"Hyperpolarized NMR Spectroscopy: d-DNP, PHIP, and SABRE Techniques","Kovtunov KV, Pokochueva EV, Salnikov OG, Cousin SF, Kurzbach D, Vuichoud B, Jannin S, Chekmenev EY, Goodson BM, Barskiy DA, Koptyug IV",U01 CA202229,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,,CA202229,Physical Dynamics of Cancer Response to Chemotherapy in 3D Microenvironments
5160,196,syn7416714,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29484795,Angew Chem Int Ed Engl,2018,Parahydrogen-Based Hyperpolarization for Biomedicine,"Hvener JB, Pravdivtsev AN, Kidd B, Bowers CR, Glggler S, Kovtunov KV, Plaumann M, Katz-Brull R, Buckenmaier K, Jerschow A, Reineri F, Theis T, Shchepin RV, Wagner S, Bhattacharya P, Zacharias NM, Chekmenev EY",U01 CA202229,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,,CA202229,Physical Dynamics of Cancer Response to Chemotherapy in 3D Microenvironments
5182,196,syn7416714,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27459542,Chemphyschem,2016,Efficient Batch-Mode Parahydrogen-Induced Polarization of Propane,"Salnikov OG, Barskiy DA, Coffey AM, Kovtunov KV, Koptyug IV, Chekmenev EY",U01 CA202229,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,,CA202229,Physical Dynamics of Cancer Response to Chemotherapy in 3D Microenvironments
4747,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28344926,Curr Opin Chem Eng,2018,Mechanotransduction in cancer,"Chin L, Xia Y, Discher DE, Janmey PA",U54 CA193417,,,,,,,"stiffness, cancer, extracellular matrix, review",,U54,,,Breast,Carcinoma in situ of Breast,Hydrogels,,,,,,,,,Breast,,,"stiffness, cancer, extracellular matrix, review",Center,,CA193417,Physical Science Oncology Center at Penn
4769,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28759889,Nature,2018,Mitotic progression following DNA damage enables pattern recognition within micronuclei,"Harding SM, Benci JL, Irianto J, Discher DE, Minn AJ, Greenberg RA",U54 CA193417,,,,,,,"DNA damage, micronuclei, editorial",,U54,,,Breast,Carcinoma in situ of Breast,CRISPR,,,,,,,tumor-immune,,Breast,,,"DNA damage, micronuclei, editorial",Center,3,CA193417,Physical Science Oncology Center at Penn
4780,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27798234,Mol Biol Cell,2017,Nuclear constriction segregates mobile nuclear proteins away from chromatin,"Irianto J, Pfeifer CR, Bennett RR, Xia Y, Ivanovska IL, Liu AJ, Greenberg RA, Discher DE",U54 CA193417,,,,,,,"nuclear envelope, constriction, imaging, mathematical modeling",,U54,,,"Lung, NOS",Carcinoma in situ of Bronchus and Lung,Fluorescent Antibody Procedure,,,,,,,,,"Lung, NOS",,,"nuclear envelope, constriction, imaging, mathematical modeling",Center,3,CA193417,Physical Science Oncology Center at Penn
5109,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29742017,Mol Biol Cell,2019,Constricted migration increases DNA damage and independently represses cell cycle,"Pfeifer CR, Xia Y, Zhu K, Liu D, Irianto J, Garca VMM, Milln LMS, Niese B, Harding S, Deviri D, Greenberg RA, Discher DE",U54 CA193417,,,,,,,,,U54,,,Liver,Carcinoma in situ of Bronchus and Lung,Micropipette Aspiration; Cell Migration Assay,,,,,,,metastasis,,Liver,,,,Center,3,CA193417,Physical Science Oncology Center at Penn
4743,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28196892,Proc Natl Acad Sci U S A,2018,Modeling the two-way feedback between contractility and matrix realignment reveals a nonlinear mode of cancer cell invasion,"Ahmadzadeh H, Webster MR, Behera R, Jimenez Valencia AM, Wirtz D, Weeraratna AT, Shenoy VB","U54 CA193417, U54 CA210173",,,,,,,"melanoma, cell morphology, invasion, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,metastasis,,Not Applicable,,,"melanoma, cell morphology, invasion, mathematical modeling",Center,,"CA193417, CA210173",Physical Science Oncology Center at Penn
4745,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=25810145,Bioessays,2016,Blood and immune cell engineering: Cytoskeletal contractility and nuclear rheology impact cell lineage and localization: Biophysical regulation of hematopoietic differentiation and trafficking,"Shin JW, Discher DE",U54 CA193417,,,,,,,"hematopoiesis, lamin, matrix, mechanobiology, myosin, review",,U54,,,Blood,Not Applicable,Rheology,,,,,,,,,Blood,,,"hematopoiesis, lamin, matrix, mechanobiology, myosin, review",Center,3,CA193417,Physical Science Oncology Center at Penn
4746,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=25411427,Blood,2015,"Cell rigidity and shape override CD47's ""self""-signaling in phagocytosis by hyperactivating myosin-II","Sosale NG, Rouhiparkouhi T, Bradshaw AM, Dimova R, Lipowsky R, Discher DE",U54 CA193417,,,,,,,"stiffness, phagocytosis, mysoin-II",,U54,,,Bone marrow,Not Applicable,Phagocytosis Assay,,,,,,,microenvironment,,Bone marrow,,,"stiffness, phagocytosis, mysoin-II",Center,3,CA193417,Physical Science Oncology Center at Penn
4748,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28341535,Biophys J,2017,"As a Nucleus Enters a Small Pore, Chromatin Stretches and Maintains Integrity, Even with DNA Breaks","Irianto J, Xia Y, Pfeifer CR, Greenberg RA, Discher DE",U54 CA193417,,,,,,,"chromatin organization, constriction, imaging, epifluorescence imaging, confocal microscopy",,U54,,,Not Applicable,Not Applicable,Nuclear Deformation Assay,,,,,,,,,Not Applicable,,,"chromatin organization, constriction, imaging, epifluorescence imaging, confocal microscopy",Center,3,CA193417,Physical Science Oncology Center at Penn
4749,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29082336,Curr Opin Syst Biol,2018,Genome variation across cancers scales with tissue stiffness - an invasion-mutation mechanism and implications for immune cell infiltration,"Pfeifer CR, Alvey CM, Irianto J, Discher DE",U54 CA193417,,,,,,,"migration, constriction, invasion, stiffness, review, mechanogenomics, monocytes, macrophages, collagen",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"migration, constriction, invasion, stiffness, review, mechanogenomics, monocytes, macrophages, collagen",Center,3,CA193417,Physical Science Oncology Center at Penn
4750,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=25395423,Blood,2015,Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopenia,"Spinler KR, Shin JW, Lambert MP, Discher DE",U54 CA193417,,,,,,,"myosin-II, rheometry",,U54,,,Blood,Not Applicable,Micropipette Aspiration,,,,,,,,,Blood,,,"myosin-II, rheometry",Center,3,CA193417,Physical Science Oncology Center at Penn
4751,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28256894,Phys Rev Lett,2018,"Persistence-Driven Durotaxis: Generic, Directed Motility in Rigidity Gradients","Novikova EA, Raab M, Discher DE, Storm C",U54 CA193417,,,,,,,"cell migration, durotaxis, matrix stiffness, mathematical modeling, stochastic simulation",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,microenvironment,,Not Applicable,,,"cell migration, durotaxis, matrix stiffness, mathematical modeling, stochastic simulation",Center,3,CA193417,Physical Science Oncology Center at Penn
4752,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28256231,Biophys J,2017,Interplay of Platelet Contractility and Elasticity of Fibrin/Erythrocytes in Blood Clot Retraction,"Tutwiler V, Wang H, Litvinov RI, Weisel JW, Shenoy VB",U54 CA193417,,,,,,,"clot contraction, mathematical modeling",,U54,,,Blood,Not Applicable,Mathematical Modeling,,,,,,,,,Blood,,,,Center,,CA193417,Physical Science Oncology Center at Penn
4753,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26168347,Nat Mater,2015,Fractal heterogeneity in minimal matrix models of scars modulates stiff-niche stem-cell responses via nuclear exit of a mechanorepressor,"Dingal PC, Bradshaw AM, Cho S, Raab M, Buxboim A, Swift J, Discher DE",U54 CA193417,,,,,,,"scars, stiffness, rheometry",,U54,,,Not Applicable,Not Applicable,Hydrogels,,,,,,,,,Not Applicable,,,"scars, stiffness, rheometry",Center,3,CA193417,Physical Science Oncology Center at Penn
4754,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28053997,Mol Ther Methods Clin Dev,2018,"""Marker of Self"" CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumors","Sosale NG, Ivanovska II, Tsai RK, Swift J, Hsu JW, Alvey CM, Zoltick PW, Discher DE",U54 CA193417,,,,,,,"lentivirus, macrophage",,U54,,,Bone marrow,Not Applicable,Single Nucleotide Polymorphism Array,,,,,,,,,Bone marrow,,,"lentivirus, macrophage",Center,3,CA193417,Physical Science Oncology Center at Penn
4755,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26172292,Curr Opin Immunol,2016,"Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific 'Marker of Self' CD47, and target physical properties","Sosale NG, Spinler KR, Alvey C, Discher DE",U54 CA193417,,,,,,,"macrophage, CD47, review",,U54,,,Blood,Not Applicable,Fluorescent Antibody Procedure,,,,,,,,,Blood,,,"macrophage, CD47, review",Center,3,CA193417,Physical Science Oncology Center at Penn
4756,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26461445,Nat Mater,2016,Cell-mediated fibre recruitment drives extracellular matrix mechanosensing inengineered fibrillar microenvironments,"Baker BM, Trappmann B, Wang WY, Sakar MS, Kim IL, Shenoy VB, Burdick JA, Chen CS",U54 CA193417,,,,,,,"extracellular matrix, mechanosensing, stiffness, atomic force microscopy, fluorescent microscopy, imaging",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,,Center,,CA193417,Physical Science Oncology Center at Penn
4757,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26536258,Biophys J,2016,A Chemomechanical Model of Matrix and Nuclear Rigidity Regulation of Focal Adhesion Size,"Cao X, Lin Y, Driscoll TP, Franco-Barraza J, Cukierman E, Mauck RL, Shenoy VB",U54 CA193417,,,,,,,"focal adhesion, extracellular matrix, stiffness, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"focal adhesion, extracellular matrix, stiffness, mathematical modeling",Center,,CA193417,Physical Science Oncology Center at Penn
4758,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26565280,Phys Rev E Stat Nonlin Soft Matter Phys,2016,Application of a free-energy-landscape approach to study tension-dependent bilayer tubulation mediated by curvature-inducing proteins,"Tourdot RW, Ramakrishnan N, Baumgart T, Radhakrishnan R",U54 CA193417,,,,,,,"Monte Carlo, Widom insertion, curvature-inducing proteins, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"Monte Carlo, Widom insertion, curvature-inducing proteins, mathematical modeling",Center,2,CA193417,Physical Science Oncology Center at Penn
4759,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26735954,PLoS One,2016,Normal and Fibrotic Rat Livers Demonstrate Shear Strain Softening and Compression Stiffening: A Model for Soft Tissue Mechanics,"Perepelyuk M, Chin L, Cao X, van Oosten A, Shenoy VB, Janmey PA, Wells RG",U54 CA193417,,,,,,,"stiffness, extracellular matrix, rheometry",,U54,,,Liver,Not Applicable,Rheology,,,,,,,,,Liver,,,"stiffness, extracellular matrix, rheometry",Center,1,CA193417,Physical Science Oncology Center at Penn
4760,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26758452,Sci Rep,2016,Uncoupling shear and uniaxial elastic moduli of semiflexible biopolymer networks: compression-softening and stretch-stiffening,"van Oosten AS, Vahabi M, Licup AJ, Sharma A, Galie PA, MacKintosh FC, Janmey PA",U54 CA193417,,,,,,,"stiffness, extracellular matrix, rheometry",,U54,,,Not Applicable,Not Applicable,Rheology,,,,,,,,,Not Applicable,,,"stiffness, extracellular matrix, rheometry",Center,1,CA193417,Physical Science Oncology Center at Penn
4761,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29212889,Physiology (Bethesda),2018,Stem Cell Differentiation is Regulated by Extracellular Matrix Mechanics,"Smith LR, Cho S, Discher DE",U54 CA193417,,,,,,,ECM,,U54,,,Not Applicable,Not Applicable,Hydrogels,,,,,,,,,Not Applicable,,,,Center,3,CA193417,Physical Science Oncology Center at Penn
4762,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28931598,Mol Biol Cell,2018,Coordinated increase of nuclear tension and lamin-A with matrix stiffness outcompetes lamin-B receptor that favors soft tissue phenotypes,"Buxboim A, Irianto J, Swift J, Athirasala A, Shin JW, Rehfeldt F, Discher DE",U54 CA193417,,,,,,,"mass spectrometry, DNA microarray, transcriptional profiling, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,microenvironment,,Not Applicable,,,"mass spectrometry, DNA microarray, transcriptional profiling, mathematical modeling",Center,3,CA193417,Physical Science Oncology Center at Penn
4763,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29178811,Nano Lett,2018,Cell-Extracellular Matrix Mechanobiology: Forceful Tools and Emerging Needs for Basic and Translational Research,"Holle AW, Young JL, Van Vliet KJ, Kamm RD, Discher D, Janmey P, Spatz JP, Saif T",U54 CA193417,,,,,,,ECM,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,ECM,Center,,CA193417,Physical Science Oncology Center at Penn
4764,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28468803,Proc Natl Acad Sci U S A,2018,Multiscale model predicts increasing focal adhesion size with decreasing stiffness in fibrous matrices,"Cao X, Ban E, Baker BM, Lin Y, Burdick JA, Chen CS, Shenoy VB",U54 CA193417,,,,,,,"matrix stiffness, mechanosensing, focal adhesion, cell contractility, matrix physical remodeling, Rho pathway, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,microenvironment,,Not Applicable,,,"matrix stiffness, mechanosensing, focal adhesion, cell contractility, matrix physical remodeling, Rho pathway, mathematical modeling",Center,,CA193417,Physical Science Oncology Center at Penn
4765,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28829941,Dev Cell,2017,Optimal Contractile Forces for a Mesenchymal Engine,"Discher DE, Dooling LJ",U54 CA193417,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,,,Not Applicable,,,,Center,3,CA193417,Physical Science Oncology Center at Penn
4766,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28810736,Langmuir,2019,Microstructure of Flow-Driven Suspension of Hardspheres in Cylindrical Confinement: A Dynamical Density Functional Theory and Monte Carlo Study,"Yu HY, Jabeen Z, Eckmann DM, Ayyaswamy PS, Radhakrishnan R",U54 CA193417,,,,,,,"mathematical modeling, density functional theory, Monte Carlo simulation, fluid flow, confinement",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"mathematical modeling, density functional theory, Monte Carlo simulation, fluid flow, confinement",Center,2,CA193417,Physical Science Oncology Center at Penn
4767,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28522599,J Leukoc Biol,2017,"Engineering macrophages to eat cancer: from ""marker of self"" CD47 and phagocytosis to differentiation","Alvey C, Discher DE",U54 CA193417,,,,,,,,,U54,,,Bone marrow,Not Applicable,Phagocytosis Assay,,,,,,,,,Bone marrow,,,,Center,3,CA193417,Physical Science Oncology Center at Penn
4768,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28805800,Nat Chem Biol,2017,Optogenetic control of kinetochore function,"Zhang H, Aonbangkhen C, Tarasovetc EV, Ballister ER, Chenoweth DM, Lampson MA",U54 CA193417,,,,,,,"optogenetic control, kinetochores, checkpoint, molecular motors, imaging, confocal microscopy",,U54,,,Not Applicable,Not Applicable,Optogenetic Assay,,,,,,,,,Not Applicable,,,"optogenetic control, kinetochores, checkpoint, molecular motors, imaging, confocal microscopy",Center,,CA193417,Physical Science Oncology Center at Penn
4770,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27531962,Proc Natl Acad Sci U S A,2018,Curvature-undulation coupling as a basis for curvature sensing and generation in bilayer membranes,"Bradley RP, Radhakrishnan R",U54 CA193417,,,,,,,"coarse-grained molecular dynamics, curvature-inducing proteins, equipartition, fluctuation analysis, membrane undulations",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"coarse-grained molecular dynamics, curvature-inducing proteins, equipartition, fluctuation analysis, membrane undulations",Center,2,CA193417,Physical Science Oncology Center at Penn
4771,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28532215,Annu Rev Biophys,2017,"Matrix Mechanosensing: From Scaling Concepts in 'Omics Data to Mechanisms in the Nucleus, Regeneration, and Cancer","Discher DE, Smith L, Cho S, Colasurdo M, Garca AJ, Safran S",U54 CA193417,,,,,,,"polymer physics, collagen, lamins, myosin, contractility, epigenetics, mechanosensing, matrix stiffness, review, lamin A",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"polymer physics, collagen, lamins, myosin, contractility, epigenetics, mechanosensing, matrix stiffness, review, lamin A",Center,3,CA193417,Physical Science Oncology Center at Penn
4772,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28669759,Curr Biol,2018,"SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors","Alvey CM, Spinler KR, Irianto J, Pfeifer CR, Hayes B, Xia Y, Cho S, Dingal PCPD, Hsu J, Smith L, Tewari M, Discher DE",U54 CA193417,,,,,,,,,U54,,,Bone marrow,Not Applicable,Unspecified; Phagocytosis Assay,,,,,,,tumor-immune,,Bone marrow,,,,Center,3,CA193417,Physical Science Oncology Center at Penn
4773,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28566555,Mol Biol Cell,2017,Cross-linked matrix rigidity and soluble retinoids synergize in nuclear lamina regulation of stem cell differentiation,"Ivanovska IL, Swift J, Spinler K, Dingal D, Cho S, Discher DE",U54 CA193417,,,,,,,"matrix stiffness, lamin A, stem cell differentiation, atomic force microscopy",,U54,,,Not Applicable,Not Applicable,Proteomics Assay,,,,,,,microenvironment,,Not Applicable,,,"matrix stiffness, lamin A, stem cell differentiation, atomic force microscopy",Center,3,CA193417,Physical Science Oncology Center at Penn
4774,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28569910,Phys Chem Chem Phys,2018,Cations induce shape remodeling of negatively charged phospholipid membranes,"Graber ZT, Shi Z, Baumgart T",U54 CA193417,,,,,,,"membrane structure, Ca2+, imaging, confocal microscopy",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"membrane structure, Ca2+, imaging, confocal microscopy",Center,,CA193417,Physical Science Oncology Center at Penn
4775,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28587976,Semin Cell Dev Biol,2018,"Mechanosensing of matrix by stem cells: From matrix heterogeneity, contractility, and the nucleus in pore-migration to cardiogenesis and muscle stem cells in vivo","Smith L, Cho S, Discher DE",U54 CA193417,,,,,,,"matrix elasticity, matrix stiffness, nucleus, lamin A, lamin C, Myosin-II, review, mechanosensing",,U54,,,Not Applicable,Not Applicable,Cell Migration Assay,,,,,,,,,Not Applicable,,,"matrix elasticity, matrix stiffness, nucleus, lamin A, lamin C, Myosin-II, review, mechanosensing",Center,3,CA193417,Physical Science Oncology Center at Penn
4776,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28591600,Biophys J,2017,Elastic-Fluid Model for DNA Damage and Mutation from Nuclear Fluid Segregation Due to Cell Migration,"Bennett RR, Pfeifer CR, Irianto J, Xia Y, Discher DE, Liu AJ",U54 CA193417,,,,,,,"DNA damage, nuclear deformation, migration, mathematical modeling, constriction",,U54,,,Brain,Not Applicable,Mathematical Modeling,,,,,,,metastasis,,Brain,,,"DNA damage, nuclear deformation, migration, mathematical modeling, constriction",Center,3,CA193417,Physical Science Oncology Center at Penn
4777,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26760315,Soft Matter,2016,Response of biopolymer networks governed by the physical properties of cross-linking molecules,"Wei X, Zhu Q, Qian J, Lin Y, Shenoy VB",U54 CA193417,,,,,,,"cross-linking, molecular dynamics, finite element-Langevin dynamics",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"cross-linking, molecular dynamics, finite element-Langevin dynamics",Center,,CA193417,Physical Science Oncology Center at Penn
4778,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27671239,Sci Rep,2018,Matrix viscoplasticity and its shielding by active mechanics in microtissue models: experiments and mathematical modeling,"Liu AS, Wang H, Copeland CR, Chen CS, Shenoy VB, Reich DH",U54 CA193417,,,,,,,"mathematical modeling, extracellular matrix, magnetic tweezers",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,,Center,,CA193417,Physical Science Oncology Center at Penn
4779,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27070691,Cancer Cell,2016,Deletion Mutations Keep Kinase Inhibitors in the Loop,"Freed DM, Park JH, Radhakrishnan R, Lemmon MA",U54 CA193417,,,,,,,"BRAF, EGFR, HER2, resistance, kinase inhibitors",,U54,,,Not Applicable,Not Applicable,Dideoxy Chain Termination DNA Sequencing,,,,,,,drug resistance/sensitivity,,Not Applicable,,,"BRAF, EGFR, HER2, resistance, kinase inhibitors",Center,2,CA193417,Physical Science Oncology Center at Penn
4781,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29116056,Phys Biol,2018,Excess area dependent scaling behavior of nano-sized membrane tethers,"Natesan R, Sreeja KK, Roychoudhuri A, Eckmann DM, Ayyaswamy PS, Baumgart T, Pucadyil T, Patil SV, Weaver VM, Radhakrishnan R",U54 CA193417,,,,,,,"atomic force microscopy, simulation, mathematical modeling, cellular membrane",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"atomic force microscopy, simulation, mathematical modeling, cellular membrane",Center,2,CA193417,Physical Science Oncology Center at Penn
4782,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27872289,Proc Natl Acad Sci U S A,2018,Fibrous nonlinear elasticity enables positive mechanical feedback between cells and ECMs,"Hall MS, Alisafaei F, Ban E, Feng X, Hui CY, Shenoy VB, Wu M",U54 CA193417,,,,,,,"3D cell traction force microscopy, cell traction force, cell?ECM interaction, collagen, fibrous nonlinear elasticity, traction force microscopy, extracellular matrix, breast cancer, imaging, brightfield microscopy",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"3D cell traction force microscopy, cell traction force, cell?ECM interaction, collagen, fibrous nonlinear elasticity, traction force microscopy, extracellular matrix, breast cancer, imaging, brightfield microscopy",Center,,CA193417,Physical Science Oncology Center at Penn
4783,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27177319,Nanomedicine (Lond),2017,Filomicelles from aromatic diblock copolymers increase paclitaxel-induced tumor cell death and aneuploidy compared with aliphatic copolymers,"Nair PR, Karthick SA, Spinler KR, Vakili MR, Lavasanifar A, Discher DE",U54 CA193417,,,,,,,"cylinder micelle, cytokinesis, drug delivery, worm micelle",,U54,,,"Lung, NOS",Not Applicable,Colorimetric Cell Viability Assay,,,,,,,,,"Lung, NOS",,,,Center,3,CA193417,Physical Science Oncology Center at Penn
4784,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27705776,Biophys J,2017,A Chemomechanical Model for Nuclear Morphology and Stresses during Cell Transendothelial Migration,"Cao X, Moeendarbary E, Isermann P, Davidson PM, Wang X, Chen MB, Burkart AK, Lammerding J, Kamm RD, Shenoy VB",U54 CA193417,,,,,,,"nuclear envelope, constriction, rupture, mathematical modeling, atomic force microscopy",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,metastasis,,Not Applicable,,,"nuclear envelope, constriction, rupture, mathematical modeling, atomic force microscopy",Center,,CA193417,Physical Science Oncology Center at Penn
4785,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27315485,Cell,2017,SnapShot: Mechanosensing Matrix,"Irianto J, Pfeifer CR, Xia Y, Discher DE",U54 CA193417,,,,,,,"stiffness, mechanosensing, extracellular matrix, review",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"stiffness, mechanosensing, extracellular matrix, review",Center,3,CA193417,Physical Science Oncology Center at Penn
4786,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27087801,Adv Planar Lipid Bilayers Liposomes,2018,Phenomenology based multiscale models as tools to understand cell membrane and organelle morphologies,"Ramakrishnan N, Radhakrishnan R",U54 CA193417,,,,,,,"Helfrich Hamiltonian, Monte Carlo, cell membrane, continuum models, curvature remodeling, detailed balance, fission and fusion, lipid bilayer, self-assembly, triangulated surfaces",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,,Center,2,CA193417,Physical Science Oncology Center at Penn
4787,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27806264,Biophys J,2017,Membrane Shape Instability Induced by Protein Crowding,"Chen Z, Atefi E, Baumgart T",U54 CA193417,,,,,,,"protein crowding, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Confocal Microscopy,,,,,,,microenvironment,,Not Applicable,,,"protein crowding, mathematical modeling",Center,,CA193417,Physical Science Oncology Center at Penn
4788,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27799529,Proc Natl Acad Sci U S A,2018,Mapping intracellular mechanics on micropatterned substrates,"Mandal K, Asnacios A, Goud B, Manneville JB",U54 CA193417,,,,,,,"cancer, cytoskeleton, microrheology, optical tweezers, viscoelasticity, experimental method, mathematical analysis",,U54,,,Not Applicable,Not Applicable,Rheology,,,,,,,,,Not Applicable,,,"cancer, cytoskeleton, microrheology, optical tweezers, viscoelasticity, experimental method, mathematical analysis",Center,,CA193417,Physical Science Oncology Center at Penn
4789,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27935261,Cytoskeleton (Hoboken),2017,Matrix rigidity regulates microtubule network polarization in migration,"Raab M, Discher DE",U54 CA193417,,,,,,,"matrix stiffness, microtubules, migration, polarity",,U54,,,Bone marrow,Not Applicable,Cell Migration Assay,,,,,,,,,Bone marrow,,,"matrix stiffness, microtubules, migration, polarity",Center,3,CA193417,Physical Science Oncology Center at Penn
4790,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27457951,Proc Natl Acad Sci U S A,2018,Mechanical signaling coordinates the embryonic heartbeat,"Chiou KK, Rocks JW, Chen CY, Cho S, Merkus KE, Rajaratnam A, Robison P, Tewari M, Vogel K, Majkut SF, Prosser BL, Discher DE, Liu AJ",U54 CA193417,,,,,,,"cardiac development, excitable media, heartbeat, mechanotransduction, reaction?diffusion, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Tandem Mass Spectrometry,,,,,,,,,Not Applicable,,,"cardiac development, excitable media, heartbeat, mechanotransduction, reaction?diffusion, mathematical modeling",Center,3,CA193417,Physical Science Oncology Center at Penn
4791,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27616867,Int J Adv Eng Sci Appl Math,2018,Thermodynamic free energy methods to investigate shape transitions in bilayer membranes,"Ramakrishnan N, Tourdot RW, Radhakrishnan R",U54 CA193417,,,,,,,"end-point-catastrophe, free energy techniques, thermodynamic integration, umbrella sampling, Widom insertion, Monte Carlo",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"end-point-catastrophe, free energy techniques, thermodynamic integration, umbrella sampling, Widom insertion, Monte Carlo",Center,2,CA193417,Physical Science Oncology Center at Penn
4792,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26967284,Cell,2016,The Dark Side of Cell Signaling: Positive Roles for Negative Regulators,"Lemmon MA, Freed DM, Schlessinger J, Kiyatkin A",U54 CA193417,,,,,,,"cell signaling, negative regulation, review",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,"cell signaling, negative regulation, review",Center,,CA193417,Physical Science Oncology Center at Penn
4793,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27570565,Cell Mol Bioeng,2019,Nuclear lamins in cancer,"Irianto J, Pfeifer CR, Ivanovska IL, Swift J, Discher DE",U54 CA193417,,,,,,,"LADs, nuclear lamina, SRF, YAP/TAZ, cancer, homeostasis, mechanotransduction, mechanosensing, nuclear organization, review",,U54,,,Not Applicable,Not Applicable,Unspecified,,,,,,,microenvironment,,Not Applicable,,,"LADs, nuclear lamina, SRF, YAP/TAZ, cancer, homeostasis, mechanotransduction, mechanosensing, nuclear organization, review",Center,3,CA193417,Physical Science Oncology Center at Penn
4794,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28043971,J Cell Biol,2017,Mechanosensing by the nucleus: From pathways to scaling relationships,"Cho S, Irianto J, Discher DE",U54 CA193417,,,,,,,"mechanosensing, review, chromosome organization",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling; Mathematical Modeling,,,,,,,,,Not Applicable,,,"mechanosensing, review, chromosome organization",Center,3,CA193417,Physical Science Oncology Center at Penn
4795,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26855753,Interface Focus,2016,A chemo-mechanical free-energy-based approach to model durotaxis and extracellular stiffness-dependent contraction and polarization of cells,"Shenoy VB, Wang H, Wang X",U54 CA193417,,,,,,,"contraction, extracellular matrix, durotaxis, stiffness, mathematical modeling",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,metastasis,,Not Applicable,,,"contraction, extracellular matrix, durotaxis, stiffness, mathematical modeling",Center,,CA193417,Physical Science Oncology Center at Penn
4796,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27989676,Curr Biol,2018,DNA Damage Follows Repair Factor Depletion and Portends Genome Variation in Cancer Cells after Pore Migration,"Irianto J, Xia Y, Pfeifer CR, Athirasala A, Ji J, Alvey C, Tewari M, Bennett RR, Harding SM, Liu AJ, Greenberg RA, Discher DE",U54 CA193417,,,,,,,"DNA damage, DNA repair, cancer, copy number variation, extracellular matrix, lamina, migration, motility, nuclear envelope, rupture, RNA-seq, FISH, imaging, epiflourescence imaging, aCGH, SNP array, DNA microarray",,U54,,,Brain,Not Applicable,Mathematical Modeling,,,,,,,microenvironment,,Brain,,,"DNA damage, DNA repair, cancer, copy number variation, extracellular matrix, lamina, migration, motility, nuclear envelope, rupture, RNA-seq, FISH, imaging, epiflourescence imaging, aCGH, SNP array, DNA microarray",Center,3,CA193417,Physical Science Oncology Center at Penn
4943,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29454938,Cell Syst,2019,Rare Cell Detection by Single-Cell RNA Sequencing as Guided by Single-Molecule RNA FISH,"Torre E, Dueck H, Shaffer S, Gospocic J, Gupte R, Bonasio R, Kim J, Murray J, Raj A",U54 CA193417,,,,,,,,,U54,,,Not Applicable,Not Applicable,,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,,CA193417,Physical Science Oncology Center at Penn
4966,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29694862,Biophys J,2018,"Multivalent Binding of a Ligand-Coated Particle: Role of Shape, Size, and Ligand Heterogeneity","McKenzie M, Ha SM, Rammohan A, Radhakrishnan R, Ramakrishnan N",U54 CA193417,,,,,,,,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,,Center,2,CA193417,Physical Science Oncology Center at Penn
4979,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29401442,Biophys J,2019,Mechanisms of Plastic Deformation in Collagen Networks Induced by Cellular Forces,"Ban E, Franklin JM, Nam S, Smith LR, Wang H, Wells RG, Chaudhuri O, Liphardt JT, Shenoy VB",U54 CA193417,,,,,,,,,U54,,,Not Applicable,Not Applicable,Rheology,,,,,,,microenvironment,,Not Applicable,,,,Center,,CA193417,Physical Science Oncology Center at Penn
4989,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28836761,ACS Nano,2019,"High-Speed ""4D"" Computational Microscopy of Bacterial Surface Motility","de Anda J, Lee EY, Lee CK, Bennett RR, Ji X, Soltani S, Harrison MC, Baker AE, Luo Y, Chou T, O'Toole GA, Armani AM, Golestanian R, Wong GCL",U54 CA193417,,,,,,,,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,,Center,,CA193417,Physical Science Oncology Center at Penn
4993,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29559526,Proc Natl Acad Sci U S A,2018,Multigenerational memory and adaptive adhesion in early bacterial biofilm communities,"Lee CK, de Anda J, Baker AE, Bennett RR, Luo Y, Lee EY, Keefe JA, Helali JS, Ma J, Zhao K, Golestanian R, O'Toole GA, Wong GCL",U54 CA193417,,,,,,,,,U54,,,Not Applicable,Not Applicable,,,,,,,,,,Not Applicable,,,,Center,,CA193417,Physical Science Oncology Center at Penn
5008,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29786613,J Phys Condens Matter,2018,Biophysics of membrane curvature remodeling at molecular and mesoscopic lengthscales,"Ramakrishnan N, Bradley RP, Tourdot RW, Radhakrishnan R",U54 CA193417,,,,,,,,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,,,Not Applicable,,,,Center,2,CA193417,Physical Science Oncology Center at Penn
5037,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29941873,Nat Methods,2018,SAVER: gene expression recovery for single-cell RNA sequencing,"Huang M, Wang J, Torre E, Dueck H, Shaffer S, Bonasio R, Murray JI, Raj A, Li M, Zhang NR",U54 CA193417,,,,,,,,,U54,,,Not Applicable,Not Applicable,FISH,,,,,,,,,Not Applicable,,,,Center,,CA193417,Physical Science Oncology Center at Penn
5039,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28858529,Biomacromolecules,2018,"Soft Substrates Containing Hyaluronan Mimic the Effects of Increased Stiffness on Morphology, Motility, and Proliferation of Glioma Cells","Pogoda K, Bucki R, Byfield FJ, Cruz K, Lee T, Marcinkiewicz C, Janmey PA",U54 CA193417,,,,,,,,,U54,,,Brain,Not Applicable,Fluorescent Antibody Procedure,,,,,,,,,Brain,,,,Center,1,CA193417,Physical Science Oncology Center at Penn
5054,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30171044,J Cell Biol,2018,Nuclear rupture at sites of high curvature compromises retention of DNA repair factors,"Xia Y, Ivanovska IL, Zhu K, Smith L, Irianto J, Pfeifer CR, Alvey CM, Ji J, Liu D, Cho S, Bennett RR, Liu AJ, Greenberg RA, Discher DE",U54 CA193417,,,,,,,,,U54,,,Not Applicable,Not Applicable,Atomic Force Microscopy,,,,,,,,,Not Applicable,,,,Center,3,CA193417,Physical Science Oncology Center at Penn
5138,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29451777,Bioconjug Chem,2019,Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong Survival,"Nair PR, Alvey C, Jin X, Irianto J, Ivanovska I, Discher DE",U54 CA193417,,,,,,,,,U54,,,Not Applicable,Not Applicable,Unspecified,,,,,,,drug resistance/sensitivity,,Not Applicable,,,,Center,3,CA193417,Physical Science Oncology Center at Penn
5220,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/28607484,Nature,2017,Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance,"Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, Beqiri M, Sproesser K, Brafford PA, Xiao M, Eggan E, Anastopoulos IN, Vargas-Garcia CA, Singh A, Nathanson KL, Herlyn M, Raj A",U54 CA193417,,,,,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97682 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97681 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97680 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97679",,"cancer therapeutic resistance, cellular noise, single-cell imaging",,U54,"syn12976715,syn12976714,syn12976713",syn12976708,Not Applicable,Not Applicable,FISH,,"GSE97679,GSE97680,GSE97681",Drug-induced reprogramming as a mode of cancer drug resistance,10.1038/nature22794,skin,University of Pennsylvania,,,Not Applicable,,,,Center,,CA193417,Physical Science Oncology Center at Penn
5223,196,syn7349747,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/28953887,Nature,2018,PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas,"Lu H, Liu S, Zhang G, Bin Wu, Zhu Y, Frederick DT, Hu Y, Zhong W, Randell S, Sadek N, Zhang W, Chen G, Cheng C, Zeng J, Wu LW, Zhang J, Liu X, Xu W, Krepler C, Sproesser K, Xiao M, Miao B, Liu J, Song CD, Liu JY, Karakousis GC, Schuchter LM, Lu Y, Mills G, Cong Y, Chernoff J, Guo J, Boland GM, Sullivan RJ, Wei Z, Field J, Amaravadi RK, Flaherty KT, Herlyn M, Xu X, Guo W",U54 CA193417,,,,,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE96902 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE96753",,"BRAF inhibition, melanoma, drug resistance",,U54,"syn12976725,syn12976726",syn12976724,Skin,Not Applicable,Mathematical Modeling,,"GSE96753, GSE96902",PAK signaling<U+00A0>and drug resistance,10.1038/nature24040,skin,University of Pennsylvania,,,Skin,,,,Center,,CA193417,Physical Science Oncology Center at Penn
5053,196,syn17084088,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27502248,Neuro Oncol,2017,Radiogenomics to characterize regional genetic heterogeneity in glioblastoma,"Hu LS, Ning S, Eschbacher JM, Baxter LC, Gaw N, Ranjbar S, Plasencia J, Dueck AC, Peng S, Smith KA, Nakaji P, Karis JP, Quarles CC, Wu T, Loftus JC, Jenkins RB, Sicotte H, Kollmeyer TM, O'Neill BP, Elmquist W, Hoxworth JM, Frakes D, Sarkaria J, Swanson KR, Tran NL, Li J, Mitchell JR",U01 CA220378,,,,,,,,,U01,,,,Glioblastoma,,,,,,,,,,,,,,,1,CA220378,Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
5113,196,syn17084088,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30219706,Neoplasia,2018,PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival,"Ding Z, Dhruv H, Kwiatkowska-Piwowarczyk A, Ruggieri R, Kloss J, Symons M, Pirrotte P, Eschbacher JM, Tran NL, Loftus JC",U01 CA220378,,,,,,,,,U01,,,Brain,Glioblastoma,Expression Array,,,,,,,metastasis,,Brain,,,,Sage,1,CA220378,Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
5181,196,syn17084088,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29016900,Neuro Oncol,2018,Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data,"Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, Giannini C, Burns TC, Kizilbash SH, Laramy JK, Swanson KR, Kaufmann TJ, Brown PD, Agar NYR, Galanis E, Buckner JC, Elmquist WF",U01 CA220378,,,,,,,,,U01,,,Brain,Glioblastoma,,,,,,,,drug resistance/sensitivity,,Brain,,,,Sage,1,CA220378,Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
5185,196,syn17084088,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29117939,Mol Cancer Res,2018,A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell Invasion,"Ding Z, Roos A, Kloss J, Dhruv H, Peng S, Pirrotte P, Eschbacher JM, Tran NL, Loftus JC",U01 CA220378,,,,,,,,,U01,,,,Glioblastoma,,,,,,,,,,,,,,,1,CA220378,Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
5199,196,syn17084088,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27509070,Neurosurgery,2017,Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study,"Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H, Bruce JN, Butler W, Cahill DP, Carter B, Orringer DA, Roberts DW, Sagher O, Sanai N, Schwartz TH, Silbergeld DL, Sisti MB, Thompson RC, Waziri AE, Ghogawala Z, McKhann G 2nd",U01 CA220378,,,,,,,,,U01,,,,Glioblastoma,,,,,,,,,,,,,,,1,CA220378,Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
5197,196,syn17084088,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29453678,J Neurooncol,2018,Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas,"Hersh DS, Peng S, Dancy JG, Galisteo R, Eschbacher JM, Castellani RJ, Heath JE, Legesse T, Kim AJ, Woodworth GF, Tran NL, Winkles JA",U01 CA220378,,,,,,,,,U01,,,Brain,Glioma,Not Applicable,,,,,,,heterogeneity/evolution,,Brain,,,,Sage,1,CA220378,Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
5064,196,syn17084088,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28482068,Nucleic Acids Res,2017,mTCTScan: a comprehensive platform for annotation and prioritization of mutations affecting drug sensitivity in cancers,"Li MJ, Yao H, Huang D, Liu H, Liu Z, Xu H, Qin Y, Prinz J, Xia W, Wang P, Yan B, Tran NL, Kocher JP, Sham PC, Wang J",U01 CA220378,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA220378,Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
5076,196,syn17084088,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30309842,AJNR Am J Neuroradiol,2018,Optimization of Acquisition and Analysis Methods for Clinical Dynamic Susceptibility Contrast MRI Using a Population-Based Digital Reference Object,"Semmineh NB, Bell LC, Stokes AM, Hu LS, Boxerman JL, Quarles CC",U01 CA220378,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA220378,Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
5155,196,syn17084088,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28670569,Front Oncol,2017,Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and Invasion,"Roos A, Ding Z, Loftus JC, Tran NL",U01 CA220378,,,,,,,,,U01,,,,,,,,,,,,,,,,,,,1,CA220378,Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
5203,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29887937,Biomicrofluidics,2018,In vitro models of molecular and nano-particle transport across the blood-brain barrier,"Hajal C, Campisi M, Mattu C, Chiono V, Kamm RD",U01 CA202177,,,,,,,,,U01,,,Brain,Head and Neck Carcinoma,Microfluidics,,,,,,,,,Brain,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5212,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30032046,Biomaterials,2018,"3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes","Campisi M, Shin Y, Osaki T, Hajal C, Chiono V, Kamm RD",U01 CA202177,,,,,,,,,U01,,,Brain,Head and Neck Carcinoma,Microfluidics,,,,,,,,,Brain,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5063,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28381031,Opt Express,2018,Integration of spectral coronagraphy within VIPA-based spectrometers for high extinction Brillouin imaging,"Edrei E, Gather MC, Scarcelli G",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Brillouin microscopy,,,,,,,,,Not Applicable,,,,Center,,CA202177,Quantitative analyses of tumor cell extravasation
5068,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27466032,Anesthesiology,2017,Raman Spectroscopy Differentiates Each Tissue from the Skin to the Spinal Cord: A Novel Method for Epidural Needle Placement?,"Anderson TA, Kang JW, Gubin T, Dasari RR, So PT",U01 CA202177,,,,,,,,,U01,,,,Pan-cancer,,,,,,,,,,,,,,Center,,CA202177,Quantitative analyses of tumor cell extravasation
5071,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26858990,Trends Cancer,2018,Microfluidics: A new tool for modeling cancer-immune interactions,"Boussommier-Calleja A, Li R, Chen MB, Wong SC, Kamm RD",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Microfluidics,,,,,,,,,Not Applicable,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5075,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27872091,Cancer Res,2017,Macrophage-Secreted TNF and TGF1 Influence Migration Speed and Persistence of Cancer Cells in 3D Tissue Culture via Independent Pathways,"Li R, Hebert JD, Lee TA, Xing H, Boussommier-Calleja A, Hynes RO, Lauffenburger DA, Kamm RD",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Microfluidics,,,,,,,,,Not Applicable,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5077,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=26988988,Cancer Res,2017,Elucidation of the Roles of Tumor Integrin 1 in the Extravasation Stage of the Metastasis Cascade,"Chen MB, Lamar JM, Li R, Hynes RO, Kamm RD",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Microfluidics,,,,,,,,,Not Applicable,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5086,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30135864,Extreme Mech Lett,2018,Complex mechanics of the heterogeneous extracellular matrix in cancer,"Malandrino A, Mak M, Kamm RD, Moeendarbary E",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Microfluidics,,,,,,,microenvironment,,Not Applicable,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5091,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29548546,Biomaterials,2019,The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model,"Boussommier-Calleja A, Atiyas Y, Haase K, Headley M, Lewis C, Kamm RD",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Microfluidics,,,,,,,metastasis,,Not Applicable,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5102,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27072748,Cancer Discov,2017,Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells,"Spiegel A, Brooks MW, Houshyar S, Reinhardt F, Ardolino M, Fessler E, Chen MB, Krall JA, DeCock J, Zervantonakis IK, Iannello A, Iwamoto Y, Cortez-Retamozo V, Kamm RD, Pittet MJ, Raulet DH, Weinberg RA",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Microfluidics,,,,,,,metastasis,,Not Applicable,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5104,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27192311,Opt Lett,2018,Pushing phase and amplitude sensitivity limits in interferometric microscopy,"Hosseini P, Zhou R, Kim YH, Peres C, Diaspro A, Kuang C, Yaqoob Z, So PT",U01 CA202177,,,,,,,,,U01,,,Not applicable,Pan-cancer,Not applicable,,,,,,,Not applicable,,Not applicable,,,,Center,,CA202177,Quantitative analyses of tumor cell extravasation
5106,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30044991,Cell Rep,2018,Epithelial-Mesenchymal Transition Induces Podocalyxin to Promote Extravasation via Ezrin Signaling,"Frse J, Chen MB, Hebron KE, Reinhardt F, Hajal C, Zijlstra A, Kamm RD, Weinberg RA",U01 CA202177,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74883,,,,U01,,,Breast,Pan-cancer,"CRISPR, mouse models, whole transcriptome sequencing",,,,,,,metastasis,,Breast,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5115,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29457129,ACS Biomater Sci Eng,2018,In Vitro Modeling of Mechanics in Cancer Metastasis,"Malandrino A, Kamm RD, Moeendarbary E",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Microfluidics,,,,,,,metastasis,,Not Applicable,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5118,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29387484,Micromachines (Basel),2018,Enhanced Axial Resolution of Wide-Field Two-Photon Excitation Microscopy by Line Scanning Using a Digital Micromirror Device,"Park JK, Rowlands CJ, So PTC",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Not Applicable,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,,CA202177,Quantitative analyses of tumor cell extravasation
5144,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28358393,Nat Protoc,2017,On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics,"Chen MB, Whisler JA, Frse J, Yu C, Shin Y, Kamm RD",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Microfluidics,,,,,,,metastasis,,Not Applicable,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5146,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=27185084,Drug Discov Today,2018,Microfluidic models for adoptive cell-mediated cancer immunotherapies,"Adriani G, Pavesi A, Tan AT, Bertoletti A, Thiery JP, Kamm RD",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Microfluidics,,,,,,,tumor-immune,,Not Applicable,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5159,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28102402,Lab Chip,2018,Brillouin flow cytometry for label-free mechanical phenotyping of the nucleus,"Zhang J, Nou XA, Kim H, Scarcelli G",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Brillouin microscopy,,,,,,,Not Applicable,,Not Applicable,,,,Center,,CA202177,Quantitative analyses of tumor cell extravasation
5173,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29713091,Appl Phys Lett,2018,Brillouin micro-spectroscopy through aberrations via sensorless adaptive optics,"Edrei E, Scarcelli G",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Brillouin microscopy,,,,,,,Not Applicable,,Not Applicable,,,,Center,,CA202177,Quantitative analyses of tumor cell extravasation
5210,196,syn7416707,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28318376,Regen Med,2018,Advances in on-chip vascularization,"Haase K, Kamm RD",U01 CA202177,,,,,,,,,U01,,,Not Applicable,Pan-cancer,Microfluidics,,,,,,,Not Applicable,,Not Applicable,,,,Center,1,CA202177,Quantitative analyses of tumor cell extravasation
5215,196,syn9773338,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30135581,Nature,2018,Allergic inflammatory memory in human respiratory epithelial progenitor cells,"Ordovas-Montanes J, Dwyer DF, Nyquist SK, Buchheit KM, Vukovic M, Deb C, Wadsworth MH 2nd, Hughes TK, Kazer SW, Yoshimoto E, Cahill KN, Bhattacharyya N, Katz HR, Berger B, Laidlaw TM, Boyce JA, Barrett NA, Shalek AK",U54 CA217377,,,,,,,,,U54,,,Nasal cavity,Carcinoma in situ of Bronchus and Lung,"ATAC-seq, whole transcriptome sequencing",,,,,,,tumor-immune,,Nasal cavity,,,,Center,,CA217377,Quantitative and Functional Characterization of Therapeutic Resistance in Cancer
5067,196,syn9773338,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30482222,Genome Biol,2019,"Linking single-cell measurements of mass, growth rate, and gene expression","Kimmerling RJ, Prakadan SM, Gupta AJ, Calistri NL, Stevens MM, Olcum S, Cermak N, Drake RS, Pelton K, De Smet F, Ligon KL, Shalek AK, Manalis SR",U54 CA217377,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121655,,,,U54,,,Brain,Malignant Neoplasm of Brain,"whole transcriptome Sequencing, Microfluidics",,,,,,,drug resistance/sensitivity,,Brain,,,,Center,,CA217377,Quantitative and Functional Characterization of Therapeutic Resistance in Cancer
4554,196,syn9773338,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28931656,Sci Transl Med,2018,Single-cell analyses to tailor treatments,"Shalek AK, Benson M",U54 CA217377,,,,,,,scRNA-Seq,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,drug resistance/sensitivity,,Not Applicable,,,scRNA-Seq,Center,,CA217377,Quantitative and Functional Characterization of Therapeutic Resistance in Cancer
4555,196,syn9773338,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29151572,Nat Commun,2018,Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation,"Cetin AE, Stevens MM, Calistri NL, Fulciniti M, Olcum S, Kimmerling RJ, Munshi NC, Manalis SR",U54 CA217377,,,,,,,"single-cell,multiple myeloma",,U54,,,Bone marrow,Not Applicable,Unspecified,,,,,,,drug resistance/sensitivity,,Bone marrow,,,"single-cell,multiple myeloma",Center,,CA217377,Quantitative and Functional Characterization of Therapeutic Resistance in Cancer
4556,196,syn9773338,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29376520,Nat Rev Cancer,2019,Targeting minimal residual disease: a path to cure?,"Luskin MR, Murakami MA, Manalis SR, Weinstock DM",U54 CA217377,,,,,,,review,,U54,,,Not Applicable,Not Applicable,Magnetic Resonance Imaging,,,,,,,drug resistance/sensitivity,,Not Applicable,,,review,Center,,CA217377,Quantitative and Functional Characterization of Therapeutic Resistance in Cancer
4652,196,syn7315808,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28111070,Cell,2017,Systemic Immunity Is Required for Effective Cancer Immunotherapy,"Spitzer MH, Carmi Y, Reticker-Flynn NE, Kwek SS, Madhireddy D, Martins MM, Gherardini PF, Prestwood TR, Chabon J, Bendall SC, Fong L, Nolan GP, Engleman EG",U54 CA209971,,,,,,,"immunology, immunotherapy, mass cytometry",,U54,,,Breast,Carcinoma in situ of Breast,Immunohistochemistry Staining Method,,,,,,,tumor-immune,,Breast,,,"immunology, immunotherapy, mass cytometry",Center,,CA209971,Stanford University Center for Cancer Systems Biology
5005,196,syn7315808,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29760045,Cancer Res,2018,GFPT2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma,"Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager JB, Ayers K, Bakr S, Gentles AJ, Diehn M, Quon A, West RB, Nair V, van de Rijn M, Napel S, Plevritis SK",U54 CA209971,,,,,,,,,U54,,,"Lung, NOS",Carcinoma in situ of Bronchus and Lung,IHC,,,,,,,"metabolism, microenvironment",,"Lung, NOS",,,,Center,3,CA209971,Stanford University Center for Cancer Systems Biology
4650,196,syn7315808,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28611041,Cancer Res,2017,An Immunosuppressive Dendritic Cell Subset Accumulates at Secondary Sites and Promotes Metastasis in Pancreatic Cancer,"Kenkel JA, Tseng WW, Davidson MG, Tolentino LL, Choi O, Bhattacharya N, Seeley ES, Winer DA, Reticker-Flynn NE, Engleman EG",U54 CA209971,,,,,,,"immunology, pancreatic cancer",,U54,,,Pancreas,Malignant Neoplasm of Pancreas,Fluorescent Antibody Procedure,,,,,,,tumor-immune,,Pancreas,,,"immunology, pancreatic cancer",Center,1,CA209971,Stanford University Center for Cancer Systems Biology
4909,196,syn7315808,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29370452,Angew Chem Int Ed Engl,2018,N-Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen-Presenting Cells through Dectin-1 and Dectin-2,"Zhou MN, Delaveris CS, Kramer JR, Kenkel JA, Engleman EG, Bertozzi CR",U54 CA209971,,,,,,,,,U54,,,Unspecified,Not Applicable,Not Applicable,,,,,,,tumor-immune,,Unspecified,,,,Sage,1,CA209971,Stanford University Center for Cancer Systems Biology
4955,196,syn7315808,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29654148,Proc Natl Acad Sci U S A,2018,DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity,"Anchang B, Davis KL, Fienberg HG, Williamson BD, Bendall SC, Karacosta LG, Tibshirani R, Nolan GP, Plevritis SK",U54 CA209971,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,,CA209971,Stanford University Center for Cancer Systems Biology
5026,196,syn7315808,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30078711,Cell,2018,Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging,"Goltsev Y, Samusik N, Kennedy-Darling J, Bhate S, Hale M, Vazquez G, Black S, Nolan GP",U54 CA209971,,,,,,,,,U54,,,"Lymph node, NOS",Not Applicable,"flow cytometry, mass cytometry",,,,,,,"microenvironment, tumor immune",,"Lymph node, NOS",,,,Center,2,CA209971,Stanford University Center for Cancer Systems Biology
4651,196,syn7315808,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27590114,Immunity,2016,Normalizing Microbiota-Induced Retinoic Acid Deficiency Stimulates Protective CD8(+) T Cell-Mediated Immunity in Colorectal Cancer,"Bhattacharya N, Yuan R, Prestwood TR, Penny HL, DiMaio MA, Reticker-Flynn NE, Krois CR, Kenkel JA, Pham TD, Carmi Y, Tolentino L, Choi O, Hulett R, Wang J, Winer DA, Napoli JL, Engleman EG",U54 CA209971,,,,,,,"colon cancer, metabolism, immunology, microbiome",,U54,,,Colon,Tumor of the Large Bowel,flow cytometry,,,,,,,metabolism,,Colon,,,,Sage,1,CA209971,Stanford University Center for Cancer Systems Biology
5190,196,syn7315808,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30201266,Biophys J,2018,Extravasation of Brownian Spheroidal Nanoparticles through Vascular Pores,"Shah PN, Lin TY, Aanei IL, Klass SH, Smith BR, Shaqfeh ESG",U54 CA209971,,,,,,,,,U54,,,Not Applicable,Pan-cancer,Mathematical modeling,,,,,,,drug resistance/sensitivity,,Not Applicable,,,,Sage,,CA209971,Stanford University Center for Cancer Systems Biology
4568,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28505145,Genes (Basel),2017,DNA Methylation Targets Influenced by Bisphenol A and/or Genistein Are Associated with Survival Outcomes in Breast Cancer Patients,"Jadhav RR, Santucci-Pereira J, Wang YV, Liu J, Nguyen TD, Wang J, Jenkins S, Russo J, Huang TH, Jin VX, Lamartiniere CA",U54 CA217297,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89107,,"breast cancer, DNAmethylation",,U54,syn12576666,syn12558070,Mammary Gland,Carcinoma in situ of Breast,Methyl Binding Domain Sequencing,,GSE89107,DNA Methylation Targets,,,,Not Applicable,,Mammary Gland,,,"breast cancer, DNAmethylation",Sage,,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4565,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29233929,Cancer Res,2018,Single-cell RNA-seq reveals a subpopulation of prostate cancer cells with enhanced cell cycle-related transcription and attenuated androgen response,"Horning AM, Wang Y, Lin CK, Louie AD, Jadhav RR, Hung CN, Wang CM, Lin CL, Kirma NB, Liss MA, Kumar AP, Sun L, Liu Z, Chao WT, Wang Q, Jin VX, Chen CL, Huang TH",U54 CA217297,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE99795,,"scRNA-seq, prostate cancer",,U54,,,Prostate Gland,Carcinoma in situ of Prostate,single-cell RNA-sequencing,,,,,,,heterogeneity/evolution,,Prostate Gland,,,,Sage,,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4956,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=26332453,Prostate,2015,DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence,"Horning AM, Awe JA, Wang CM, Liu J, Lai Z, Wang VY, Jadhav RR, Louie AD, Lin CL, Kroczak T, Chen Y, Jin VX, Abboud-Werner SL, Leach RJ, Hernandez J, Thompson IM, Saranchuk J, Drachenberg D, Chen CL, Mai S, Huang TH",U54 CA217297,,,,,,,,,U54,,,Prostate Gland,Carcinoma in situ of Prostate,Methyl Binding Domain Sequencing,,,,,,,drug resistance/sensitivity,,Prostate Gland,,,,Sage,,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
5119,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29844167,Proc Natl Acad Sci U S A,2018,Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13,"Chen Z, Wu D, Thomas-Ahner JM, Lu C, Zhao P, Zhang Q, Geraghty C, Yan PS, Hankey W, Sunkel B, Cheng X, Antonarakis ES, Wang QE, Liu Z, Huang TH, Jin VX, Clinton SK, Luo J, Huang J, Wang Q",U54 CA217297,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE99378,,,,U54,,,Prostate Gland,Carcinoma in situ of Prostate,ChIP-Seq,,,,,,,Not Applicable,,Prostate Gland,,,,Center,,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4559,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28809778,Int J Mol Sci,2017,"Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor -Positive Breast Cancer","Buchegger K, Riquelme I, Viscarra T, Ili C, Brebi P, Huang TH, Roa JC",U54 CA217297,,,,,,,"DNAmethylation, breast cancer",,U54,,,Breast,Intraductal carcinoma in situ of breast,Methyl Binding Domain Sequencing,,,,,,,Not Applicable,,Breast,,,"DNAmethylation, breast cancer",Sage,,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4561,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29212856,Cancer Res,2018,Tamoxifen resistance in breast cancer is regulated by the EZH2-ER-GREB1 transcriptional axis,"Wu Y, Zhang Z, Cenciarini ME, Proietti CJ, Amasino MF, Hong T, Yang M, Liao Y, Chiang HC, Kaklamani V, Jeselsohn R, Vadlamudi RK, Huang TH, Li R, De Angelis C, Fu X, Elizalde PV, Schiff R, Brown M, Xu K",U54 CA217297,,,,,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103243 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103242 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92316",,"breast cancer, endocrine resistance, epigenetics",,U54,,,Breast,Intraductal carcinoma in situ of breast,"Whole Transcriptome Sequencing, ChIP-Seq",,,,,,,drug resistance/sensitivity,,Breast,,,"breast cancer, endocrine resistance, epigenetics",Sage,,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4563,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28938868,BMC Genomics,2017,START: a system for flexible analysis of hundreds of genomic signal tracks in few lines of SQL-like queries,"Zhu X, Zhang Q, Ho ED, Yu KH, Liu C, Huang TH, Cheng AS, Kao B, Lo E, Yip KY",U54 CA217297,,,https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP073877,,,,genomics,,U54,,,Liver,Liver and Intrahepatic Bile Duct Carcinoma,Methylation Profiling by Array,,,,,,,heterogeneity/evolution,,Liver,,,genomics,Sage,1,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4560,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29113562,J Bioinform Comput Biol,2018,Utilizing networks for differential analysis of chromatin interactions,"Liu L, Ruan J",U54 CA217297,,,,,,,"networks, Hi-C, chromatin",,U54,,,Not Applicable,Not Applicable,Hi-C,,,,,,,Not Applicable,,Not Applicable,,,,Center,1,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4562,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28334224,Bioinformatics,2018,Computational modeling of in vivo and in vitro protein-DNA interactions by multiple instance learning,"Gao Z, Ruan J",U54 CA217297,,,,,,,"networks, TF-DNA",,U54,,,Not Applicable,Not Applicable,"ChIP-Seq, Computational modeling",,,,,,,Not Applicable,,Not Applicable,,,"networks, TF-DNA",Center,,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4564,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28885554,Genes (Basel),2017,Advances in Genomic Profiling and Analysis of 3D Chromatin Structure and Interaction,"Tang B, Cheng X, Xi Y, Chen Z, Zhou Y, Jin VX",U54 CA217297,,,,,,,"HI-C, chromatin structure",,U54,,,Unspecified,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,"HI-C, chromatin structure",Sage,3,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4567,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28984206,BMC Genomics,2018,Logo2PWM: a tool to convert sequence logo to position weight matrix,"Gao Z, Liu L, Ruan J",U54 CA217297,http://www.cs.utsa.edu/~jruan/logo2pwm,,,,,,TF-DNA,,U54,,,Not Applicable,Not Applicable,ChIP-Seq,,,,,,,Not Applicable,,Not Applicable,,,TF-DNA,Center,1,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4569,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28956817,Genes (Basel),2018,Pathway Enrichment Analysis with Networks,"Liu L, Wei J, Ruan J",U54 CA217297,,,,,,,pathwayEnrichment,,U54,,,Not Applicable,Not Applicable,Computational Modeling,,,,,,,Not Applicable,,Not Applicable,,,pathwayEnrichment,Center,1,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4557,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28419278,Nucleic Acids Res,2017,Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence,"Sunkel B, Wu D, Chen Z, Wang CM, Liu X, Ye Z, Horning AM, Liu J, Mahalingam D, Lopez-Nicora H, Lin CL, Goodfellow PJ, Clinton SK, Jin VX, Chen CL, Huang TH, Wang Q",U54 CA217297,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63034,,,,U54,,,Prostate Gland,Carcinoma in situ of Prostate,"ChIP-Seq, Whole Transcriptome Sequencing",,,,,,,metastasis,,Prostate Gland,,,,Sage,,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4558,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28620196,Sci Rep,2017,Integration of DNA methylation and gene transcription across nineteen cell types reveals cell type-specific and genomic region-dependent regulatory patterns,"Tang B, Zhou Y, Wang CM, Huang TH, Jin VX",U54 CA217297,,,,,,,"DNAmethylation, regression",,U54,,,Not Applicable,Pan-cancer,Statistical Modeling,,,,,,,Not Applicable,,Not Applicable,,,"DNAmethylation, regression",Sage,,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4566,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28859663,Genome Biol,2017,Sparse conserved under-methylated CpGs are associated with high-order chromatin structure,"Lin X, Su J, Chen K, Rodriguez B, Li W",U54 CA217297,,,,,,,DNAmethylation,,U54,,,Not Applicable,Not Applicable,Computational modeling,,,,,,,Not Applicable,,Not Applicable,,,DNAmethylation,Sage,,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4941,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29665865,Genome Med,2018,Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicing,"Li T, Liu Q, Garza N, Kornblau S, Jin VX",U54 CA217297,,,,,,,,,U54,,,Not Applicable,Not Applicable,"ChIP-Seq, Whole Transcriptome Sequencing",,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
5024,196,syn9773346,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30097071,Genome Biol,2018,Homeobox oncogene activation by pan-cancer DNA hypermethylation,"Su J, Huang YH, Cui X, Wang X, Zhang X, Lei Y, Xu J, Lin X, Chen K, Lv J, Goodell MA, Li W",U54 CA217297,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE90780,,,,U54,,,Not Applicable,Pan-cancer,Bisulfite Sequencing,,,,,,,Not Applicable,,Not Applicable,,,,Sage,2,CA217297,Systems Analysis of Epigenomic Architecture in Cancer Progression
4642,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29208669,Clin Cancer Res,2017,Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective Invasion,"Richardson AM, Havel LS, Koyen AE, Konen JM, Shupe J, Wiles WG 4th, Martin WD, Grossniklaus HE, Sica G, Gilbert-Ross M, Marcus AI",U54 CA209992,,,,,,,"lung cancer, metastasis",,U54,,,Lung,Carcinoma in situ of Bronchus and Lung,Not Applicable,,,,,,,metastasis,,Lung,,,"lung cancer, metastasis",Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5176,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29795571,PLoS Comput Biol,2018,The complex ecosystem in non small cell lung cancer invasion,"Haney S, Konen J, Marcus AI, Bazhenov M",U54 CA209992,,,,,,,,,U54,,,Lung,Carcinoma in situ of Bronchus and Lung,computational modeling,,,,,,,metastasis,,Lung,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5025,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28500274,Proc Natl Acad Sci U S A,2017,Combined HMG-COA reductase and prenylation inhibition in treatment of CCM,"Nishimura S, Mishra-Gorur K, Park J, Surovtseva YV, Sebti SM, Levchenko A, Louvi A, Gunel M",U54 CA209992,,,,,,,,,U54,,,Brain,Central Nervous System Cavernous Hemangioma,Not Applicable,,,,,,,not applicable,,Brain,,,,Sage,1,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4640,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29020634,Cell Rep,2017,Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer,"Shah SR, David JM, Tippens ND, Mohyeldin A, Martinez-Gutierrez JC, Ganaha S, Schiapparelli P, Hamilton DH, Palena C, Levchenko A, Quiones-Hinojosa A",U54 CA209992,,,,,,,glioblastoma,,U54,,,Brain,Glioblastoma,Not applicable,,,,,,,Not Applicable,,Brain,,,glioblastoma,Sage,1,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4643,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28805815,Nat Neurosci,2017,AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma,"Chow RD, Guzman CD, Wang G, Schmidt F, Youngblood MW, Ye L, Errami Y, Dong MB, Martinez MA, Zhang S, Renauer P, Bilguvar K, Gunel M, Sharp PA, Zhang F, Platt RJ, Chen S",U54 CA209992,,,,,,,"CRISPR,glioblastoma",,U54,,,Brain,Glioblastoma,CRISPR,,,,,,,drug resistance/sensitivity,,Brain,,,"CRISPR,glioblastoma",Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4645,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=27292647,Cell Rep,2016,Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes,"Smith CL, Kilic O, Schiapparelli P, Guerrero-Cazares H, Kim DH, Sedora-Roman NI, Gupta S, O'Donnell T, Chaichana KL, Rodriguez FJ, Abbadi S, Park J, Quiones-Hinojosa A, Levchenko A",U54 CA209992,,,,,,,"glioblastoma, migration",,U54,,,Brain,Glioblastoma,Not applicable,,,,,,,"metastasis, heterogeneity/evolution",,Brain,,,"glioblastoma, migration",Sage,1,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4644,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28655842,Proc Natl Acad Sci U S A,2017,Mechanochemical feedback underlies coexistence of qualitatively distinct cell polarity patterns within diverse cell populations,"Park J, Holmes WR, Lee SH, Kim HN, Kim DH, Kwak MK, Wang CJ, Edelstein-Keshet L, Levchenko A",U54 CA209992,,,,,,,"migration, cellMorphology,mathematicalModels",,U54,,,Not Applicable,Melanoma,Mathematical Modeling,,,,,,,metastasis,,Not Applicable,,,"migration, cellMorphology,mathematicalModels",Sage,1,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4641,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29427530,Proteins,2018,"Comparing side chain packing in soluble proteins, protein-protein interfaces, and transmembrane proteins","Gaines JC, Acebes S, Virrueta A, Butler M, Regan L, O'Hern CS",U54 CA209992,,,,,,,protein design,,U54,,,Unspecified,Not Applicable,Not Applicable,,,,,,,not Applicable,,Unspecified,,,protein design,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4962,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29153834,Cell,2017,Precise Editing at DNA Replication Forks Enables Multiplex Genome Engineering in Eukaryotes,"Barbieri EM, Muir P, Akhuetie-Oni BO, Yellman CM, Isaacs FJ",U54 CA209992,,,,,,,,,U54,,,Unspecified,Not Applicable,Dideoxy Chain Termination DNA Sequencing,,,,,,,drug resistance/sensitivity,,Unspecified,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4976,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29443972,Nat Chem Biol,2018,The ABCs of PTMs,"Barber KW, Rinehart J",U54 CA209992,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5048,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29121460,ACS Chem Biol,2018,Diverse Class 2 CRISPR-Cas Effector Proteins for Genome Engineering Applications,"Pyzocha NK, Chen S",U54 CA209992,,,,,,,,,U54,,,Unspecified,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Unspecified,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5168,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30332652,Cell Rep,2018,Insights into Bidirectional Gene Expression Control Using the Canonical GAL1/GAL10 Promoter,"Elison GL, Xue Y, Song R, Acar M",U54 CA209992,,,,,,,,,U54,,,Unspecified,Not Applicable,CRISPR,,,,,,,Not Applicable,,Unspecified,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5041,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30072739,Oncogene,2018,Sno-derived RNAs are prevalent molecular markers of cancer immunity,"Chow RD, Chen S",U54 CA209992,,,,,,,,,U54,,,Unspecified,Pan-cancer,smRNA-seq,,,,,,,"microenvironment, tumor-immune",,Unspecified,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5151,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30244832,Mol Cell,2018,A Loss of Epigenetic Control Can Promote Cell Death through Reversing the Balance of Pathways in a Signaling Network,"Vanaja KG, Timp W, Feinberg AP, Levchenko A",U54 CA209992,,,,,,,,,U54,,,Colon,Carcinoma in situ of Colon,"Real Time PCR, ",,,,,,,Not Applicable,,Colon,,,,Sage,1,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4744,196,syn7315810,"PS-ON, CSBC",https://www.ncbi.nlm.nih.gov/pubmed/?term=28988771,Cell,2017,EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics,"Freed DM, Bessman NJ, Kiyatkin A, Salazar-Cavazos E, Byrne PO, Moore JO, Valley CC, Ferguson KM, Leahy DJ, Lidke DS, Lemmon MA","U54 CA193417, U54 CA209992",,,,,,,,,U54,,,Not Applicable,Not Applicable,"X-Ray Crystallography, Small-Angle X-ray Scattering, Surface Plasmon Resonance",,,,,,,Not Applicable,,Not Applicable,,,,Sage,,"CA193417, CA209992",Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4903,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29228311,Protein Eng Des Sel,2017,A new method for post-translationally labeling proteins in live cells for fluorescence imaging and tracking,"Hinrichsen M, Lenz M, Edwards JM, Miller OK, Mochrie SGJ, Swain PS, Schwarz-Linek U, Regan L",U54 CA209992,,,,,,,,,U54,,,Not Applicable,Not Applicable,microscopy,,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4933,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29675464,Sci Adv,2018,Heritable stress response dynamics revealed by single-cell genealogy,"Chatterjee M, Acar M",U54 CA209992,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4969,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29765043,Nat Commun,2018,Programmable sequential mutagenesis by inducible Cpf1 crRNA array inversion,"Chow RD, Kim HR, Chen S",U54 CA209992,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5000,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29709259,Trends Cancer,2018,Cancer CRISPR Screens In Vivo,"Chow RD, Chen S",U54 CA209992,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,Not Applicable,Not Applicable,Not Applicable,Not Applicable,Not Applicable,Not Applicable,Not Applicable,,Not Applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5016,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29920078,Biochemistry,2018,Kinase Substrate Profiling Using a Proteome-wide Serine-Oriented Human Peptide Library,"Barber KW, Miller CJ, Jun JW, Lou HJ, Turk BE, Rinehart J",U54 CA209992,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5018,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29889213,Nat Biotechnol,2018,Encoding human serine phosphopeptides in bacteria for proteome-wide identification of phosphorylation-dependent interactions,"Barber KW, Muir P, Szeligowski RV, Rogulina S, Gerstein M, Sampson JR, Isaacs FJ, Rinehart J",U54 CA209992,,https://www.ebi.ac.uk/pride/archive/projects/PXD008707,SUB3834588,,,,,,U54,,,Not Applicable,Not Applicable,"Liquid Chromatography/Tandem Mass Spectrometry, Dideoxy Chain Termination DNA Sequencing",,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5020,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30062046,Cell Discov,2018,Programmable DNA repair with CRISPRa/i enhanced homology-directed repair efficiency with a single Cas9,"Ye L, Wang C, Hong L, Sun N, Chen D, Chen S, Han F",U54 CA209992,,,,,,,,,U54,,,Not Applicable,Not Applicable,CRISPR,,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5021,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30027155,iScience,2018,Live-Cell Imaging of Chromatin Condensation Dynamics by CRISPR,"Xue Y, Acar M",U54 CA209992,,,,,,,,,U54,,,Not Applicable,Not Applicable,"CRISPR, Imaging",,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5030,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28472054,PLoS Comput Biol,2017,A mathematical model coupling polarity signaling to cell adhesion explains diverse cell migration patterns,"Holmes WR, Park J, Levchenko A, Edelstein-Keshet L",U54 CA209992,,,,,,,,,U54,,,Not Applicable,Pan-cancer,Mathematical Modeling,,,,,,,Metastasis,,Not applicable,,,,Sage,1,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5049,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30257679,BMC Syst Biol,2018,Multi-component gene network design as a survival strategy in diverse environments,"Luo X, Song R, Acar M",U54 CA209992,,,,,,,,,U54,,,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5060,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30198622,Protein Sci,2018,A threonine zipper that mediates protein-protein interactions: Structure and prediction,"Oi C, Treado JD, Levine ZA, Lim CS, Knecht KM, Xiong Y, O'Hern CS, Regan L",U54 CA209992,,https://www.rcsb.org/structure/6CIU,,,,,,,U54,,,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,Not applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5183,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30470750,Nat Commun,2018,Entropy production rate is maximized in non-contractile actomyosin,"Seara DS, Yadav V, Linsmeier I, Tabatabai AP, Oakes PW, Tabei SMA, Banerjee S, Murrell MP",U54 CA209992,,,,,,,,,U54,,,Not applicable,Not applicable,Mathematical Modeling,,,,,,,Not applicable,,Not applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5085,196,syn17084053,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30346945,PLoS Biol,2018,Quantitative assessment of cell population diversity in single-cell landscapes,"Liu Q, Herring CA, Sheng Q, Ping J, Simmons AJ, Chen B, Banerjee A, Li W, Gu G, Coffey RJ, Shyr Y, Lau KS",U01 CA215798,,,,,"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117615 , https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114044",,,,U01,,,colon,Not Applicable,single-cell RNA sequencing,,,,,,,Not applicable,,colon,,,,Sage,1,CA215798,"Systems approaches to understanding the relationships between genotype, signaling, and therapeutic efficacy"
5170,196,syn17084053,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29153838,Cell Syst,2018,Unsupervised Trajectory Analysis of Single-Cell RNA-Seq and Imaging Data Reveals Alternative Tuft Cell Origins in the Gut,"Herring CA, Banerjee A, McKinley ET, Simmons AJ, Ping J, Roland JT, Franklin JL, Liu Q, Gerdes MJ, Coffey RJ, Lau KS",U01 CA215798,,,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE102698,,,,U01,,,small intestine,Not Applicable,"single-cell RNA sequencing, mass spectrometry, mathematical modeling",,,,,,,Not Applicable,,small intestine,,,,Sage,1,CA215798,"Systems approaches to understanding the relationships between genotype, signaling, and therapeutic efficacy"
4657,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28319113,Nat Methods,2017,Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions,"Shen JP, Zhao D, Sasik R, Luebeck J, Birmingham A, Bojorquez-Gomez A, Licon K, Klepper K, Pekin D, Beckett AN, Sanchez KS, Thomas A, Kuo CC, Du D, Roguev A, Lewis NE, Chang AN, Kreisberg JF, Krogan N, Qi L, Ideker T, Mali P",U54 CA209891,www.ndexbio.org,,,,,,,,U54,,,"Lung, NOS; Kidney; Ovary",Carcinoma in situ of Bronchus and Lung,CRISPR,,,,,,,heterogeneity/evolution,,"Lung, NOS; Kidney; Ovary",,,,Center,2,CA209891,The Cancer Cell Map Initiative
5031,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29636367,Mol Cancer Ther,2019,Disruption of NSD1 in Head and Neck Cancer Promotes Favorable Chemotherapeutic Responses Linked to Hypomethylation,"Bui N, Huang JK, Bojorquez-Gomez A, Licon K, Sanchez KS, Tang SN, Beckett AN, Wang T, Zhang W, Shen JP, Kreisberg JF, Ideker T",U54 CA209891,,,,,,,,,U54,,,Nasal cavity,Head and Neck Carcinoma,Bisulfite Sequencing; Colorimetric Cell Viability Assay; Dideoxy Chain Termination DNA Sequencing; Whole Exome Sequencing; Whole Transcriptome Sequencing,,,,,,,heterogeneity/evolution,,Nasal cavity,,,,Center,,CA209891,The Cancer Cell Map Initiative
5192,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30209081,Cancer Discov,2019,Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein Network,"Eckhardt M, Zhang W, Gross AM, Von Dollen J, Johnson JR, Franks-Skiba KE, Swaney DL, Johnson TL, Jang GM, Shah PS, Brand TM, Archambault J, Kreisberg JF, Grandis JR, Ideker T, Krogan NJ",U54 CA209891,,,,,,,,,U54,,,Nasal cavity,Head and Neck Carcinoma,Liquid Chromatography Mass Spectrometry; Western Blotting,,,,,,,tumor-immune,,Nasal cavity,,,,Center,,CA209891,The Cancer Cell Map Initiative
4653,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28481362,Nat Methods,2017,Genetic interaction mapping in mammalian cells using CRISPR interference,"Du D, Roguev A, Gordon DE, Chen M, Chen SH, Shales M, Shen JP, Ideker T, Mali P, Qi LS, Krogan NJ",U54 CA209891,,,,,,,,,U54,,,Kidney,Not Applicable,CRISPR,,,,,,,Not Applicable,,Kidney,,,,Center,2,CA209891,The Cancer Cell Map Initiative
4655,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29092941,Cancer Res,2017,NDEx 20: A Clearinghouse for Research on Cancer Pathways,"Pratt D, Chen J, Pillich R, Rynkov V, Gary A, Demchak B, Ideker T",U54 CA209891,www.ndexbio.org,,,,,,,,U54,,,Not Applicable,Pan-cancer,Mathematical Modeling,,,,,,,Not Applicable,,Not Applicable,,,,Center,,CA209891,The Cancer Cell Map Initiative
4952,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29605183,Cell Syst,2019,Systematic Evaluation of Molecular Networks for Discovery of Disease Genes,"Huang JK, Carlin DE, Yu MK, Zhang W, Kreisberg JF, Tamayo P, Ideker T",U54 CA209891,,,,,,,,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,Not Applicable,,Not Applicable,,,,Center,,CA209891,The Cancer Cell Map Initiative
5029,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30077634,Cell Syst,2019,Quantitative Yeast Genetic Interaction Profiling of Bacterial Effector Proteins Uncovers a Role for the Human Retromer in Salmonella Infection,"Patrick KL, Wojcechowskyj JA, Bell SL, Riba MN, Jing T, Talmage S, Xu P, Cabello AL, Xu J, Shales M, Jimenez-Morales D, Ficht TA, de Figueiredo P, Samuel JE, Li P, Krogan NJ, Watson RO",U54 CA209891,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Center,,CA209891,The Cancer Cell Map Initiative
5033,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29932943,J Mol Biol,2018,Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls,"Shen JP, Ideker T",U54 CA209891,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,drug resistance/sensitivity,,Not Applicable,,,,Center,,CA209891,The Cancer Cell Map Initiative
5038,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30017701,J Struct Biol,2018,A simple and robust procedure for preparing graphene-oxide cryo-EM grids,"Palovcak E, Wang F, Zheng SQ, Yu Z, Li S, Betegon M, Bulkley D, Agard DA, Cheng Y",U54 CA209891,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Center,1,CA209891,The Cancer Cell Map Initiative
5052,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29908887,J Mol Biol,2018,The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine,"Ozturk K, Dow M, Carlin DE, Bejar R, Carter H",U54 CA209891,,,,,,,,,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,,CA209891,The Cancer Cell Map Initiative
4654,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29107334,Cell,2017,MHC-I Genotype Restricts the Oncogenic Mutational Landscape,"Marty R, Kaabinejadian S, Rossell D, Slifker MJ, van de Haar J, Engin HB, de Prisco N, Ideker T, Hildebrand WH, Font-Burgada J, Carter H",U54 CA209891,,,,,,,"immunotherapy, tumor-antigens,",,U54,,,Not Applicable,Pan-cancer,Whole Exome Sequencing,,,,,,,heterogeneity/evolution,,Not Applicable,,,"immunotherapy, tumor-antigens,",Center,,CA209891,The Cancer Cell Map Initiative
4656,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=28188128,Cancer Discov,2017,Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer,"Carter H, Marty R, Hofree M, Gross AM, Jensen J, Fisch KM, Wu X, DeBoever C, Van Nostrand EL, Song Y, Wheeler E, Kreisberg JF, Lippman SM, Yeo GW, Gutkind JS, Ideker T",U54 CA209891,,,,,,,"tumor evolution, genetic interactions",,U54,,,Not Applicable,Pan-cancer,Single Nucleotide Polymorphism Array; Whole Exome Sequencing,,,,,,,heterogeneity/evolution,,Not Applicable,,,"tumor evolution, genetic interactions",Center,,CA209891,The Cancer Cell Map Initiative
4940,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29610481,Nat Genet,2018,A global transcriptional network connecting noncoding mutations to changes in tumor gene expression,"Zhang W, Bojorquez-Gomez A, Velez DO, Xu G, Sanchez KS, Shen JP, Chen K, Licon K, Melton C, Olson KM, Yu MK, Huang JK, Carter H, Farley EK, Snyder M, Fraley SI, Kreisberg JF, Ideker T",U54 CA209891,,,,,,,,,U54,,,Skin; Breast,Pan-cancer,Western Blotting; Whole Genome Sequencing; Whole Transcriptome Sequencing,,,,,,,heterogeneity/evolution,,Skin; Breast,,,,Center,,CA209891,The Cancer Cell Map Initiative
5034,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29608663,Bioinformatics,2018,pyNBS: a Python implementation for network-based stratification of tumor mutations,"Huang JK, Jia T, Carlin DE, Ideker T",U54 CA209891,,,,,,,,,U54,,,Not Applicable,Pan-cancer,Whole Exome Sequencing,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,,CA209891,The Cancer Cell Map Initiative
5036,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29949979,Bioinformatics,2019,Classifying tumors by supervised network propagation,"Zhang W, Ma J, Ideker T",U54 CA209891,,,,,,,,,U54,,,Not Applicable,Pan-cancer,Mathematical Modeling,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,,CA209891,The Cancer Cell Map Initiative
5051,196,syn10140998,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=30297789,Nat Commun,2019,Typing tumors using pathways selected by somatic evolution,"Wang S, Ma J, Zhang W, Shen JP, Huang J, Peng J, Ideker T",U54 CA209891,,,,,,,,,U54,,,Not Applicable,Pan-cancer,Whole Exome Sequencing,,,,,,,heterogeneity/evolution,,Not Applicable,,,,Center,,CA209891,The Cancer Cell Map Initiative
4600,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29062065,Sci Rep,2018,A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery,"Wolfram J, Nizzero S, Liu H, Li F, Zhang G, Li Z, Shen H, Blanco E, Ferrari M",U54 CA210181,,,,,,,"biodistribution, drug delivery, nanoparticles, imaging",,U54,,,Breast,Carcinoma in situ of Breast,Liquid Chromatography/Tandem Mass Spectrometry,,,,,,,drug resistance/sensitivity,,Breast,,,,Center,1,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4604,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28416485,Cancer Res,2017,Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity,"Ban Y, Mai J, Li X, Mitchell-Flack M, Zhang T, Zhang L, Chouchane L, Ferrari M, Shen H, Ma X",U54 CA210181,,,,,,,"immunotherapy, flow cytometry, immunohistochemistry",,U54,,,Breast,Carcinoma in situ of Breast,"murine model, flow cytometry, Real Time PCR, IHC",,,,,,,tumor-immune,,Breast,,,,Center,1,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4610,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29290791,Theranostics,2018,A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells,"Liu H, Mai J, Shen J, Wolfram J, Li Z, Zhang G, Xu R, Li Y, Mu C, Zu Y, Li X, Lokesh GL, Thiviyanathan V, Volk DE, Gorenstein DG, Ferrari M, Hu Z, Shen H",U54 CA210181,,,,,,,"DNA aptamer, active targeting, liposome, myeloid-derived suppressor cells (MDSCs), tumor microenvironment, immunotherapy",,U54,,,Breast,Carcinoma in situ of Breast,murine model,,,,,,,microenvironment,,Breast,,,"DNA aptamer, active targeting, liposome, myeloid-derived suppressor cells (MDSCs), tumor microenvironment, immunotherapy",Center,,CA210181,The Center for Immunotherapeutic Transport Oncophysics
5007,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29921732,Clin Cancer Res,2018,Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer,"Mu C, Wu X, Zhou X, Wolfram J, Shen J, Zhang D, Mai J, Xia X, Holder AM, Ferrari M, Liu X, Shen H",U54 CA210181,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,murine model,,,,,,,drug resistance/sensitivity,,Breast,,,,Center,,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4938,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29386574,Sci Rep,2018,Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer,"Tang C, Hobbs B, Amer A, Li X, Behrens C, Canales JR, Cuentas EP, Villalobos P, Fried D, Chang JY, Hong DS, Welsh JW, Sepesi B, Court L, Wistuba II, Koay EJ",U54 CA210181,,,,,,,,,U54,,,"Lung, NOS",Carcinoma in situ of Bronchus and Lung,IHC,,,,,,,"tumor-immune, drug resistance/sensitivity",,"Lung, NOS",,,,Center,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4611,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29325699,J Control Release,2019,Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma,"Zhu M, Ding X, Zhao R, Liu X, Shen H, Cai C, Ferrari M, Wang HY, Wang RF",U54 CA210181,,,,,,,"melanoma, immunotherapy",,U54,,,Skin,Carcinoma in situ of Skin,"IHC, murine model, Confocal Microscopy, ELISA",,,,,,,tumor-immune,,"Lung, NOS",,,"melanoma, immunotherapy",Center,1,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4613,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28231510,Biomaterials,2017,Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination,"Persano S, Guevara ML, Li Z, Mai J, Ferrari M, Pompa PP, Shen H",U54 CA210181,,,,,,,"immunotherapy, mRNA vaccine",,U54,,,Skin,Carcinoma in situ of Skin,"murine model, in vivo Bioluminescence",,,,,,,tumor-immune,,Skin,,,"immunotherapy, mRNA vaccine",Center,1,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4605,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29042320,J Control Release,2018,Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity,"Wu X, Hu Z, Nizzero S, Zhang G, Ramirez MR, Shi C, Zhou J, Ferrari M, Shen H",U54 CA210181,,,,,,,"myelodysplastic syndrome, bone marrow, delivery, nanoparticle, decitabine, arscenic trioxide, imaging, atomic force microscopy, tranmission electron microscopy, scanning electron microscopy, fluorescence microscopy",,U54,,,Bone marrow,"Leukemia, Unspecified",Not Applicable,,,,,,,Not Applicable,,Bone marrow,,,"myelodysplastic syndrome, bone marrow, delivery, nanoparticle, decitabine, arscenic trioxide, imaging, atomic force microscopy, tranmission electron microscopy, scanning electron microscopy, fluorescence microscopy",Center,1,CA210181,The Center for Immunotherapeutic Transport Oncophysics
5193,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30309642,Semin Radiat Oncol,2018,Radiation-Induced Liver Disease and Modern Radiotherapy,"Koay EJ, Owen D, Das P",U54 CA210181,,,,,,,,,U54,,,Liver,Liver and Intrahepatic Bile Duct Carcinoma,Not Applicable,,,,,,,Not Applicable,,Liver,,,,Center,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
5189,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30385724,JCI Insight,2018,Sitravatinib potentiates immune checkpoint blockade in refractory cancer models,"Du W, Huang H, Sorrelle N, Brekken RA",U54 CA210181,,,,,,,,,U54,,,Lung,Lung Non-Small Cell Carcinoma,Not Applicable,,,,,,,tumor-immune,,Lung,,,,Sage,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4599,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28534517,Oncogene,2017,Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth,"Li X, Kang Y, Roife D, Lee Y, Pratt M, Perez MR, Dai B, Koay EJ, Fleming JB",U54 CA210181,,,,,,,"pancreatic adenocarcinoma, imaging, PDX",,U54,,,Pancreas,Malignant Neoplasm of Pancreas,flow cytometry,,,,,,,microenvironment,,Pancreas,,,,Sage,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4602,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28864681,Mol Cancer Ther,2018,Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma,"Aguilera KY, Huang H, Du W, Hagopian MM, Wang Z, Hinz S, Hwang TH, Wang H, Fleming JB, Castrillon DH, Ren X, Ding K, Brekken RA",U54 CA210181,,,,,,,"pancreatic ductal adenocarcinoma, immunohistochemistry",,U54,,,Pancreas,Malignant Neoplasm of Pancreas,"murine model, IHC",,,,,,,drug resistance/sensitivity,,Pancreas,,,"pancreatic ductal adenocarcinoma, immunohistochemistry",Center,,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4607,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29110053,Abdom Radiol (NY),2019,The role of imaging in the clinical practice of radiation oncology for pancreatic cancer,"Koay EJ, Hall W, Park PC, Erickson B, Herman JM",U54 CA210181,,,,,,,"pancreatic cancer, imaging, radiation",,U54,,,Pancreas,Malignant Neoplasm of Pancreas,Not Applicable,,,,,,,Not Applicable,,Pancreas,,,"pancreatic cancer, imaging, radiation",Center,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4608,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29180468,Cancer Res,2018,Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer,"Ludwig KF, Du W, Sorrelle NB, Wnuk-Lipinska K, Topalovski M, Toombs JE, Cruz VH, Yabuuchi S, Rajeshkumar NV, Maitra A, Lorens JB, Brekken RA",U54 CA210181,,,,,,,"pancreatic cancer, Axl, small-molecule inhibitor, immune suppression",,U54,,,Pancreas,Malignant Neoplasm of Pancreas,murine model,,,,,,,"tumor-immune, drug resistance/sensitivity",,Pancreas,,,"pancreatic cancer, Axl, small-molecule inhibitor, immune suppression",Center,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4609,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29200531,Comput Methods Appl Mech Eng,2019,A composite smeared finite element for mass transport in capillary systems and biological tissue,"Kojic M, Milosevic M, Simic V, Koay EJ, Fleming JB, Nizzero S, Kojic N, Ziemys A, Ferrari M",U54 CA210181,,,,,,,"biological tissue, capillary system, composite smeared finite element, convection, diffusion, partitioning, smeared model",,U54,,,Not Applicable,Not Applicable,computational modeling,,,,,,,Not Applicable,,Not Applicable,,,"biological tissue, capillary system, composite smeared finite element, convection, diffusion, partitioning, smeared model",Center,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4612,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29370450,Cancer,2018,Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy,"Amer AM, Zaid M, Chaudhury B, Elganainy D, Lee Y, Wilke CT, Cloyd J, Wang H, Maitra A, Wolff RA, Varadhachary G, Overman MJ, Lee JE, Fleming JB, Tzeng CW, Katz MH, Holliday EB, Krishnan S, Minsky BD, Herman JM, Taniguchi CM, Das P, Crane CH, Le O, Bhosale P, Tamm EP, Koay EJ",U54 CA210181,,,,,,,"pancreatic cancer, clinical trial",,U54,,,Pancreas,Malignant Neoplasm of Pancreas,computed tomography,,,,,,,Not Applicable,,Pancreas,,,"pancreatic cancer, clinical trial",Center,,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4936,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29602802,Clin Cancer Res,2019,SMAD4 gene mutation renders pancreatic cancer resistance to radiotherapy through promotion of autophagy,"Wang F, Xia X, Yang C, Shen J, Mai J, Kim HC, Kirui D, Kang Y, Fleming JB, Koay EJ, Mitra S, Ferrari M, Shen H",U54 CA210181,,,,,,,,,U54,,,Pancreas,Malignant Neoplasm of Pancreas,"flow cytometry, shrna",,,,,,,drug resistance/sensitivity,,Pancreas,,,,Center,,CA210181,The Center for Immunotherapeutic Transport Oncophysics
5013,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30082477,Clin Cancer Res,2019,A visually apparent and quantifiable CT imaging feature identifies biophysical subtypes of pancreatic ductal adenocarcinoma,"Koay EJ, Lee Y, Cristini V, Lowengrub JS, Kang Y, San Lucas FA, Hobbs BP, Ye R, Elganainy D, Almahariq M, Amer AM, Yu S, Chatterjee D, Yan H, Park PC, Rios Perez MV, Li D, Garg N, Reiss K, Chauhan A, Zaid MM, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MHG, Wang H, Bhosale P, Tamm EP, Fleming JB",U54 CA210181,,,,,,,,,U54,,,Pancreas,Malignant Neoplasm of Pancreas,computed tomography,,,,,,,Not Applicable,,Pancreas,,,,Center,,CA210181,The Center for Immunotherapeutic Transport Oncophysics
5117,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30333153,Mol Cancer Res,2019,Cyclooxygenase-2 inhibition potentiates the efficacy of vascular endothelial growth factor blockade and promotes an immune stimulatory microenvironment in preclinical models of pancreatic cancer,"Zhang Y, Kirane A, Huang H, Sorrelle NB, Burrows FJ, Dellinger MT, Brekken RA",U54 CA210181,,,,,,,,,U54,,,Pancreas,Malignant Neoplasm of Pancreas,,,,,,,,drug resistance/sensitivity,,Pancreas,,,,Center,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
5147,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30244621,Expert Opin Ther Targets,2019,Does Axl have potential as a therapeutic target in pancreatic cancer?,"Du W, Brekken RA",U54 CA210181,,,,,,,,,U54,,,Pancreas,Malignant Neoplasm of Pancreas,"CRISPR, murine model, flow cytometry, IHC,",,,,,,,Not Applicable,,Pancreas,,,,Center,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
5202,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30198024,Ann Pancreat Cancer,2018,"Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy","Ng SP, Koay EJ",U54 CA210181,,,,,,,,,U54,,,Pancreas,Malignant Neoplasm of Pancreas,Radiotherapy,,,,,,,Not Applicable,,Pancreas,,,,Center,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4597,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28719856,Colloids Surf B Biointerfaces,2018,Contribution of Kupffer cells to liposome accumulation in the liver,"Samuelsson E, Shen H, Blanco E, Ferrari M, Wolfram J",U54 CA210181,,,,,,,"biodistribution, drug delivery, nanoparticles",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Center,1,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4601,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28522922,Mater Today (Kidlington),2018,Taking the vehicle out of drug delivery,"Shen J, Wolfram J, Ferrari M, Shen H",U54 CA210181,,,,,,,comment,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,drug resistance/sensitivity,,Not Applicable,,,comment,Center,,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4603,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28947107,Semin Immunol,2018,Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells,"Shen H, Sun T, Hoang HH, Burchfield JS, Hamilton GF, Mittendorf EA, Ferrari M",U54 CA210181,,,,,,,"immunotherapy, review, nanotechnology",,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,tumor-immune,,Not Applicable,,,"immunotherapy, review, nanotechnology",Center,1,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4606,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28392183,J Theor Biol,2018,Evaluating the influence of mechanical stress on anticancer treatments through a multiphase porous media model,"Mascheroni P, Boso D, Preziosi L, Schrefler BA",U54 CA210181,,,,,,,"mathematical modeling, drug efficacy",,U54,,,Not Applicable,Not Applicable,Mathematical Modeling,,,,,,,drug resistance/sensitivity,,Not Applicable,,,,Sage,,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4961,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29182964,Comput Biol Med,2019,Mass release curves as the constitutive curves for modeling diffusive transport within biological tissue,"Kojic M, Milosevic M, Kojic N, Koay EJ, Fleming JB, Ferrari M, Ziemys A",U54 CA210181,,,,,,,,,U54,,,Pancreas,Malignant neoplasm of pancreas,Not Applicable,,,,,,,microenvironment,,Not Applicable,,,,Center,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4965,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=29782608,J Serbian Soc Comput Mech,2017,Extension of the composite smeared finite element (CSFE) to include lymphatic system in modeling mass transport in capillary systems and biological tissue,"Kojic M, Milosevic M, Simic V, Koay EJ, Kojic N, Ziemys A, Ferrari M",U54 CA210181,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,microenvironment,,Not Applicable,,,,Sage,2,CA210181,The Center for Immunotherapeutic Transport Oncophysics
5196,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30382084,Nat Commun,2018,Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics,"Dogra P, Adolphi NL, Wang Z, Lin YS, Butler KS, Durfee PN, Croissant JG, Noureddine A, Coker EN, Bearer EL, Cristini V, Brinker CJ",U54 CA210181,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,drug resistance/sensitivity,,Not Applicable,,,,Sage,1,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4598,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28648185,Trends Mol Med,2017,Exosomes as Reconfigurable Therapeutic Systems,"Conlan RS, Pisano S, Oliveira MI, Ferrari M, Mendes Pinto I",U54 CA210181,,,,,,,"review, exosomes",,U54,,,Not Applicable,Pan-cancer,Not Applicable,,,,,,,drug resistance/sensitivity,,Not Applicable,,,,Sage,,CA210181,The Center for Immunotherapeutic Transport Oncophysics
4614,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=28025978,Cell Res,2017,Immune targets and neoantigens for cancer immunotherapy and precision medicine,"Wang RF, Wang HY",U54 CA210181,,,,,,,"immunotherapy, review",,U54,,,Not Applicable,Pan-cancer,Not Applicable,,,,,,,"drug resistance/sensitivity, tumor-immune",,Not Applicable,,,"immunotherapy, review",Sage,,CA210181,The Center for Immunotherapeutic Transport Oncophysics
5126,196,syn7349757,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30133130,Mol Oncol,2018,Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors,"Rye IH, Trinh A, Saetersdal AB, Nebdal D, Lingjaerde OC, Almendro V, Polyak K, Brresen-Dale AL, Helland , Markowetz F, Russnes HG",,,,,,,,,,U54,,,Breast,Carcinoma in situ of Breast,FISH,,,,,,,heterogeneity/evolution,,Breast,,,,Sage,,CA193461,Dana-Farber Cancer Institute Physical Sciences-Oncology Center
5178,196,syn7349762,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30152073,Cancer Med,2018,Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma,"Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ",,,,,,,,,,U54,,,Liver,Liver and Intrahepatic Bile Duct Carcinoma,Not Applicable,,,,,,,drug resistance/sensitivity,,Liver,,,,Sage,,CA210181,The Center for Immunotherapeutic Transport Oncophysics
5014,196,syn7349764,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30003344,Pharm Res,2018,Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine,"Kim M, Kizilbash SH, Laramy JK, Gampa G, Parrish KE, Sarkaria JN, Elmquist WF",,,,,,,,,,U54,,,Not Applicable,Malignant Neoplasm of Brain,Not Applicable,,,,,,,drug resistance/sensitivity,,Not Applicable,,,,Sage,,CA210180,MIT Mayo Physical Sciences Center for Drug Distribution and Drug Efficacy in Brain Tumors
4970,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29846762,Curr Genet,2018,Mechanisms for the epigenetic inheritance of stress response in single cells,"Xue Y, Acar M",,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
4980,196,syn9773338,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29871632,BMC Biol,2018,Harnessing single-cell genomics to improve the physiological fidelity of organoid-derived cell types,"Mead BE, Ordovas-Montanes J, Braun AP, Levy LE, Bhargava P, Szucs MJ, Ammendolia DA, MacMullan MA, Yin X, Hughes TK, Wadsworth MH 2nd, Ahmad R, Rakoff-Nahoum S, Carr SA, Langer R, Collins JJ, Shalek AK, Karp JM",,,https://www.omicsdi.org/dataset/massive/MSV000081369,,,https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE100274,,,,U54,,,Small intestine,Not Applicable,"Single Cell RNA-Sequencing, Liquid Chromatography/Tandem Mass Spectrometry, Confocal Microscopy",,,,,,,heterogeneity/evolution,,Small intestine,,,,Center,2,CA217377,Quantitative and Functional Characterization of Therapeutic Resistance in Cancer
4995,196,syn7315810,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29872908,Curr Genet,2018,Scarless genome editing: progress towards understanding genotype-phenotype relationships,"Elison GL, Acar M",,,,,,,,,,U54,,,Not Applicable,Not Applicable,Not Applicable,,,,,,,Not Applicable,,Not Applicable,,,,Sage,,CA209992,Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
5019,196,syn9775665,CSBC,https://www.ncbi.nlm.nih.gov/pubmed/?term=29738558,PLoS One,2018,Inflammatory signatures distinguish metabolic health in African American women with obesity,"Denis GV, Sebastiani P, Bertrand KA, Strissel KJ, Tran AH, Slama J, Medina ND, Andrieu G, Palmer JR",,,,,,,,,,U01,,,Breast,Carcinoma in situ of Breast,Fluorescent Antibody Procedure,,,,,,,metabolism,,Breast,,,,Sage,,CA182898,CSBC U01 Project Boston University
5156,196,syn7349742,PS-ON,https://www.ncbi.nlm.nih.gov/pubmed/?term=30143891,Chromosome Res,2018,Condensin controls mitotic chromosome stiffness and stability without forming a structurally contiguous scaffold,"Sun M, Biggs R, Hornick J, Marko JF",,,,,,,,,,U54,,,Not Applicable,Not Applicable,Fluorescence Microscopy,,,,,,,mechanobiology,,Not applicable,,,,Sage,3,CA193419,Chicago Region Physical Science Oncology Center